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MAIN ABSTRACT 
Background Severe idiopathic constipation is a disorder that can significantly 
impair Quality of Life (QOL). Idiopathic constipation refers to the situation where no 
organic, biochemical, structural, endocrine or neurological explanations can be found 
to account for symptoms. 
Little is known about the factors that predict poor QOL in such patients. The 
pathophysiological processes involved are not fully understood, particularly with 
reference to subsets of patients defined by their symptoms (such as the urge to 
defecate). A proportion of patients remain unresponsive to treatment with life style 
changes, high fibre diet, laxatives and non-invasive therapies. They can be regarded 
as having severe refractory idiopathic constipation. They may ultimately be 
considered for surgical intervention. 
The main aims of this thesis were to examine three key themes regarding severe 
refractory idiopathic constipation; 
1) To identify factors that can predict disease-specific QOL. 
2) To explore the pathophysiology of the urge to defecate and determine whether 
there are differences between patient groups defined by this symptom. 
3) To prospectively evaluate the efficacy of a novel therapy that is a potential 
alternative to surgery. 
Predictors of Disease specific QOL: This study involved gathering data with QOL 
questionnaires (PAC-QOL and SF-36). Before identifying predictors, it was 
necessary to evaluate the psychometric properties (validity and reliability) of the 
QOL measures. It was important to confirm that their use was appropriate in patients 
with severe refractory idiopathic constipation. Confirming the psychometric 
properties of the measures was a prerequisite secondary aim of the study. 
Determining predictors of poorer QOL could enable clinicians to identify patients in 
whom the impact and severity of constipation is greatest. Predictors could be used to 
target therapies to those with greatest need. The relationships between demographics, 
15 
symptoms assessed by clinician, symptoms assessed by the patient, results of 
objective tests and the patient's perception of health were studied. 
Psychometric testing of the QOL and health perception measures validated their use 
in patients with severe refractory idiopathic constipation. Multiple linear regression 
suggested that symptom intensity assessed by the patient and patient perception of 
mental health were the main predictors of disease specific QOL. With these results in 
mind, it is possible that therapeutic strategies that reduce symptoms and address 
problems of mental health may improve QOL. 
Pathophysiology of the urge to defecate: Approximately 60% of patients with 
idiopathic constipation have a reduced rectal urge to defecate (RRUD). They may 
represent a distinct group with differences in the properties and motility of the ano- 
rectum including a reduced frequency of the sampling reflex. This reflex describes 
relaxation of the anal sphincter allowing rectal contents to come into contact with 
sensory receptors in the proximal anal canal prior to defecation. 
The frequency of sampling events in patients with reduced urge and normal rectal 
urge to defecate (NRUD) was measured in a prospective comparative study using 
solid state, semi-ambulatory continuous anorectal manometry. The mean frequency 
of sampling events was 8.91/hr (sd 5.9) in the normal rectal urge group and 8.77/hr 
(sd 7.2) in the reduced urge group (NS). No differences in anorectal sensation or 
colonic transit time were found. 
The explanation for the noticeable division of patients into those with NRUD and 
RRUD remains unclear. Frequency of sampling is no different between the groups 
and is unlikely that sampling dictates a RRUD. Further study is required to evaluate 
the role of other potential determinants such as rectal compliance, rectosigmoid 
motility and central processing of sensory perceptions. 
Evaluation of a novel therapy: Percutaneous Endoscopic Colostomy (PEC) in the 
left colon is a minimally invasive endoscopic technique that can be used to irrigate 
the left colon and relieve constipation. The technique offers a potential alternative to 
16 
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surgery in severe cases. The aim was to perform a prospective efficacy study in 
refractory idiopathic constipation. 
The initial step was a retrospective data analysis of patients who had PEC inserted at 
our unit over a four year period. This is presented in the thesis. The results were to be 
used to inform the design of a prospective study. Over the 4 year period 31 patients 
attended for PEC. Indications included idiopathic constipation, recurrent sigmoid 
volvulus, colonic pseudo-obstruction and neurological constipation. Although 
symptoms were improved in the majority of patients and recurrent sigmoid volvulus 
prevented, complications were common. Infection and abdominal pain necessitated 
the removal of PEC in the majority of patients. Patients with refractory idiopathic 
constipation were particularly susceptible to these complications. Two deaths 
occurred due to faecal peritonitis occurring after insertion. 
Insertion was associated with significant morbidity and mortality. The widespread 
use of PEC is not recommended and insertion should be restricted to specially 
selected cases. The results did not support the initiation of a prospective study of 
efficacy. Consequently, this aim of the thesis was not fulfilled. 
Conclusions By producing this thesis, predictors of disease specific QOL have been 
identified. These predictors could be studied in future hypothesis testing studies of 
QOL. Experience has been gained in the use of physiological techniques that could 
be utilised in further studies of pathophysiology in idiopathic constipation. 
Evaluation of PEC has added valuable information to the existing literature and has 
directly influenced clinical practice. 
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THESIS INTRODUCTION 
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1.1 Background 
Constipation is a common but heterogeneous digestive disorder defined by the 
presence of symptoms. These symptoms can include infrequent defecation, passage 
of hard stool, straining, sensations of incomplete evacuation, using manual 
manoeuvres to facilitate defecation and abdominal fullness or discomfort 1.3 
In Europe the prevalence in the self reported adult population is between 6 and 23% 
4. Hanay described an "iceberg of symptoms" where the majority of gastrointestinal 
symptoms experienced by individuals do not become the subject of medical 
consultation 5. However, a proportion of patients with constipation will present to 
primary care with an estimated 3 million consultations to general practice per annum 
in theUK6. 
A proportion of these patients remain refractory to treatment with life style changes, 
high fibre diet and laxatives. Causes of refractory constipation include mechanical 
obstruction, neurological disease, anatomical abnormalities of the anorectum, 
idiopathic constipation, systemic diseases or adverse effects of medication. Such 
patients may be referred to secondary / tertiary care, either because of the condition 
precipitating constipation (such as neurological disease e. g. Multiple Sclerosis) or 
because of the burden of constipation symptoms and the affect this has on quality of 
life. 
In an audit of new referrals to the specialist constipation clinic at University Hospital 
North Durham, constipation was found to be idiopathic in 79% of cases 7. The clinic 
was established to deal with cases of refractory constipation referred from the North 
Eastern region. The referrals represent a distinct group compared to those whose 
symptoms can be self controlled or managed within primary care or less specialised 
secondary care clinics. 
The clinic provides an opportunity to study refractory idiopathic constipation and to 
explore several key areas. These include; the effect of symptom intensity and 
pathophysiological factors (such as colonic transit) on constipation severity and its 
impact on quality of life; the pathophysiology of the condition in subgroups defined 
by their urge to defecate and finally; the role of Percutaneous Endoscopic 
20 
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Colostomy. This is a novel treatment that may represent an alternative to surgery in 
refractory idiopathic constipation. 
1.2 Definition of constipation 
In 1982, Drossman et al proposed a general definition of constipation that refers to 
two or fewer stools per week and / or straining at stool more than 25% of the time 8. 
In a recent review the American College of Gastroenterology described constipation 
as "a symptom based disorder defined as unsatisfactory defecation and is 
characterised by infrequent stools, difficult stool passage, or both. Difficult stool 
passage includes straining, a sense of difficulty passing stool, incomplete evacuation, 
hard /lumpy stools, prolonged time to stool or need for manual manoeuvres to pass 
stool" 
9. 
Definitions for idiopathic or functional constipation (where no organic, biochemical, 
structural, endocrine or neurological explanations can be found to account for 
symptoms) are enshrined in the Rome criteria for Functional Gastrointestinal 
Disorders. These criteria were initially proposed at the 13th International Congress of 
Gastroenterology in Rome, Italy in 1988. They have been refined over time; 1999, 
Rome II criteria 10 and more recently 2006, Rome III criteria 11. These criteria have 
been applied in research settings but it is recognised that in the clinical setting they 
can have limitations 12. 
In this thesis the Rome II criteria were utilised because recruitment of subjects began 
before the release of the Rome III consensus document. The Rome II criteria 
recognise symptoms of constipation occurring in three categories of functional 
gastrointestinal disorders including; Constipation predominant Irritable Bowel 
Syndrome (IBS-C), Functional Constipation (FC) and Pelvic Floor Dyssynergia 
(PFD), (Figure 1). 
It has been suggested that in practice a clearly delineating patients with Irritable 
Bowel Syndrome (IBS-C) and Functional Constipation (FC) can be difficult because 
9 
. of symptom overlap 
between these categories , 12,13 
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Figure 1: Rome II diagnostic categories with constipation 
Diagnostic criteria for Constipation predominant Irritable Bowel 
Syndrome (IBS) 
At least 12 weeks, which need not be consecutive, in the preceding 12 
months of abdominal discomfort or pain that has two or more of three 
features; 
(1) Relived with defecation; and / or 
(2) Onset associated with a change in frequency of stool; and / or 
(3) Onset associated with a change in form (appearance) of stool 
With one or more features supportive of constipation predominance; 
Fewer than 3 defecations per week 
Lumpy or hard stools 
Straining during bowel movement 
Diagnostic criteria for Functional Constipation (FC) 
At least 12 weeks, which need not be consecutive, in the preceding 12 
months of two or more of; 
(1) Straining in more than 25% of defecations; 
(2) Lumpy or hard stools in more than 25% of defecations; 
(3) Sensation of incomplete evacuation in more than 25% of defecations; 
(4) Sensation of anorectal obstruction/blockade in more than 25% of 
defecations; 
(5) Manual manoeuvres to facilitate in more than 25% of defecations e. g. 
(digital evacuation, support of the pelvic floor) and/or 
(6) <3 defecations /week 
Loose stools are not present and there are insufficient criteria for IBS 
Diagnostic criteria for Pelvic Floor Dyssynergia (PFD) 
(1) The patient must satisfy diagnostic criteria for Functional 
Constipation (above); 
(2) There must be manometric, EMG or radiological evidence for 
inappropriate contraction or failure to relax the pelvic floor muscles 
during repeated attempts to defecate; 
(3) There must be evidence of adequate propulsive forces during 
attempts to defecate; and; 
(4) There must be evidence of incomplete evacuation 
Loose stools are not present and there are insufficient criteria for IBS 
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1.3 Aetiology of constipation 
The symptom of constipation has multiple aetiologies (Table 1). The colon is subject 
to both intrinsic and extrinsic factors that affect function. Dietary fibre deficiency is 
recognised as a common cause of mild to moderate constipation. Social factors, such 
ease of access to toileting facilities, should be considered. In the elderly, mobility 
issues that can inhibit evacuation should be considered. Endocrinological causes such 
as hypothyroidism must be considered although in young and middle aged women 
the prevalence of hypothyroidism appears to be low 
14. Furthermore, approximately 
70% of patients with hypothyroidism actually defecate at least every other day 
is 
Primary abnormalities of the central, autonomic and peripheral nervous system can 
produce constipation. 
A distinction can made between constipation where a biochemical, endocrinological, 
structural or primary neurological cause can be found and constipation of an 
idiopathic origin. As stated in section 1.2 diagnostic criteria exist for the 
classification of idiopathic or functional constipation. This thesis concerns refractory 
idiopathic constipation. 
Slow transit colonic constipation refers to a disorder of colonic motility characterised 
by reduced frequency, amplitude and duration of propulsive contractions in the large 
bowel. Pathophysiological differences in colonic function have been identified in 
patients with normal transit and slow transit. In slow transit constipation, the colon 
is hypersensitive to cholinergic stimulation 16, may have greater innervation by non- 
cholinergic inhibitory nerves 17 and in the postprandial state be characterised by 
increased secretion of proximal gut hormones 18. 
Another aetiology is disordered defecation. This description, often used 
synonymously with outlet obstruction, obstructed defecation, disordered defecation, 
etc, can be due to weakness or impaired coordination of the pelvic floor muscles 19. 
Paradoxical pelvic floor or sphincter contraction (or inadequate relaxation) during 
defecation may cause a functional or idiopathic outlet obstruction 20. This problem 
1 has also been termed as anismus or pelvic floor dyssynergia , 21 
In many cases the precise pathophysiological cause of disordered defecation may not 
be clear. Furthermore, slow colonic transit may coexist in patients with disordered 
23 
defecation. Abnormalities of colonic motility (evidenced by reduced amplitude of 
propagating pressure waves) can be demonstrated in patients with obstructed 
22 defecation 
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Table 1: Aetiology of constipation 
Dietary Inadequate fibre 
Immobility 
Social factors Environmental changes (hospitalisation) Ignoring call to stool 
Increasing age 
Endocrine and 
Hypothyroidism Hypokalaemia Lead poisoning 
Metabolic Hypercalcaemia Pregnancy Porphyria 
Hypopituitarism 
Central Nervous CVA Multiple Sclerosis 
System Pathology 
Autonomic Nervous Parkinson's disease Multiple Sclerosis 
System Pathology Diabetes 
Drugs 
Iron Supplement Anticholinergics Opioids 
Anti-depressants Calcium channel blockers 
Psychiatric Depression Psychoses Anorexia nervosa 
Colonic stricture 
Structural Neoplastic 
Intussusception 
Volvulus 
Constipation predominant IBS " 
Gastrointestinal Idiopathic Functional Constipation * Slow transit colonic constipation 
Normal transit colonic constipation 
Intestinal pseudo-obstruction 
Other Hirschsprung's Disease 
Mega colon / Mega rectum 
Anal stenosis 
Anal fissure 
Structural Rectocoele 
Enterocoele 
Disordered Defecation Pelvic floor weakness 
Anismus 
Idiopathic Outlet obstruction 
Pelvic Floor Dyssynergia " 
* Rome II criteria 
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1.4 Prevalence and epidemiology of constipation 
Constipation is a prevalent problem within the UK. In 2006 in England, more than 12 
million prescriptions for laxatives were written by GP's 23. The prevalence of 
constipation will vary depending on what definition is used. In the North American 
population prevalence of self reported constipation was 27.2%. However, when the 
Rome II criteria were applied prevalence was only 14.9% 24. Geographical and 
cultural variation may also occur, with prevalence varying between countries. In a 
survey of European subjects Stanghellini et al found that in the UK, self reported 
prevalence was 6% whilst in Germany prevalence was 10% and in Italy 23%4 . Age- 
related increases in the prevalence of constipation have been demonstrated in both 
men and women. Prevalence is also found to be greater in females compared to 
males 25. In addition to age and sex, social class also affects prevalence, with 
constipation occurring more frequently in men and women from lower rather than 
higher social classes 26. 
Increased prevalence has also been demonstrated in patients with concurrent 
psychiatric disorders (affective psychoses, schizophrenia and depression) 27. The 
association with psychiatric morbidity is likely to be multi-factorial with direct action 
on GI tract physiology or the impact of medications contributing to constipation. 
In addition to the above epidemiological observations, it has been suggested that 
constipation is more common in women who have undergone hysterectomy or 
abdominal-pelvic surgery 28,29. It is hypothesised that such surgery (and even in 
childhood appendectomy) precipitates abnormalities of autonomic innovation 28 
Furthermore, it has been suggested that vaginal delivery and caesarean section during 
labour, have been associated pudendal nerve damage (possibly due to significant 
stretching of the pelvic floor tissue) and pelvic autonomic nerve dysfunction 30,31 
Childbirth has been associated with the development of rectocoele, a recognised 
cause of evacuatory difficulties and constipation. Dietz et at prospectively studied 
nulliparous pregnant females before delivery. Pre-delivery rectocoeles were not 
uncommon. Vaginal delivery increased the size of pre-existing rectocoeles but also 
led to new rectocoeles. However, only a small proportion of the rectocoeles post- 
delivery was associated with symptoms of constipation 32. 
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Prospective studies of the effect of childbirth on the prevalence and incidence of 
constipation (controlled against the background general population) are lacking. 
However, the importance of obtaining a history of pelvic-abdominal surgery and 
childbirth is stressed by authors 31,33 Shytt et al have demonstrated that constipation 
was problematic for 20% of women after childbirth when assessed at two months 
after delivery 34. In this study no comparison of prevalence in age matched non- 
pregnant females was made. Our own experience in the constipation clinic is that 
childbirth and pelvic-abdominal surgery (including caesarean section and 
hysterectomy) are triggers for the onset or deterioration of severe constipation in up 
to a third of patients. 
1.5 Assessment of constipation 
A patient centred approach is required. The exclusion of organic disease is necessary, 
particularly if patients are to be recruited into studies of idiopathic or functional 
constipation. The choice of investigation must reflect the fact that constipation is a 
heterogeneous condition that can be caused by multiple pathophysiologies. 
Clinical examination 
Assessment includes physical examination to detect evidence of systemic disease. 
Anorectal examination may reveal anal stricture, anal fissure, colorectal masses or 
rectal blood. During rectal examination, perianal descent during straining can be 
estimated. Anal sphincter tone at rest and squeeze can also be assessed. Rectocoele 
may be detected during this examination. 
Relaxation of the external sphincter and perianal descent can be evaluated by 
simulated defection during per rectum examination. Abnormalities during this 
examination may suggest disordered defecation. 
In those patients with a primary neurological diagnosis (such as multiple sclerosis or 
spinal cord injury) assessment may include examination of the relevant motor and 
sensory systems. 
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Assessment of symptom severity 
Self-report of symptoms may be influenced by subjectivity on the part of the patient. 
Stool diaries can be prone to inaccuracy and may not correspond with recognised 
definitions of constipation 35. The possibility of quantifying severity of constipation 
using scoring systems has been explored. The Cleveland Clinic score was developed 
by Agachen et al and assesses the duration of constipation and the severity of key 
symptoms 36. The results from the questions can be expressed as a cumulative score, 
with a higher score representing more severe symptoms. Damon et al have 
previously found a moderate correlation between the cumulative Cleveland Clinic 
Score and QOL 37. Knowles et al validated an 11 point system of different symptoms 
(Knowles Eccersley Scoring System, KESS) that could be used to score the severity 
of constipation 38. However, this system has not been widely used in the literature. 
Psychological profile 
Psychiatric illness (such as depression, obsessive compulsive disorder and anorexia 
nervosa) has been recognised as a risk factor for constipation 39. Mason et al have 
demonstrated that female patients with constipation have significantly increased 
psychological and social morbidity (expressed as anxiety, depression, and social 
dysfunction) compared to healthy women 40. Recognising such factors is important 
and some authors have recommended psychological assessment for patients 
attending with refractory constipation 
41. Furthermore, psychological status may also 
influence response to treatment 42. 
Quality of life 
Considering the effect of constipation on quality of life (QOL) can be an important 
part of assessing the overall impact of the disorder on the patient. Overall QOL in 
idiopathic constipation has been shown to be lower than that of the normal 
population 42. Increased reporting of fatigue, headaches and dizziness has been 
demonstrated in patients with Functional Constipation 43 and has been linked with 
absenteeism from work. 
Biochemistry 
A clinical index of suspicion will prompt laboratory blood testing that can be used to 
exclude organic causes of constipation. 
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Visualisation of the colon 
The role of endoscopic visualisation of the colon in the assessment of constipation is 
controversial. The American Gastroenterology Association position statement 
recommends that structural evaluation of the colon is indicated 44. In contrast, the 
American Society of Gastrointestinal Endoscopy document on indications for 
flexible sigmoidoscopy and colonoscopy does not include constipation as an 
as indication 
Pepin et al evaluated the diagnostic yield of colonoscopy and flexible sigmoidoscopy 
in patients in whom the procedures were performed because of constipation. They 
suggested that chronic constipation alone was not an appropriate indication for lower 
endoscopy. The polyp and neoplasia pick up rate in subjects where the indication 
was constipation were comparable to that expected in asymptomatic subjects 
undergoing surveillance procedures 
46. The utility of barium enema examination has 
not been studied in detail. Patriquin et al used barium enema in a selected group of 
62 patients with chronic constipation, however this modality did not demonstrate any 
unexpected organic lesions 
47. 
Whilst debate exists about the utility of visualising the colon in clinical practice, such 
investigation may form the basis of inclusion criteria for studies of functional or 
idiopathic constipation. 
Proctography 
A defecating proctogram can provide information about the anatomy of the pelvic 
floor. Proctography can be used to investigate disordered defecation. Proctographic 
parameters form part of the diagnostic criteria for Pelvic Floor Dyssynergia (PFD) in 
the Rome II criteria and for Dyssynergic Defecation in Rome III ýýý 1 
Defecating proctography can be used to diagnose rectocoele or enterocoele. The 
technique can provide data regarding the size and impact of a rectocoele on 
evacuation 48. The reported prevalence of rectocoeles in idiopathic or functional 
constipation varies within the literature (between 9 and 71% 49"51). Radiographic and 
scintigraphic proctography remain the mainstay of investigation of rectocoele, 
although techniques using Magnetic Resonance Imaging continue to evolve 52. 
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Colonic transit studies 
Colonic transit time can be measured using two methods; ingestion of radio-opaque 
markers followed by plain abdominal X-rays or by using scintigraphy. 
Radio-opaque marker studies are relatively inexpensive to perform (compared to 
other tests of gut motility) and are widely available. Comparison with norm 
referenced data allows arbitrary classifications to be made of what constitutes slow 
colonic transit in constipated patients 53. It has been suggested that the distribution of 
markers can be used to identify different subtypes of constipation' 
1. 
In scintigraphic transit studies, Indium-111 diethylenetriamine penta-acetic acid 
(DTPA) is ingested and the abdomen scanned using a gamma camera. Segmental 
and total transit can be calculated. 
Physiological studies 
Anorectal manometry provides an objective method of assessing physiology of the 
anorectal sphincter in evacuation. The presence of the rectal anal inhibitory reflex 
can be used to exclude Hirschsprung's disease. Balloon expulsion studies and pelvic 
floor and sphincter electromyography (EMG) studies may also be employed to assess 
the physiology of defecation 54 
However, controversy exists as to whether the results of physiological studies alter 
decision making or whether the tests have clinical utility 55,56. Methodological 
differences exist between units, and reference values for normality and disease states 
are not universally agreed. In recognition of these issues, guidelines for anorectal 
physiology testing have been produced 
57. A further criticism is that anorectal 
physiology testing performed in the left lateral position in a laboratory does not 
reflect the true physiological state of the subject. This observation has led some 
authors to postulate that anismus is in fact over diagnosed 
58 59. Evolving techniques 
in the field of anorectal manometry include the use of ambulatory manometry and 
, 60 54,60 planimetry 
Colonic manometry studies have increased knowledge regarding evacuation. Low 
amplitude non-propagating pressure waves and high amplitude propagating waves 
have been observed in the period prior to defecation using manometry catheters 
placed transnasally or at colonoscopy 61-63. Abnormalities of colonic physiology have 
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been documented in constipated individuals; Dinning et al demonstrated that patients 
with obstructed defecation lacked the normal predefecatory augmentation in 
frequency and amplitude of propagating pressure waves 22. They postulated that 
these abnormalities contributed to an inability to effectively expel stool. 
Role of diagnostic test in constipation 
Many of the above investigations are recommended in published guidelines for the 
evaluation of constipated patients 44. They have a role in excluding organic causes 
and exploring physiology in idiopathic and functional cases of constipation. 
However, it is not clear whether these investigations provide data that predicts the 
severity of the patient's constipation as measured by their quality of life. This theme 
will be discussed further in section 2. 
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1.6 Management of constipation 
The approach to management is currently divided into established treatments and 
evolving or novel therapies that had been developed within recent years. The 
evidence base behind many of the established treatments is limited. The following 
section provides a brief overview. 
A review of the effectiveness of treatment is available from the BMJ Clinical 
Evidence resource M. The original search date was 2003 although the publication is 
continually updated. Table 2 summarises the key outcomes. The American College 
of Gastroenterology has also published a review of therapies that in addition to 
lifestyle and laxatives also considered Tegaserod 9. 
The BMJ Clinical Evidence resource categorises the effects of treatments along a 
spectrum that includes beneficial treatments through to treatments likely to be 
ineffective or harmful. Categorisation is determined by the level of benefit (or harm) 
of an intervention, the level of evidence (RCT or observational data) and the level of 
certainty around the findings of the studies. Beneficial interventions are those where 
effectiveness has been demonstrated by clear evidence from well designed RCT. 
Regarding the evaluation of constipation treatments; only a minority of interventions 
fell into the beneficial category (Macrogols). The majority of interventions were 
categorised as being likely to be beneficial or of unknown effectiveness. Here the 
effectiveness is less well established (e. g. lacking in large well designed RCT 
evidence) or assessment of effectiveness is based on insufficient data or data of 
inadequate quality. The Evaluation undertaken by the BMJ Clinical Evidence 
resource illustrates that the evidence base behind many of the common therapies is 
not great. If the example of bisacodyl, a stimulant laxative, is considered; at the time 
of the evaluation no systematic reviews of the drug had been produced. Only one 
small RCT existed. This studied a small cohort of only 55 people (aged 19 to 89 
years) with acute idiopathic constipation. The RCT compared 10 mg of bisacodyl 
once daily for three successive days versus placebo. The period of evaluation and 
follow up was very short (3 days only). Bisacodyl significantly increased stool 
. 
frequency and stool consistency compared to placebo. The drug was well tolerated 65 
The application of these results for management of patients in the constipation clinic 
is difficult. Firstly, our cohort has chronic rather than acute symptoms, secondly the 
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patients require long term treatment and thirdly they generally already use a laxative 
and indeed often use multiple laxatives. Comparison of a therapy with placebo does 
not reflect the reality that our patients use multiple laxatives. Such deficiencies in the 
evidence base are being addressed (for example, Kienzele-Horn et al have compared 
bisacodyl and sodium picosulphate in subjects with chronic constipation 66) however, 
evidence is still lacking to support the effectiveness of other interventions (such as 
lifestyle and dietary modification) in patients with severe chronic idiopathic 
constipation. 
A therapeutic trial of fibre is often encouraged at the initial presentation of patients 
with idiopathic constipation (either as increased dietary fibre or prescribed fibre 
supplements). It is likely that fibre increases stool bulk and plasticity, so increasing 
colonic distension and increasing colonic transit through increased propulsive 
activity. However, side effects (bloating and flatulence) limit effectiveness. Many 
patients presenting to a specialist constipation clinic have already failed to improve 
with additional fibre and laxatives. Such failure often prompts further investigation 
of pelvic floor function and colonic transit. 
Lifestyle may affect constipation and generally patients are advised to avoid ignoring 
the call to stool. Although large RCTs of the effect of exercise are lacking, it does 
appear that physically active subjects suffer less constipation then more sedentary 
subjects 67-69. 
The findings of the BMJ Clinical Evidence review of laxative treatments are also 
shown in Table 2. Macrogols (polyethylene glycols) were found to be beneficial for 
treatment with evidence available demonstrating that macrogols improved symptoms 
compared to placebo. Macrogols also improved symptoms and global satisfaction 
when compared to other laxatives (ispaghula husk and lactulose)TM. The tolerability 
of laxatives may limit effectiveness. In some patients' symptoms remain refractory 
even with multiple laxatives. 
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Interest in serotonin agonists for the treatment of constipation has grown in recent 
years. Several placebo controlled studies of Tegaserod (5HT4 agonist) have shown 
symptomatic benefit. Subjects receiving Tegaserod have increased rates of complete 
spontaneous bowel movement, improved self assessment of symptom severity, 
improved global assessment of bowel habit and improvement of IBS symptoms. 
Through its action on 5HT4 receptors, Tegaserod stimulates the peristaltic reflex, 
increases colonic motility, decreases visceral hypersensitivity and facilitates 
secretion into the colon 
70"72. 
However, in March 2007 at the request of the FDA, the manufacturer of Tegaserod 
agreed to stop selling the drug 73. Analyses of 29 studies suggested an increase risk 
of cardiovascular and cerebrovascular events in those treated with Tegaserod, 
compared to placebo. Tegaserod is therefore off the market for general use. In 
America the FDA has approved its use in special cases where alternative therapies 
are not possible for patients with irritable bowel syndrome with constipation (IBS-C) 
and chronic idiopathic constipation. 
Biofeedback behavioural training is a non-invasive technique that has been used to 
successfully manage disordered defecation / dyssynergic defecation . The 
74 
mechanism of action is poorly understood but improved extrinsic innervation to the 
gut is implicated 75,76. Biofeedback may also improve colonic transit time and has 
also been used in slow transit constipation75,77. 
Chiarioni et al found that in patients with severe pelvic floor dyssynergia, 
biofeedback was more effective than macrogols. Biofeedback significantly improved 
symptoms, reduced the need for laxatives and frequency of abdominal pain. 
Furthermore, patients who reported major improvements demonstrated the ability to 
relax the pelvic floor and improved balloon defecation 78. Improvements from 
biofeedback may also be due to beneficial effects arising from a close relationship 
between practitioner and patient. 
Rectal irrigation 
Rectal irrigation is a method of achieving a transanal retrograde washout of the distal 
colon. The technique can be used in selected patients with constipation and other 
defecatory disturbances. The procedure is performed with water, using equipment 
-35- 
similar to that for stoma irrigation. Irrigation can be performed in the patient's home. 
After irrigation, evacuation usually occurs within 15 minutes. The frequency of 
irrigation can be tailored to suit individual needs. A retrospective evaluation of 
effectiveness was performed by Crawshaw et al. They studied a heterogeneous group 
of 48 patients with idiopathic defecatory disturbances (including 15 with 
constipation). During a median follow up of 11 months, rectal irrigation provided 
symptomatic improvement. Christensen et al have studied the effectiveness in 
patients with spinal cord injury and neurogenic bowel dysfunction. In a prospective, 
controlled, multi-centre trial, 87 patients were randomized to receive transanal 
irrigation or conservative bowel management. Compared with conservative bowel 
management, transanal irrigation improved constipation, faecal incontinence, and 
symptom-related QOL 79. 
Botulinum toxin 
Botulinum toxin has been used to weaken the external anal sphincter muscle and 
puborectalis muscle in constipation. Experience is growing, suggesting a role for 
this technique in selected patients 80. Maria et al studied 24 consecutive patients with 
chronic outlet obstruction constipation who demonstrated impaired relaxation of 
puborectalis. Botulinum toxin was injected into puborectalis muscle under 
ultrasonographic guidance. At 2 months, anorectal manometry demonstrated 
improvement during straining. Furthermore, symptoms of incomplete, prolonged and 
difficult evacuation were resolved 81. However, these results have not been verified 
in clinical practice, and few units are offering this treatment. 
Sacral nerve stimulation 
Sacral nerve stimulation (SNS) has been used to treat urinary and faecal incontinence 
82.83. Subsequent studies suggested additional benefits, with increased stool frequency 
in patients with constipation 84-86. A recent Cochrane review concluded that SNS can 
improve symptoms in selected patients with constipation 87. Dinning et al studied 
eight patients with idiopathic slow-transit colonic constipation. Their findings give 
some insight into the mode of action of SNS. They evaluated the effect of stimulation 
on colonic pressure patterns using a manometry catheter positioned at colonoscopy. 
Electrical stimulation of the sacral nerve increased pan-colonic antegrade 
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propagating sequences. Six of the eight patients reported increased bowel frequency 
and reduced laxative use after a3 week stimulation trial 88. 
Surgery 
Surgical treatment for constipation can be performed when specific abnormalities of 
the lower gastrointestinal tract are identified that directly precipitate constipation (for 
example, functionally significant rectocoele). Alternatively surgery is performed in 
idiopathic constipation in patients who have remained refractory to conservative 
treatments (for example in severe slow transit colonic transit). In these cases surgery 
represents an invasive approach associated with the inherent risks of general 
anaesthesia and possible short and long term complications. There has been an 
impetus to develop less invasive measures that can be used as an alternative to 
established surgical techniques such as colectomy. 
Rectocoele repair 
A rectocoele is an out-pouching of the anterior rectal and posterior vaginal wall into 
the lumen of the vagina. Many Rectocoeles are asymptomatic and prevalence is not 
accurately known in the general population. Between 20-80% of patients attending 
pelvic floor clinics have rectocoele 89. Disordered defecation may arise. Surgical 
intervention is considered if the rectocoele is associated with significant retention of 
contrast after evacuation, size is greater than 3cm and there is a need for manual 
assistance for defecation. Criteria for selecting patients for surgery may vary between 
units. Rectocoele repair can be performed via anal, transvaginal, transperitoneal 
90 
. approaches or by a laparoscopic technique 
Antegrade Colonic Enema 
Antegrade irrigation of the colon may be used as an alternative to colectomy and 
ileostomy in patients with refractory constipation. Malone reported on the archetypal 
procedure that allowed antegrade irrigation of the colon using the appendix and good 
results have been reported particularly in the paediatric population93.94. 
Colectomy 
Subtotal colectomy with ileorectal anastomosis (STC-IRA) is recognised as a 
surgical approach in carefully selected patients with colonic slow transit 95.96 Hassan 
et al found that 85% of their patients reported satisfaction with bowel function post 
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surgery. Furthermore, STC-IRA led to sustained improvement in symptoms and 
quality of life 97. Post operative diarrhoea is a recognised complication of the 
procedure98. Recent developments have focussed on surgery that retains the 
ileocaecal valve; sub total colectomy with ceacorectal anastomosis (STC-CRA). 
99 
. Small case series 
have shown promising results for this procedure , 100 
Summary 
Constipation is a common disorder with multiple aetiologies. A structured approach 
is required for assessment and investigation. Idiopathic constipation may be 
associated with identifiable physiological changes affecting colonic transit or pelvic 
floor function (e. g. STCC and PFD). Management relies on the use of established 
measures that in some instances are not supported by a strong evidence base. 
Standard therapies, such as laxatives, may be ineffective and other non invasive 
interventions (such as biofeedback) may not work in all cases. In some instances 
definitive surgery is performed. Development of novel therapies and less invasive 
procedures (such as SNS) may allow patients to avoid major surgery. 
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2 QUALITY OF LIFE IN CONSTIPATION 
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2.1 Introduction 
2.1.1 Defining Quality of Life 
"Quality of life" (QOL) is a common place term used in everyday life by both lay 
people and clinicians. Most people in the western world are familiar with the 
expression and have an intuitive understanding of what it comprises. It has been 
suggested that QOL is a multidimensional construct influenced by several 
dimensions such as: physical functioning, physical symptoms, psychological 
symptoms, perceived distress and life satisfaction (to name but a few)'°' It is 
impractical to assess all dimensions simultaneously. As a result instruments 
purporting to assess QOL may concentrate on specific dimensions at the expense of 
others. The terms Quality of life (QOL) and Health Related Quality of Life 
(HRQOL) are often used interchangeably and reflect the physical, social and 
emotional attitudes and behaviours of an individual as they relate to their prior and 
102 current health state 
2.1.2 Why measure Quality of Life in constipated patients? 
In certain gastrointestinal disorders, the severity of the condition can be assessed 
using validated tools. For example, the Crohn's Disease Activity Index (CDAI) uses 
both qualitative and quantitative data to assess severity 103 In constipation there are 
no similar measures of disease activity. Clinicians rely on a combination of methods 
to assess severity such as: symptom self-report by patients, a clinician record of 
symptoms or the results of objective tests (e. g. colonic transit study and anorectal 
physiology). 
However, criticisms can be levelled at these approaches. Symptoms can be evaluated 
via a clinician led interview (during history taking), clinician led questionnaires or 
through patient self-report with diaries and questionnaires. These methods have 
potential for inaccuracy and bias. Studies of diseases, including GI disorders, show a 
general pattern of only weak to moderate agreement between the rating of symptoms 
by the patient and clinician 104108 The most common finding is for clinicians to 
underestimate the incidence of and severity of symptoms relative to patient 
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ratings108. Agreement on the presence and abscence of symptoms is generally better 
than agreement about symptom intensity 109 
Patient self-report and symptom diaries can be inacurate because of subjectivity and 
impaired recall. The respondent burden of diaries can be high and retrospective 
completion of entries has been reported llo Unfortunately, recall errors can be 
increased by such retrospective diary completion. Another problem with diaries is 
that subjects become conditioned and more tolerant of their symptoms during the 
diary exercise"'. Consequently, the reporting of events diminishes during the diary 
period. Conversely, the problem of sensitisation is recognised. Here the awareness of 
symptoms heightens during the diary period, leading to increased reporting of 
12 symptoms or events 1. 
Symptom questionnaires, either self administered or via clinician, require patients to 
remember symptom occurrence and intensity. Recall error can arise through 
omission or misplacing the occurrence of a symptom in time. Bias can occur 
particularly if the questionnaire is clinician administered. In this situation the subject 
alters answers to confirm with perceived behavioural or social norms (e. g. omitting 
to answer questions about potentially embarrassing issues such as digital manoeuvres 
to assist defecation). It is also important that the questionnaires used are well 
designed with robust psychometric properties and have been validated in the 
population for which they are intended for use in112.113 
The role of objective tests for assessing severity has not been fully explored. Using 
symptoms as a measure of severity, some authors have found no correlation between 
the results of objective tests and symptom intensity (of course, the problems of 
symptom evaluation as outlined above must also be considered when interpreting this 
observation)' 14 
Therefore, measuring QOL represents, at the very least, an adjunct to symptom 
assessment but may even provide a more complete and comprehensive way for 
clinicians to assess the severity and effect of constipation. This is certainly the case 
in other chronic diseases, where quality of life status gives a closer representation of 
the patient's well-being and disease impact then the results of laboratory 
1 investigations and measures of disease activity 15'116 
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QOL can be used as an outcome measure in clinical trials of treatment in conjunction 
with other endpoints like symptom evaluation or the results of objective tests. In 
cluding QOL assessment is likely to give a more complete picture of the effect of 
treatment than using symptom evaluation or objective testing in isolation. The 
problems of symptom assessment already mentioned may introduce inaccuracy if 
this modality is used as the only endpoint. Traditionally, clinicians have aimed to 
treat and remove symptoms to cure or palliate a condition rather then considering the 
effect the disorder has on the global concept of QOL. Constipated patients 
themselves often express the opinion that overall QOL is more important to them 
then the treatment of an individual symptom. By using QOL as an endpoint in trials, 
treatments can be developed that address this issue. 
QOL has also been shown to be a predictor of whether a patient will respond to 
treatment. For example, pre treatment QOL has been shown to predict the response 
to biofeedback therapy. Mason et al found that constipated subjects in whom pre 
treatment QOL was impaired by physical pain, emotional problems and low vitality 
were less likely to respond to therapy 42. Measuring QOL may inform management 
decisions in clinical practice and represent a useful endpoint in clinical trials. 
2.1.3 Measuring Quality of Life in constipation 
There are a variety of instruments available for measuring QOL that include generic 
1 and disease-specific measures 13 
Generic quality of life instruments are designed to assess the overall health, well- 
being and functioning of an individual. They have no specific reference to any 
particular condition or disease and can also be used in healthy subjects. They can be 
applied to different patient groups and can be used to make comparisons of quality of 
life between diseases. They may detect unexpected or unusual effects of the disorder. 
Since these instruments are very general, small important changes, particularly those 
caused by the specific disorder, may not be detected. The Short Form-36 Health 
Survey (SF-36) is an example of a generic QOL measure that can be used to assess a 
subjects' QOL and perceived health status 17. 1 
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Disease-specific instruments are applied to patients with a specific condition (such as 
gastrointestinal disease or respiratory disease). These instruments are designed to 
identify relevant problems associated with the particular condition and are generally 
more sensitive to patient concerns and changes in health status 118 However, a 
potential disadvantage is that unexpected effects that influence general health may be 
missed. The Patient Assessment of Constipation - Quality of Life questionnaire 
(PAC-QOL) is an example of a disease specific instrument 119 
Combining both generic and specific questionnaires allows the advantages of both to 
be incorporated into analyses. It has been suggested that generic and disease-specific 
measures of quality are complementary rather than interchangeable and the use of 
120 both types of measure in parallel is recommended 
2.1.4 Description of the Quality of Life instruments used in the thesis 
Short Form-36 Health Survey (SF-36) 
The Short form-36 was originally developed by the Rand Corporation for cost utility 
analyses in health insurance schemes 121. It assesses generic health that is not specific 
to age, disease or treatment. Aspects of physical, social and emotional functioning 
are considered. The SF-36 contains 36 items categorised into eight domains: physical 
functioning, social functioning, physical limitation, mental role limitation, mental 
health, energy and vitality, bodily pain and general health perception. Scores for 
each domain are normalised to a reference population that was originally from the 
United States, however referenced norms are now available for a variety of disorders 
and populations from outside America. Two summary measures can be derived for 
physical health and mental health expressed as the Physical Component Score (PCS) 
and the Mental Component Score (MCS). The SF-36 can be completed in a short 
period of time (approximately 10 minutes). This represents an advantage for studies 
where several questionnaires are used together. Data regarding reliability and validity 
for this questionnaire in various populations and settings are widely published122.117 
Coons et al suggested that the SF-36 possessed the attributes of a "robust instrument 
having good validity, reliability" and having "extensive cultural and language 
adaptation and low administrative burden" 122. When compared with other generic 
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measures, the SF-36 was found to have high scores for internal consistency, 
reliability and validity 123. The SF-36 is commonly used in contemporary health 
124 
services research 
The Patient Assessment of Constipation - Quality of Life (PAC-QOL) 
The Patient Assessment of Constipation (PAC) was developed to address the need 
for "a disease-specific patient reported outcomes measure" that could be used to 
assess symptoms and QOL 119. It consists of two separate questionnaires; PAC-SYM 
(evaluating constipation-specific symptoms) and PAC-QOL (evaluating 
constipation-specific QOL)l19,12s The content was derived directly from individuals 
affected by constipation and from clinicians involved in the treatment of 
gastrointestinal disorders. Validation studies (conducted in North America, Europe 
and Australia) demonstrated an acceptable level of reliability, validity and 
responsiveness. PAC-QOL is a comprehensive but brief assessment of the burden of 
constipation on patients everyday functioning and well-being. 
Both PAC-QOL and PAC-SYM are relatively new instruments in the field of 
constipation. They appear to be well-designed and conceived instruments. Item 
development was predominantly patient centred, rather than dictated by clinicians. 
Extensive patient led focus groups were used during the conception stage. It is 
believed that this approach has led to an instrument that truly reflects the patients' 
experience of constipation in terms of symptoms and QOL. 
Currently there is no gold standard for measuring severity in constipation. Using a 
patient derived evaluation of symptoms and QOL may offer an alternative to relying 
on symptom evaluation by the clinician or the results of objective tests. 
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2.1.5 Quality of Life in constipation 
Studies that have examined the burden of constipation with reference to QOL have 
involved observational studies and cross-sectional comparisons. Until recently, many 
authors relied on generic measures that assess overall QOL and health. Disorder- 
specific instruments for evaluating QOL across a range of gastrointestinal disorders 
(eg Gastro Intestinal QOL index, GIQLI126), that are not specific to constipation per 
se, have also been used to study QOL in constipation. It can be argued that using 
measures specifically designed for constipation is preferable for evaluating QOL in 
this disorder. Table 3 lists the instruments that have been employed in previous work. 
Studies of QOL in constipation have involved community dwelling patients and 
subjects from the general population with self reported constipation or subjects 
recruited from dedicated clinics dealing with constipation. 
Generic measures of health status 
Short Form 36 SF-36 
Measures of psychological well being 
Psychological General Well-Being index PGWB 
Hopkins Symptoms Check list SCL-90-R 
General Health Questionnaire GHQ-28 
Hospital Anxiety Depression scale HADS 
Disorder specific measures 
Gastrointestinal Symptom Rating scale GSRS 
Gastrointestinal Quality of Life Index GIQLI 
Disease (constipation) specific measures 
Patient Assessment of Constipation-Symptoms PAC-SYM 
Patient Assessment of Constipation-QOL PAC-QOL 
Table 3: Quality of Life Measures used in constipation. 
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2.1.6 Constipation and Quality of Life in the general population 
Table 4 summarises the findings of studies in the general population. In a mail 
survey of Canadian subjects using SF-36, those with self-reported functional 
constipation (Rome II criteria) had a significantly lower QOL compared to general 
population norms. In these study participants, a factor predicting physician visits 
was impaired quality of life 127. Constipation also affects QOL in community 
dwelling elderly subjects; manifest by psychological disability 128,129. Donald et at 
demonstrated higher scores for psychological distress and depression in such patients 
compared to the non constipated or controls 130. O'Keefe et at demonstrated lower 
SF-36 scores in independent subjects (age 60-80 years) who had constipation 
131 compared to controls 
2.1.7 Quality of Life in patients with severe constipation. 
Table 5 summarises the finding of studies in patients referred to specialist clinics. 
Overall, it appears that QOL is impaired. Sailer et al demonstrated reduced quality of 
life in 14 constipated patients referred to a tertiary centre using GIQLI 132. Scores in 
these patients were significantly less then those of age-matched controls or patients 
with benign anorectal disorders (faecal incontinence, anal fissure, perianal abscess, 
fistula in ano, haemorrhoids etc). 
Using SF-36, Mason et al found that QOL was less then that of normal UK age 
matched subjects in a study of 22 patients 42. Damon et al studied QOL in 78 patients 
with chronic constipation referred for anorectal physiological testing. Again, QOL 
was less in the constipated patients then that reported for healthy subjects and 
patients suffering from faecal incontinence 37. 
Glia et al performed an observational study of symptoms and QOL in 84 patients 
with idiopathic constipation 133 The Gastrointestinal Symptom Rating Scale (GSRS) 
and the Psychological General Well-being Index (PGWBI. ) were used. The result 
suggested that emotional well-being, perceived health and overall well-being were 
reduced compared to the general population. 
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In patients where a rectocoele contributed to constipation, preoperative disease 
134 specific quality of life has been shown to be impaired 
These preceding studies support the concept that QOL in severe chronic constipation 
is reduced in comparison to healthy subjects and to patients suffering from other 
gastrointestinal diseases. However, they are limited by relatively small sample sizes. 
The choice of quality of life measures in some of the studies can be questioned. For 
example, GIQLI was designed to evaluate a wide variety of both upper and lower 
gastrointestinal disorders. The proportion of constipated patients from the 204 used 
to validate the initial GIQLI is not stated in the original paper. The instrument's 
responsiveness to change was assessed in patients undergoing laparoscopic 
cholecystectomy rather then in patients with constipation. A criticism can therefore 
be levelled at the use of GIQLI to evaluate constipation in that it is not specific to 
this disorder. Of the 36 items that make up this measure, only one refers directly to 
constipation. Similarly, neither GSRS nor PGWBI were specifically designed to 
evaluate constipation. Furthermore, the PGWBI essentially only assesses one 
dimension of QOL, i. e. psychological wellbeing. There is a need to evaluate QOL in 
this patient group using measures specifically designed for the index condition 
(constipation). In addition, the concurrent use of generic QOL measures is 
advocated. Generic QOL measures may detect changes in a wide range of aspects of 
health that might not register on more focused specific measures. Generic measures 
are more likely to detect non-specific effects caused by co morbidities. They may 
also detect unexpected general effects (either positive or negative) caused through 
interventions used to treat the index condition being studied. Thus, the use of generic 
120 and specific measures is complementary 
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2.1.8 Correlation between Quality of Life and symptoms, transit time 
and anorectal physiology. 
A picture is emerging that suggests poor QOL in constipated patients referred to 
tertiary and secondary centres. The factors that dictate why QOL is impaired have 
not been fully studied. The relationship between disease specific factors (such as 
colonic transit time, symptoms intensity etc) remain unclear. 
Damon et al studied QOL with GIQLI and symptoms with the Cleveland Clinic 
Symptom score 37. A weak to moderate correlation was demonstrated between QOL 
and symptom intensity. Again, the choice of QOL instrument may have influenced 
this result. In contrast Glia et al found a strong correlation between symptoms and 
the psychological dimension of QOL (measured by PGWB) 133. Symptoms were 
assessed by GSRS rather than a condition specific measure and this limitation must 
be kept in mind. 
Four studies suggest worse psychological status in normal colonic transit 
constipation than in slow chronic transit constipation. Grotz 
2 and Wald 135 used the 
SCL-90-R and an abbreviated SCL-90-R respectively to assess psychological status 
and transit time. Patients with normal transit time constipation reported greater 
psychological distress then those with slow transit constipation. Glia et al 
demonstrated worse psychological status (as measured by PGWB) in normal transit 
constipated patients compared to slow transit constipated patients 
133. Towers et al 
examined psychological parameters and transit time in older subjects; those with 
slow colonic transit constipation had less psychological distress then constipated 
subjects with more rapid transit 137. Studies using constipation specific measures of 
QOL have not been performed to assess the effect of colonic transit. Again, these 
studies rely on QOL measures that are not specific to constipation. 
Defecating proctography and a variety of anorectal physiological tests are often 
employed as investigations for constipation. Damon et al assessed QOL in relation to 
anal pressure (resting and squeeze) and rectal compliance but did not demonstrate a 
correlation between QOL scores and these parameters 37. Several other studies have 
assessed anorectal physiology and defecating proctography however, results 
pertaining to any relationship between these tests and QOL were not specifically 
2 documented in the papers , 
133435 
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2.1.9 Studies of Quality of Life and treatment of constipation 
Charach et al demonstrated increased stool frequency following a trial of laxative 
therapy in 52 patients over the age of sixty. In addition, mood improved and the 
authors suggested that treatment of constipation was associated with an improvement 
in QOL 136 Nyam et al reported long term outcomes following surgery for chronic 
constipation. Overall QOL was "good or improved" in 90% of patients five years 
after surgery. The authors used a simple graded scale to obtain a global assessment of 
QOL rather then a recognised and validated generic measure 138. This is a limitation 
of the study. 
Mason et al studied the effects of biofeedback therapy in 22 patients with idiopathic 
constipation 42. Symptoms improved following biofeedback. QOL (measured by SF- 
36) and psychological status (by General Health Questionnaire-28, GHQ-28 and 
Hospital Anxiety and Depression Scale, HADS) also improved after treatment. 
Furthermore, pre treatment QOL (SF-36 pain, vitality and emotional subscales) 
predicted response to treatment. Reduced QOL expressed by low scores in these 
domains was associated with a poor response to biofeedback. 
2.2 Summary 
Within the general population QOL is reduced in those who have constipation. There 
are fewer studies of QOL in patients with refractory constipation severe enough to 
warrant referral to a specialist clinic. In these studies, the choice of QOL instrument 
has been inconsistent. To improve our understanding of the impact of constipation on 
QOL, there is a need to perform studies using disease specific measures of QOL. 
Concurrent use of generic QOL instruments may also provide additional information 
about the burden of the disorder and the impact of interventions, including 
unexpected positive and negative effects of therapy. The relationships between QOL 
and parameters that are believed to have an impact on or predict the severity of the 
condition (such as symptoms, colonic transit and proctographic findings) have not 
been studied in depth. 
Measures of QOL are becoming accepted as useful overall indicators of severity in 
many disease states because they may provide a more accurate representation of the 
complete experience of the individual than indices based only on symptoms, 
physiological tests or radiological imaging. The ability to identify factors associated 
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with poor QOL may help to appropriately target therapeutic interventions for those 
suffering the greatest burden of constipation. Review of the existing literature 
suggests that: normal colonic transit is associated with reduced QOL; functionally 
significant rectocoeles adversely affect QOL and; symptom intensity is weakly to 
moderately associated with QOL. 
Our aim was to explore empirically the effect of these and other factors on disease 
specific QOL in a population of patients with idiopathic constipation severe enough 
to warrant referral to a specialist clinic. 
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3 AIMS OF THE STUDY OF QOL IN IDIOPATHIC 
CONSTIPATION 
The primary aim of the study was; 
To examine the factors that predict disease specific QOL in patients with refractory 
idiopathic constipation. 
An important secondary aim and prerequisite of the primary aim, was; 
To confirm the reliability and validity of the QOL instruments by evaluating their 
psychometric properties. 
This was of interest because the original validation of the constipation-specific 
instruments had not been in a population of patients from a specialist clinic. This aim 
was addressed initially so that we could be confident of the results arising from the 
studies of the primary aim. 
3.1 Design 
This was a cross sectional, observational study of a sample of patients with 
idiopathic constipation recruited from a specialist clinic dedicated to the management 
of refractory constipation. 
3.2 Ethical considerations 
The study was conducted in accordance with the in the 2004 Declaration of Helsinki 
and approval was granted by the local research ethics committee (County Durham 
ethics committee). All participants gave written informed consent. 
3.3 Sample size calculation 
A convenience sample of all available patients with refractory idiopathic constipation 
was used. No specific power calculation was performed as it was felt that a 
population of approximately a hundred would be enough for the purpose of an 
exploratory analysis to address the aims of the project. 
3.4 Inclusion criteria 
Only patients with a diagnosis of idiopathic constipation were considered for 
inclusion. In such patients systemic, biochemical, pharmacological, primary 
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neurological, structural abnormalities of the colon or endocrinological explanations 
for symptoms of constipation had been excluded by appropriate investigation. 
The diagnosis of constipation required at least a 12 week history (which need not be 
consecutive) of 2 of the following in patients who had not responded to previous 
interventions (e. g. refractory constipation) and who had been referred to the 
dedicated clinic at University Hospital of North Durham; 
(a) Fewer than 3 defecations /week; 
(b) Straining in more than 25% of defecations; 
(c) Lumpy or hard stools in more than 25% of defecations; 
(d) Sensation of incomplete evacuation in more than 25% of defecations; 
(e) Sensation of anorectal obstruction/blockade in more than 25% of defecations; 
(fl Manual manoeuvres to 
facilitate in more than 25% of defecations 
e. g. (digital evacuation, support of the pelvic floor) 
Male and female patients over the age of 18 were included. Details regarding 
inclusion criteria were obtained at a clinician led face to face interview. 
The inclusion criteria were designed to allow recruitment of patients with idiopathic 
constipation rather than the more specific categories enshrined in the Rome II criteria 
(i. e. Functional Constipation and constipation predominant Irritable Bowel 
Syndrome, IBS-C). As previously stated (section 1.2), and in keeping with our past 
experience, it can be difficult to differentiate between these two categories and 
overlap may exist. 
3.5 Exclusion criteria 
The presence of any of the criteria disqualified the patient for inclusion. 
a) Age less than 18 years 
b) Severe psychiatric disease 
c) Known pregnancy, suspected pregnancy or patient trying to conceive. 
d) Incapacity of higher mental function such that informed consent could not be 
achieved 
e) Evidence of diarrhoea predominant Irritable Bowel Syndrome (IBS-D) according 
to Rome II criteria. 
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3.6 Subject recruitment 
Subjects were recruited from the specialist constipation clinic at the University 
Hospital of North Durham. The clinic receives referrals from primary care (general 
practitioners) and secondary care. Referrals from secondary care originate from 
within the North Eastern region and also from outside the region. The referrals are 
generally from consultant clinicians (predominately gastroenterologists and general 
surgeons). A referral bias exists since the patients represent an extreme of the 
constipation spectrum. These patients have chronic symptoms that have not 
responded to prior therapies7. It is therefore recognised that the clinic population is 
not representative of the general population of constipated patients but only those 
with sufficient problems to warrant referral to a specialist clinic. 
3.7 Subject disposition 
One hundred and forty eight patients were identified in the constipation clinic as 
potential participants. Informed consent was obtained from 122 patients who were 
then included in the study (Figure 2). The remaining 26 subjects declined the 
invitation to be included. There were no important differences between the 26 non 
participants and the 122 participants. Comparisons of the demographics between 
these two groups are presented in section 4.5. 
148 eligible patents 
(meeting inclusion I exclusion criteria) identified in clinic 
Consent obtained from 122 1 
122 patients with data set completeness sufficient for 
inclusion in psychometric analyses 
122 patients with data set completeness sufficient for 
inclusion in analyses to address primary aims 
Figure 2. Subject disposition 
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3.8 Study protocol 
Patient characteristics 
Data regarding demographics (age, sex etc) were obtained at face to face clinician 
led interview (SC or YY). Other features of the history that have previously been 
held to be important in patients with constipation (section 1.4) were explored (past 
medical history, surgical history, prior psychiatric history, exposure to child birth). 
Regarding the characteristics of constipation; age of onset and duration of symptoms 
were also assessed. 
During the consultation with subjects, symptoms were assessed by the clinician (SC 
or YY). On the same day, patient self assessment of symptoms, disease specific QOL 
and generic QOL and were undertaken by a single administration of the appropriate 
questionnaires (in the following order; PAC-SYM, PAC-QOL and SF-36). 
Radiological assessments with transit study and proctography were also undertaken 
(below). Detailed descriptions of these procedures are outlined in section 7.5.3 and 
section 7.5.4. 
Assessment of symptoms and chacteristics 
The clinician performed an evaluation of symptoms using a question based proforma 
that scored individual symptoms on Likert scales. The questions assesseds symptom 
including bowel frequency, pain at evacuation, sensation of incomplete evacuation, 
abdominal pain, abdominal bloating, time spent at toilet, requirement for digital 
manoeuvres to facilitate defecation and unsuccessful attempts. Coding details for the 
symptoms and characteristics assessed in the proforma questions are included in 
Appendix B, table 2. Symptoms were also self-assessed by the patient by completing 
the PAC-SYM measure 125 
QOL assessment 
QOL was evaluated using PAC-QOL and SF-36 117'119. These measures were self- 
administered by the patients. 
Colonic transit 
Colonic transit time was determined using radio-opaque marker studies. In this 
multiple bolus, single abdominal X-ray technique, a known number of markers are 
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ingested on days 1,2 and 3 followed by a single plain abdominal X-ray on day 4 53 
One advantage of this method is that subjects need only refrain from laxatives for 
three days. This is of relevance since many patients are dependent on daily laxatives 
because of the intensity of symptoms. A second advantage is that in contrast to 
multiple bolus, multiple X-ray methods the current technique minimises radiation 
exposure. 
Radionuclide Defecating Proctography 
Radioisotope defecating proctography was used to give a dynamic assessment of 
defecation. This technique involves the use of a radioisotope neo-stool inserted per 
rectum that is visualised using a gamma camera during different stages of 
evacuation. The technique can provide quantative, qualitative and morphological 
data regarding defecation in constipated patients. It is an alternative to barium 
defecating proctography (a method that utilises barium paste visualised by 
fluoroscopy). Radioisotope proctography is associated with less radiation exposure 
than barium proctography 139 This is an important issue since many patients with 
idiopathic constipation are women of child bearing age. 
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4 EVALUATION OF THE PSYCHOMETRIC 
PROPERTIES OF PAC-QOL 
4.1 Abstract 
Introduction The psychometric properties of the Patient Assessment of Constipation 
-QOL (PAC-QOL) have been examined in American patients. The aim of the 
evaluation reported here was to confirm the reliability and validity of the measure for 
use in the main study of idiopathic constipation patients recruited from a dedicated 
UK clinic. 
Methods A single self-administration of PAC-QOL was undertaken by 122 patients. 
Item-total correlations and Cronbach's a coefficient were calculated to test reliability 
(internal consistency). Construct validity was assessed by comparison with the Short 
Form 36 Health Survey (SF-36). 
Results Cronbach's a coefficients were high. Moderate item-total correlations were 
demonstrated. There were moderate inverse correlations between SF-36 and PAC- 
QOL domains that shared construct similarities. There were weak inverse 
correlations between SF-36 and PAC-QOL domains that did not share construct 
similarities. Only 4% of the study population had no abdominal pain. Adequate 
evaluation of known group validity was not possible. 
Conclusions The psychometric evaluations suggest that PAC-QOL is reliable and 
valid for assessing QOL in patients with idiopathic constipation. The use of the 
measure for analysing data in the main study is supported. 
Preliminary validation of the PAC-QOL questionnaire for chronic idiopathic 
constipation. 
Cowlam S, McColl E, Millburn S, Yiannakou Y 
Gastroenterology. 2007; 132(4), Suppl 2, A476 
Accepted for poster presentation at DDW 2007, Washington DC, USA. 
Data collection SRC, YY 
Data entry SRC 
Data Analysis SRC (advice from EM) 
Data interpretation SRC, EM 
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4.2 Introduction 
The PAC-QOL is a relatively new instrument designed to evaluate a patient's 
perceived quality of life specifically related to constipation. The measure was 
developed by Marquis and colleagues to address the lack of a constipation-specific 
measure for assessing patient experience of constipation and for use in treatment 
trials of constipation' 19 It was designed to complement the Patient Assessment of 
Constipation - Symptoms (PAC-SYM). The two instruments can be used separately 
or in combination. 
In order to select material for the PAC-QOL questions (items), the developers 
reviewed the literature and performed semi-structured interviews with patients 
suffering from constipation. At interview, groups of patients were asked open ended 
questions addressing the impact of constipation and its treatment on social 
functioning, psychological functioning, physical functioning, perceived wellbeing 
and level of impairment. The patient comments were used to identify relevant QOL 
issues and to generate PAC-QOL items. 
To confirm the initial interview findings and to further evaluate effects on QOL, the 
patients also completed a structured survey that explored the impact of constipation 
on activities of daily living, social interaction, emotional status and general well- 
being. The survey findings were reviewed by the developers and an international 
panel of clinical gastroenterologists and a concept model of important QOL issues 
was created. This model was used by interviewers as a guide in subsequent patient 
focus groups. These focus groups were conducted in the UK to further explore QOL 
issues and generate items for the measure. Using verbatim quotes from the initial 
interviews and from the focus groups, a provisional 35 item questionnaire was 
developed. This was administered to 260 patients in the US and UK. Item reduction 
was undertaken to produce the final 28 item version of the PAC-QOL. This measure 
assesses QOL from the preceding 2 weeks (2 week recall) with response options 
scored with a five-point (0-4) Likert scale. The questionnaire is made up of 4 
domains including constipation related worries and concerns (11 items), physical 
discomfort (4 items), psychosocial discomfort (8 items) and satisfaction (5 items). 
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Validation of the PAC-QOL has been performed in a group of 223 American patients 
with chronic idiopathic constipation (minimum duration of three months) 119. The 
patients were recruited either through physician clinics or via advertisement. The 
patients were observed over a6 week period. In the first 2 weeks, patients 
maintained their usual regime of management for constipation. In the following 4 
weeks, patients were treated with a standardised regime (Magnesium tablets and 
bisacodyl). Patients completed the PAC-QOL at baseline, two weeks and 6 weeks. 
The results of psychometric analyses suggested that measure was valid, internally 
consistent and responsive to change over time. 
However, it is recommended that the validity and reliability of a measure is 
restablished when applying the measure in a different population 113. In order to use 
the questionnaire with confidence in our patients various psychometric 
characteristics of PAC-QOL were assessed and the results compared with those from 
previous studies. Where possible, the methods used in previous studies were used in 
these analyses. 
Reliability and validity were tested by evaluating internal consistency and construct 
validity. Reliability is the ability to produce consistent results from items within the 
instrument purporting to measure the same trait or concept. Validity refers to the 
ability of an instrument to accurately measure the trait that it was designed to 
measure. Construct validity refers to the establishment of quantitative relationships 
(based on theory or previous empirical evidence), between scores on the instrument 
under examination and those on other instruments measuring similar constructs, and 
to relationships with demographic and clinical variables ("known groups" validity). 
4.3 Aim 
To evaluate the psychometric properties of PAC-QOL for use in our own population. 
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4.4 Patients and method 
4.4.1 Subjects 
One hundred and forty-eight patients with idiopathic constipation were identified as 
potential participants and 122 provided informed consent and completed the 
questionnaire (section 3.6) 
4.4.2 Psychometric analysis 
Missing data 
Total scores and domain scores from a measure cannot be confidently estimated if 
the number of missing items is high. A high level of missing data is also suggestive 
that the items in the questionnaire are unacceptable to respondents and / or poorly 
understood. The number and percentage of patients with missing PAC-QOL items 
was computed for the total sample. Overall and domain scores can still be accurately 
calculated even if some items are missing, unless a critical number of items are 
absent. In these situations a "missing data handling rule" is invoked that invalidates 
the measure. 
Scores 
PAC-QOL is made up of 4 domains including; worries and concerns (11 items), 
physical discomfort (4 items), psychosocial discomfort (8 items) and satisfaction (5 
items). Items are scored on a five-point (0-4) Likert scale. High scores are indicative 
of a worse QOL. 
Sub-scale scores (constipation related worries and concerns; physical discomfort; 
psychosocial discomfort; satisfaction) and PAC-QOL total scores were calculated 
according to the developers' instructions, by summing scores across all non-missing 
items in the sub-scale (or total instrument) and dividing by the number of non- 
missing items in that sub-scale (or in the instrument as a whole). The PAC-QOL 
questionnaire, domain summaries, scoring algorithm and data handling rule (for 
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calculating overall and subscale scores in the presence of missing data) are displayed 
in Appendix A, Table 1; Appendix A, Table 2 and Appendix A, Table 3. 
Floor and ceiling effects 
The PAC-QOL domain scores were assessed for ceiling and floor effects. Ceiling 
effect refers to the percentage of patients achieving the highest possible score; floor 
effect refers to the percentage of patients achieving the lowest possible score. 
In PAC-QOL, high scores are indicative of a worse QOL. Therefore, if there are 
marked ceiling effects at baseline in an intervention study or a longitudinal 
observation study, the potential to detect deterioration over time is compromised. 
Likewise, marked floor effects at baseline diminish the ability to detect improvement 
over time. It has been suggested that when more than 20% of respondents score at 
either extreme, the instrument may be considered to have marked ceiling and/or floor 
effects 14O The distribution of responses for each PAC-QOL domain was examined 
using frequency histograms. 
Internal consistency 
The internal consistency of the PAC-QOL domains was assessed using Cronbach's a 
coefficient. A commonly accepted minimum standard of reliability is a coefficient of 
>0.70 for comparisons at group level 141 
Item-total correlation 
A further measure of internal consistency is corrected item-total correlation. This 
approach is also referred to as item-domain correlation. This is the correlation 
between the item and the domain (sub-scale) total but omitting that item. It allows us 
to determine whether an item is related to its own domain (e. g. the extent to which 
item 1 of PAC-QOL: "felt bloated to the point of bursting" correlates with the 
physical discomfort domain of PAC-QOL). An item-total correlation coefficient of 
0.40 or higher suggests adequate internal consistency. Item-total correlation less than 
0.2 suggests that an item does not fit well with the other items in the domain or sub- 
scale'42. 
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Construct validity 
Validity can be expressed by evaluating agreement between domains from different 
measures. For example, domain scores from PAC-QOL can be compared with 
domain scores from SF-36 and the strength of association studied. Construct validity 
tests the proposition that SF-36 domains that share similarities in construct and 
assess similar concepts as PAC-QOL domains will be related, i. e. that correlations 
will be moderate to high. Conversely, the association between domains that measure 
different concepts will be weaker (eg where the SF-36 and PAC-QOL domains do 
not share similarities of construct). 
In this study, inverse correlations are expected between SF-36 and PAC-QOL 
because a low PAC-QOL score indicates better QOL, whereas high SF-36 scores are 
indicate better QOL. The strength of the expected relationships was informed using 
the definitions proposed by McHorney et al for interpreting correlation coefficients: 
strong association (r <_ -0.70), moderate association (r = -0.69 to -0.31), weak 
association (r>_ -0.3) 
143 
It was hypothesised that the PAC-QOL domain of physical discomfort would have 
moderate associations with the SF-36 domains of bodily pain, vitality, social 
functioning and mental health. 
Weak associations only were predicted between PAC-QOL physical discomfort and 
SF-36 role-physical, general health, role-emotional and physical functioning 
domains. Stronger associations were not proposed because the content of these SF- 
items address different concepts to those measured in the physical discomfort domain 
of PAC-QOL. For example, in SF-36, role-physical and physical functioning items 
refer to physical activity (lifting, carrying, shopping, bathing and dressing etc) or 
limitation of physical activity. In contrast, the PAC-QOL physical discomfort items 
focus on abdominal symptoms (feeling heavy or bloated) rather than physical 
activity. 
It was postulated that PAC-QOL psychosocial discomfort would be moderately 
associated with the SF-36 domains of social functioning, general health, role 
emotional and mental health. The association between SF-36 physical functioning, 
role-physical, vitality and bodily pain with PAC-QOL psychosocial discomfort was 
expected to be weak. 
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The association between PAC-QOL worries and concerns and the SF-36 domain of 
mental health, was expected to be at least moderate. A stronger association was not 
postulated because the concepts addressed in this PAC-QOL domain are slightly 
different to those addressed in the SF-36 mental health domain. In the former, 
feelings of "irritability", "stress", "obsession", "upset" and "self-confidence" are 
evaluated. In the SF-36, items in the mental health domain assess more specific 
depressive symptoms. It is likely that the feelings evaluated in PAC-QOL will be 
influenced to a certain extent by depressive symptoms. Consequently, a moderate 
association is predicted between these domains. 
Moderate associations were hypothesised for the relationship between PAC-QOL 
worries and concerns and the SF-36 domains of general health, bodily pain, vitality, 
social functioning, physical functioning, role physical and role emotional. It was 
postulated that the association between worries and concerns and bodily pain would 
be weak. 
Regarding PAC-QOL satisfaction, association with SF-36 physical function, role 
physical, bodily pain, social functioning, role emotional, vitality and mental health 
was expected to be weak. The association with SF-36 general health was expected to 
be moderate. 
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Known group validity 
A feature of a psychometrically valid measure is the ability to discriminate between 
patients where a known or recognised difference in a parameter (eg QOL) has been 
previously shown. 
Marquis et al studied 223 patients with idiopathic constipation and found that 26% 
suffered no abdominal paint 19 A comparison of mean PAC-QOL scores 
demonstrated significant difference between subjects with abdominal pain and 
patients without abdominal pain. Overall PAC-QOL was lower, with a mean of 1.37, 
in patients without pain compared to a mean of 2.17 in patients with pain (p=0.001). 
This observation suggested that we could evaluate the "known group validity" of 
PAC-QOL in the current study population by comparing PAC-QOL scores of those 
subjects reporting abdominal pain with the scores of those subjects who suffer no 
abdominal pain. It was hypothesised that QOL would be worse in patients who have 
abdominal pain compared to those without. A statistically significant difference in 
scores was expected. 
SPSS® version 12 for Windows (SPSS, Chicago, Illinois, USA) was used to analyse 
data. A value p<0.05 was considered statistically significant. 
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4.5 Results 
One hundred and forty eight patients were identified in the constipation clinic as 
potential participants. Informed consent was obtained from 122 patients who were 
then included in the study. Mean age of the total group was 43 years (sd 14.0). The 
mean duration of constipation was 17.7 years (sd 15.5). There were 118 females 
(97%) with a mean age of 42.5 years (sd 13.9) and 4 males (3%) with a mean age of 
57.3 years (sd 5.3). 
Patients who decided not to participate were not significantly different from the 
responders in terms of age, sex or duration of constipation (Table 6). 
Study participants Non-participants p value 
Mean age (years) 43 (sd 14.0) 44 (sd 15.1) 0.73 
Sex distribution Female = 118 Female = 23 0.10* 
Male =4 Male =3 
Duration of constipation (years) 17.6 (sd 15.5) 19.8 (sd 14.5) 0.37 
Table 6: Comparison of participants and non-participants. 
* Fisher's Exact test. 
4.5.1 Missing data 
Completion of the instrument was high with 105 subjects (86% of subjects) 
responding to all items. Of the 17 patients who did not complete every item, 13 left a 
single item blank and 4 left two items blank. 
Fifteen patients did not enter a value in response to item 28. The missing value rate 
for this item was therefore 12.3%. Item 28 forms part of the satisfaction domain 
(during the past two weeks, to what extent or intensity have you been satisfied with 
your treatment? ). The missing value rate for the other uncompleted items (items 12, 
13,16,17,19,20,24,26,27) was low; 0.8%. 
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4.5.2 PAC-QOL scores 
The mean overall PAC-QOL score was 2.4 (sd 0.73). Regarding the specific 
domains: worries and concerns mean score was 2.5 (sd 0.88), physical discomfort 2.7 
(sd 0.77), psychosocial discomfort 1.8 (sd 0.95) and satisfaction 3.3 (sd 0.72). 
Table 7 shows a comparison of the mean scores from the current study and scores 
from 223 patients studied by Marquis et al 19 The current study scores are higher in 
all domains except satisfaction. This suggests a worse QOL in the current study 
population. Marquis et al found the mean satisfaction score in idiopathic constipation 
to be 3.49, reflecting "substantial dissatisfaction with the frequency and regularity of 
bowel movements, overall bowel function and treatment". In the current study the 
satisfaction score is 3.3. 
Current study 
Idiopathic constipation 
Marquis et al 19 
Idiopathic constipation 
Domains n=122 n=223 
Mean sd Mean sd 
Overall PAC-QOL 2.4 0.73 1.85 0.93 
Worries and concerns 2.5 0.88 1.69 0.90 
Physical symptoms 2.7 0.77 2.09 0.87 
Psychosocial discomfort 1.8 0.95 0.93 0.80 
Satisfaction 3.3 0.72 3.49 0.60 
Table 7. Mean PAC- QOL domain scores. 
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4.5.3 Floor and ceiling effects for PAC-QOL 
Only one patient PAC-QOL recorded the minimum score (in the psychosocial 
discomfort domain) suggesting no meaningful floor effect. The ceiling effect (the 
percentage of patients achieving the highest score) was encountered in the in the 
psychosocial discomfort domain; 18% of patients scored the maximum score of 4 
(Table 8). This value was therefore close to the threshold of 20% indicative of a 
marked ceiling effect. 
The distributions of responses for each domain are displayed in frequency histograms 
(Figure 4, Figure 5, Figure 6 and Figure 6). Distribution of scores was uni-modal and 
for the domains of worries and concerns, physical discomfort, psychosocial 
discomfort appeared to show a normal distribution. The satisfaction domain, 
however, showed a negatively skewed distribution. 
Number of patients with the 
minimum possible domain 
score (%) 
Number of patients with the 
maximum possible domain 
score (%) 
Overall PAC-QOL score 0(0) 1 (0.8) 
satisfaction score 0 (0) 22 (18) 
physical symptoms score 0 (0) 4 (3.3) 
psychosocial discomfort score 1(0.8) 2 (1.6) 
worries and concerns score 0 (0) 6 (4.9) 
Table 8. Ceiling and floor effects for PAC-QOL. 
The minimum possible score for PAC-QOL is 0 and the maximum possible score is 4. 
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Figure 4. Histogram of responses for physical discomfort domain of PAC-QOL 
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4.5.4 Internal consistency for PAC-QOL 
Internal consistency of PAC-QOL was assessed by calculating Cronbach's a 
coefficient. Table 9 shows the Cronbach's a coefficient values and item-total 
correlations for each domain. 
Cronbach's a coefficient values were above 0.7 suggesting adequate internal 
consistency. The range of coefficients for the item-total correlations was 0.28 to 
0.81. In all but two cases the items from each domain met the criteria for item-total 
correlation with their own domain (>0.40). The exceptional cases were items 4 and 
28. Regarding item 4 (during the past two weeks how much of the time have you felt 
the need to have a bowel movement but not been able to? ) the item-total correlation 
was 0.37. In the case of item 28 (during the past two weeks, to what extent or 
intensity have you been satisfied with your treatment? ) the item-total correlation was 
0.28. 
Table 10 compares Cronbach's a coefficients obtained by Marquis et al in the 
validation study of patients with idiopathic constipation with the results from our 
study. 
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Cronbach's a Item-total correlations 
Physical symptoms domain 0.72 0.37-0.64 
Psychosocial discomfort domain 0.84 0.50-0.67 
Worries and concerns domain 0.91 0.41-0.81 
Satisfaction domain 0.76 0.28-0.71 ** 
Table 9. Cronbach's a values and Item-total correlations for each domain of PAC-QOL. 
* Item 4 fell below the 0.4 value at 0.37. ** Item 28 fell below the 0.4 value at 0.28. 
Cronbach's a Cronbach's a 
Marquis et al 119 Current study 
Physical symptoms domain 0.86 0.72 
Psychosocial discomfort domain 0.91 0.84 
Worries and concerns domain 0.83 0.91 
Satisfaction domain 0.81 0.76 
Table 10. Comparison of Cronbach's a values for PAC-001from current and previous 
studies. 
72 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
4.5.5 Construct validity for PAC-QOL 
The definitions proposed by McHorney et al were used as the basis for interpreting 
the strength of the correlation coefficients (strong association; r _S -0.70, moderate 
association; r= -0.69 to -0.31, weak association; r? -0.3)143. 
Moderate strength associations were demonstrated between SF-36 domains and 
PAC-QOL domains that had been postulated to share construct similarities (range - 
0.49 to -0.32). The Pearson correlation coefficients are displayed in Table 11. The 
strength of association was weaker between domains hypothesised not to share 
construct similarities (range - 0.3 to -0.03). 
In several instances the actual strength of association was different to that 
hypothesised (Table 12). For example, weak associations were predicted between the 
following; PAC-QOL satisfaction and SF-36 bodily pain, physical discomfort and 
general health, physical discomfort and role emotional, PAC-QOL psychosocial 
discomfort and SF-36 role physical. However, in these instances a moderate strength 
of association was found, although the coefficients (r= -0.33, -0.34, -0.32, -0.34 
respectively) were at the lower limit of accepted definitions for moderate association 
(r = -0.69 to -0.30). 
In two cases, completely unexpected results were demonstrated. Strength of 
association between PAC-QOL psychosocial discomfort and SF-36 bodily pain was 
weak; r -0.27 (a moderate correlation had been predicted). A weak association was 
postulated to exist between PAC-QOL worries and concerns and SF-36 bodily pain 
but a moderate association was present; r-0.40). 
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PAC-QOL domain 
SF-36 domain Satisfaction Physical Psychosocial Worries & discomfort discomfort concerns 
Physical 
-0.03 -0.13 -0.26 -0 20 functioning . 
Role physical -0.17 -0.29 -0.34 -0.31 
Bodily pain -0.33 -0.34 -0.27 -0.40 
General health -0.26 -0.32 -0.37 -0.39 
Vitality -0.26 -0.36 -0.30 -0.35 
Social 
-0.23 -0.44 -0.47 -0.49 functioning 
Role emotional -0.19 -0.34 -0.38 -0.37 
Mental health -0.18 -0.41 -0.41 -0.44 
Table 11. Pearson correlation coefficients between PAC-QOL domain scores and SF- 
36 domain scores. 
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4.5.5.1 Known group validity for PAC-QOL 
Only 5 (4%) patients reported no abdominal pain. This result is in contrast to that 
reported by Marquis et al, where approximately a quarter of subjects reported no 
abdominal pain119. No significant differences were demonstrated in the overall or 
specific domain scores for PAC-QOL between groups defined by the presence of 
pain (Table 13). 
With 
sd 
Without 
sd p value abdominal pain abdominal pain 
Domains n=5 n=117 
Overall score 2.1 1.2 2.4 0.7 0.37 
Physical discomfort 2.6 1.1 2.7 0.76 0.75 
Psychosocial discomfort 1.8 1.1 1.8 0.95 0.93 
Worries and concerns 2.3 0.72 2.4 0.89 0.16 
Satisfaction 3.4 0.58 3.3 0.73 0.69 
Table 13. PAC-QOL results for known groups 
Mean scores for "known groups"; with abdominal pain and without abdominal pain. 
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4.6 Discussion 
The study results provide preliminary evidence that suggests PAC-QOL is a reliable 
and valid measure of QOL in patients with chronic idiopathic constipation. 
Satisfactory internal consistency, item total correlation and construct validity have 
been demonstrated. 
The total PAC-QOL scores are higher than those reported by Marquis et al 119. It is 
likely that the current study population is different to that previously evaluated. This 
possibility illustrates the importance of confirming validity and reliability of PAC- 
QOL with regard to evaluation of our own population. 
It would appear that the current study population suffer more severe constipation and 
greater impairment of QOL compared to the subjects in Marquis' paper (as 
evidenced by higher PAC-QOL scores). The patients were recruited from a clinic 
population that deals with the extreme end of the spectrum of constipation sufferers. 
They have severe intractable constipation with chronic symptoms unresponsive to 
conservative therapies implemented in primary and secondary care7. In comparison, 
the subjects studied by Marquis et al were not recruited from such a clinic but were 
recruited from primary care and from the general population through advertising. 
Although Marquis' subjects had chronic constipation, it appears that the burden and 
severity was less extreme. This observation is supported by the fact that more than 
two thirds responded to a simple regime of dietary fibre, magnesium supplement and 
as required low dose bisacodyl. In contrast, the majority of patients seen in the 
constipation clinic in Durham have already failed similar simple regimes and require 
multiple laxatives taken daily at high doses7. 
Confirmations of psychometric properties pertaining to a single administration were 
evaluated in this chapter. Other recognised psychometric evaluations (test-retest 
reliability) require administration of the instrument on more than one occasion. 
Assessment of predictive validity, responsiveness and sensitivity to change (eg 
following treatment) also require the measure to be administered on multiple 
occasions and were not examined. 
Factor analysis is a technique that has also been employed for evaluating internal 
consistency 14o However, it is generally accepted that larger sample sizes are required 
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for such analyses than were available for the current study. For example, a rule of 
thumb is that 10 responses per item are required so that factor analysis for PAC-QOL 
would require a minimum sample of 280. 
The values for Cronbach's a coefficient in the current study were, for the most part, 
lower than those demonstrated by Marquis et al. However, the requirements for 
confirming adequate internal consistency for PAC-QOL in group comparisons are 
met. The item-total correlations also support the reliability of the measure. In only 
two instances did an individual item not appear to correlate at the expected level with 
the other items in its own domain. Item 4 of the physical discomfort score refers to 
how often the subject felt the need to have a bowel movement but been unable to. 
Unlike items 1,2 and 3, item 4 does not directly refer to abdominal discomfort. 
Consequently, it is perhaps unsurprising that the item-total correlation was lower 
than for the other items in the subscale. A similar situation exists in the case of item 
28 of the satisfaction domain where item-total correlation was only 0.28. The other 
items in this domain (items 24-27) specifically explore the patient's sense of 
satisfaction with the frequency and regularity of bowel movements. These concepts 
appear to be different to those evaluated in item 28 which concerns satisfaction with 
treatment rather than satisfaction with frequency of bowel movements. Again, it is 
perhaps unsurprising that item-total correlation is lower for this item. Unfortunately, 
reference data regarding item-total correlations for PAC-QOL are not quoted in the 
literature. 
Overall, the construct validity of the instrument was confirmed. Items in PAC-QOL 
and SF-36 that measured similar concepts shared similarities in construct and their 
scores were correlated. The strength of these associations were moderate rather than 
strong. This was to be expected, because generic QOL measures (eg SF-36) assess 
slightly different concepts to those assessed by a disease specific measure (eg PAC- 
QOL). However, if the study had involved the administration of two generic quality 
of life measures we might have expected stronger associations. 
In four instances weak associations were hypothesised between domains but the 
actual results showed moderate associations. In these cases, the coefficients only just 
qualified as moderate associations. The results did not differ dramatically from the 
original hypotheses of weak relationships. For all intents and purposes, the results 
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can be considered as being supportive of the original hypotheses and thus construct 
validity. 
Completeness of data was high with 86% of subjects responding to all items. This 
suggests that PAQ-QOL contains items that were readily understood and acceptable 
to patients and could be self administrated with minimal respondent burden. 
However, another factor contributing to high completeness is that the study group 
was motivated to complete the measure and be involved in the study. 
No significant floor effects were demonstrated. Ceiling effects were encountered in 
the psychosocial discomfort domain where 18% of patients recorded the highest 
score possible. The percentage almost reached the threshold value of 20% for 
significant ceiling effects 140 The fact that 18% of patients perceived their QOL in 
this domain to be at the worst possible level is relevant if an intervention or 
longitudinal study were to be performed in this patient sample. If the intervention 
actually worsened the existing psychosocial discomfort then this effect would not be 
picked up by changes in their psychosocial discomfort scores. Marquis et al did not 
specifically provide values for ceiling and floor effects in their validation study. 
PAC-QOL was not fully completed by 17 subjects. In each of these cases the degree 
of incompleteness did not invalidate their PAC-QOL scores because the missing data 
handling rule was not violated. As a result all 122 questionnaires could be analysed. 
Item 28 of the satisfaction domain had the highest missing value rate of 12.3%. It is 
recognised that items that are difficult to understand, unclear or present a large 
respondent burden (eg require a lot of cognition to answer) might be omitted by 
respondents. Marquis et al did not report similar problems with missing values for 
item 28 and in fact found high rates of completion. 
It is difficult to believe that this specific item was confusing or ambiguous because 
almost universally the other questions in this domain were completed. The poor 
response to item 28 may be related to some quality that has specific relevance to the 
patients recruited for this study. These subjects may not have responded on the 
grounds that, expressing dissatisfaction with their treatment would be construed as a 
criticism of the clinician who referred them. Therefore, instead of entering a response 
that they feared would be misinterpreted they decided not to answer at all. This 
explanation is of course conjecture. 
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The possibility of performing known group analyses was entertained because of the 
observation made by Marquis et at that patients who did not complain of abdominal 
pain had better QOL. For our study it was hypothesised that QOL would be 
significantly worse in patients with abdominal pain compared to those without. No 
statistically significant differences were detected between the groups. However, the 
limitations of this comparison must be considered when interpreting these results. 
The number of subjects in the no pain group is extremely small (only 4% of the 
whole cohort had no abdominal pain). With such small numbers it is difficult to 
undertake meaningful known group analyses with regard to the presence of pain. 
In our study patients with idiopathic constipation were recruited. Our experience is 
that it can be difficult to classify further into Functional Constipation (FC) or 
Constipation predominant Irritable Bowel Syndrome (IBS-C). This observation has 
9 
. been made by other authors also . 
13 
The description of Functional Constipation, as defined in Rome II, refers to two or 
more symptom sets (present in a defined time period) including straining, lumpy or 
hard stools, sensations of incomplete evacuation, sensation of anorectal obstruction, 
manual manoeuvres to facilitate defection and less than three defecations per week. 
Insufficient criteria for constipation predominant IBS must be present to qualify for 
Functional Constipation. A cardinal feature for classifying as IBS is the presence of 
abdominal pain or discomfort that may be relieved by defecation (in addition to other 
descriptor symptoms). Abdominal pain and discomfort was clearly common in our 
cohort (as evidenced by the PAC-QOL subscale scores). However, it can be difficult 
for patients and clinicians to clarify the relationship between abdominal pain and 
constipation. It is not always any easy task to separate constipation related pain that 
is relived by defecation from constipation pain that is also present but not relieved by 
defecation. It becomes a matter of judgement to decide whether a patient can be 
confidently classified as having exclusively Functional Constipation (FC) and not 
constipation predominant Irritable Bowel Syndrome (IBS-C) when the issue of 
abdominal pain and discomfort is considered. 
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4.7 Conclusion 
The results of the psychometric analyses confirm the reliability and validity of PAC- 
QOL for evaluating QOL in the current population of constipated patients. These 
results support the findings of the previous validation study of the measure 119 
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5 EVALUATION OF THE PSYCHOMETRIC 
PROPERTIES OF PAC-SYM 
5.1 Abstract 
Introduction The psychometric properties of the Patient Assessment of Constipation 
- Symptoms (PAC-SYM) have been examined in American patients and patients 
with opioid induced constipation. The aim of the current study was to confirm the 
reliability and validity of the measure for use in the main study of idiopathic 
constipation patients recruited from a dedicated UK clinic. 
Methods A single self-administration of PAC-SYM was undertaken by 122 patients. 
Item-total correlations and Cronbach's a coefficient were calculated to test reliability 
(internal consistency). Construct validity was assessed by comparison with the Short 
Form 36 Health Survey (SF-36). 
Results Cronbach's a coefficients were high. Moderate to high item-total 
correlations were demonstrated. There were moderate inverse correlations between 
SF-36 and PAC-SYM domains that shared construct similarities. There were weak 
inverse correlations between SF-36 and PAC-SYM domains that did not share 
construct similarities. 
Conclusions The psychometric evaluations suggest that PAC-SYM is reliable and 
valid for assessing symptoms in patients with idiopathic constipation. The use of the 
measure for analysing data from the main study is supported. 
Data collection SRC, YY 
Data entry SRC 
Data Analysis SRC (advice from EM) 
Data interpretation SRC, EM 
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5.2 Introduction 
The PAC-SYM is a relatively new instrument designed to evaluate a patient's 
perception of symptoms of constipation. The measure was developed by Frank and 
colleagues to address the lack of a constipation-specific measure for assessing patient 
experience of constipation and for use in treatment trials for constipation 
125. It was 
designed to complement the Patient Assessment of Constipation - Quality of Life 
Questionnaire (PAC-QOL); the two instruments can be used separately or in 
combination. 
Item content for the PAC-SYM was identified through a review of the literature and 
through focus groups with a range of patients with constipation. The group provided 
the range of symptoms important to patients and provided insight into the language 
used by patients to describe constipation. Two broad symptom classes emerged from 
the focus group work; constipation specific symptoms (i. e. pain with bowel 
movement, frequent small bowel movements, incomplete evacuation) and systemic 
symptoms that were associated with constipation by some patients (i. e. nausea and 
fatigue). 
In an attempt to maximise the relevance of the PAC-SYM assessment for patients, 
the symptom description and language used by patients in the focus groups was used 
to construct the items in the questionnaire. A recall of two weeks was chosen. This 
allowed a period long enough for sufficient occurrences of infrequent bowel 
movements to take place and also reduced recall burden for subjects. Five pilot 
subjects completed the initial questionnaire to evaluate comprehensiveness and ease 
of understanding. 
The initial version of PAC-SYM comprised 44 items, including both constipation- 
specific symptoms (e. g. pain on defecation) and systemic symptoms that patients 
associated with constipation (e. g. nausea). Each item had a 5-point Likert scale 
response format; 23 of these items assessed symptom frequency and 21 assessed 
symptom severity. Item reduction, (based on the initial US validation sample of 216 
patients with a history of chronic idiopathic constipation) led to the deletion of all the 
frequency items, the reduction of the symptom items to twelve and to the removal of 
the items relating to systemic symptoms. 
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PAC-SYM is thus made up of 12 items, covering three domains: abdominal 
symptoms (4 items); rectal symptoms (3 items) and stool symptoms (5 items). The 
items are scored on a five-point (0-4) Likert scale (absent, mild, moderate, severe, 
very severe). High subscale and total scores are indicative of worsening severity of 
symptoms. Sub-scale and total scores are computed by taking the average of item 
scores across the non-missing items in that sub-scale (domain) or across all non- 
missing items in the instrument. The PAC-SYM questionnaire and data handling rule 
are displayed in Appendix A, Table 4 and Appendix A, Table 5. 
Validation of the PAC-SYM has been performed in two previous studies examining 
different groups of patients; chronic idiopathic constipation and opioid induced 
125 
constipation . 
144 
In chronic idiopathic constipation, Frank et al studied 216 American patients from 
multiple sites who participated in a 6-week psychometric evaluation of PAC-SYM. 
Subjects were male and female, aged 18 - 70 years. All had a history of idiopathic 
constipation in the preceding 3 months. Two thirds were recruited from medical 
practices whilst the remainder were recruited through advertising. Subjects were 
assessed over a6 week period; for two weeks they controlled their symptoms with 
their existing treatments. In the subsequent 4 weeks they received a regime of fibre 
supplements and magnesium tablets. For those in whom there was no improvement 
bisacodyl was added. PAC-SYM was completed at week zero, 2 and 6. The 
psychometric proprieties of the PAC-SYM were confirmed and the measure was 
found to be internally consistent, reproducible, valid and responsive to change125 
In the study of opioid induced constipation, in addition to evaluating psychometric 
properties, Slappendel et al tested for differences in opioid-induced constipation 
between a transdermal opioid and an oral sustained-release opioid in patients with 
chronic low back pain. Six hundred and eighty male and female patients were 
randomised to receive either transdermal (n=338) or oral opioid analgesia (n=342) in 
a 13-month, open-label, parallel-group study. Assessments were made at baseline, 
after 29 days and at 13 months. PAC-SYM was completed at these assessments. 
Laxative therapy was used by the patients as required. The authors concluded that 
PAC-SYM was a reliable, valid and responsive measure of the presence and severity 
of opioid-induced constipation. 
84 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
To assess whether the PAC-SYM was appropriate for use in our patients, various 
psychometric characteristics of PAC-SYM (in particular internal consistency 
reliability and construct validity) were assessed and the results compared with those 
from previous studies 125,144 In as far as possible, the methods used in the previous 
studies were used in these analyses. 
Reliability and validity were tested by evaluating internal consistency and construct 
validity respectively. Internal consistency refers to the coherence or consistency of 
items purporting to measure the same trait or concept. Validity refers to the ability 
of an instrument to measure accurately the trait that it was designed to measure. 
Construct validity refers to the establishment of quantitative relationships, based on 
theory or previous empirical evidence, between scores on the instrument under 
examination and those on other instruments measuring similar constructs, and to 
relationships with demographic and clinical variables. 
5.3 Aims 
To evaluate the psychometric properties of PAC-SYM so that the use of the measure 
could be legitimised in the main study. 
5.4 Patients and method 
5.4.1 Subjects 
148 patients with idiopathic constipation were identified as potential participants, 
122 gave consent and completed the questionnaires (section 3.6) 
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5.4.2 Psychometric analysis 
Missing data 
The number and percentage of patients with missing PAC-SYM items was computed 
for the total sample. Where more than half of the items in a particular sub-scale are 
missing, the developers of the PAC-SYM recommend that the sub-scale score should 
be treated as missing (Appendix A, Table 5). 
Scores 
Sub-scale scores (bowel symptoms; abdominal symptoms; rectal symptoms) and 
PAC-SYM total scores were calculated according to the developers' instructions, by 
summing scores across all non-missing items in the sub-scale (or total instrument) 
and dividing by the number of non-missing items in that sub-scale (or in the 
instrument as a whole). Data handling rules are described in Appendix A, Table 5. 
The mean PAC-SYM scores from our study were compared to those from the 
validation study (Frank et al125) using independent sample t-tests. 
Two comparisons were made. The first comparison was with the mean scores of all 
patients studied by Frank et al. The second comparison was with the mean scores of 
a subset of patients who failed to respond to laxative treatment. Comparison with 
these patients was performed because they were deemed to share similarities with 
our cohort in terms of severity (i. e. severe refractory constipation resistant to 
therapy). The non-responder group in the Frank et al125 study comprised 36 patients 
unresponsive to four weeks with either dietary fibre and magnesium or dietary fibre 
with magnesium plus bisacodyl. The group contained patients in whom symptoms 
remained static with these treatments (n = 28) and patients in whom symptoms 
worsened (n = 6) with treatment. 
Ceiling and floor effects 
Ceiling and floor effects for PAC-SYM domain scores were evaluated using the 
techniques described in section 4.4.2. 
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Internal consistency 
Reliability of the PAC-SYM domains was assessed using Cronbach's a coefficient (a 
coefficient of >0.70 was used to define a minimum standard of internal consistency 
for group comparisons 141). A further measure of internal consistency was provided 
by corrected item-total correlations (section 4.4.2). 
Construct validity 
Construct validity in this study was assessed by examining the pattern of correlations 
between PAC-SYM and SF-36 scores, reflecting the analyses conducted by 
Slappendel and colleagues' 44. More specifically, we tested the proposition that PAC- 
SYM and SF-36 scores that share similarities in construct (e. g. pain) would be 
correlated with one another. Conversely, the association between domains that 
measure different concepts should be weaker (i. e. where the SF-36 and PAC-SYM 
domains do not share similarities of construct). Hypotheses regarding the pattern of 
correlations expected were based on findings from the previous validation study in 
patients with opioid induced constipation 
144 Since high scores on the SF-36 are 
indicative of better quality of life, while high scores on the PAC-SYM denote more 
severe symptoms, we expected correlates to be negative, though low to moderate. 
SPSS® version 12 for Windows (SPSS, Chicago, Illinois, USA) was used to analyse 
data. A value p<0.05 was considered statistically significant. 
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5.5 Results 
Of the 148 patients identified as potential participants, informed consent was 
obtained from 122. The mean age of this group was 43 years (sd 14.0). There were 
119 females (97%) with a mean age of 42.5 years (sd 13.9) and 4 males (3%) with a 
mean age of 57.3 years (sd 5.3). The mean duration of constipation was 17.7 years 
(sd 15.5). 
There was no significant difference between those patients who agreed to participate 
in the study and those who did not give consent for inclusion in the study in terms of 
age, sex or duration of constipation (Table 6). 
5.5.1 Missing data 
Data completeness was high. The number of patients who fully completed PAC- 
SYM was 112 (92%). Of the 10 patients who did not complete every item, 7 left a 
single item blank and 3 left two items blank. Missing item rates were uniformly low; 
0.8% for items 3,9,11 and 12, item 5 (1.6%), item 4 (2.5%) and item 12 (3.3%). 
5.5.2 PAC-SYM scores 
The mean overall PAC-SYM score was 2.13 (sd 0.68). Mean scores for each of the 
three domains were: stool symptoms 2.35 (sd 0.89); abdominal symptoms 2.39 (sd 
0.89); rectal symptoms 1.40 (0.97). The mean scores for stool and abdominal 
symptoms thus correspond to a rating between `moderate' and `severe', while that 
for rectal symptoms corresponds to a rating between `mild' and `moderate'. 
Table 14 compares the PAC-SYM scores from our study with those from 157 
patients with idiopathic constipation studied by Frank et al 125. Overall PAC-SYM 
score was significantly higher in our study than in the Frank et al study (p <0.001). 
Table 15 makes the comparison with the subset of patients studied by Frank et al 
who had refractory constipation despite laxative treatment. Overall PAC-SYM score 
was significantly higher (p <0.001) in our sample, as were domain scores for 
abdominal and stool symptoms (p = 0.002 and p <0.001 respectively). Mean scores 
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for rectal symptoms were slightly higher in Frank et al's study but the difference was 
not statistically significant (p = 0.195). 
Current study Frank et al 
Idiopathic Idiopathic t-test 
constipation constipation 
n=122 n=157* 
95% Cl for 
Domains Mean sd Mean sd mean tp 
difference 
Overall PAC-SYM 2.13 0.68 1.61 0.69 0.36,0.68 6.28 <0.001 
Abdominal 2.39 0.89 2.05 0.89 0.13,0.55 3.17 0.002 
symptoms 
Rectal symptoms 1.40 0.97 1.54 0.83 0.35,0.07 -1.30 0.195 
Stool symptoms 2.35 0.89 0.98 0.86 1.16,1.59 12.94 <0.001 
Table 14: Comparison of mean PAC-SYM scores 
Current study Frank et a1725 
Idiopathic Refractory 
constipation 
idiopathic t-test 
constipation 
n=122 n=36* 
95% Cl for 
Domains Mean sd Mean sd mean tp 
difference 
Overall PAC-SYM 2.13 0.68 1.44 0.66 0.44,0.94 5.38 <0.001 
Abdominal 2.39 0.89 1.68 0.90 0.37,1.04 4.20 <0.001 symptoms 
Rectal symptoms 1.40 0.97 0.73 0.66 0.33,1.01 3.88 <0.001 
Stool symptoms 2.35 0.89 1.68 0.80 0.34,0.99 4.06 <0.001 
* Subgroup of 36 patients from the initial 157 patients (see table 12) who were 
unresponsive to laxatives 
Table 15: Comparison of PAC-SYM scores in refractory constipation 
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5.6 Floor and ceiling effects for PAC-SYM 
The number of patients that recorded the maximum score of 4 in each domain was 
low; no appreciable ceiling effects were demonstrated. These results are displayed in 
Table 16. Just fewer than 10% of patients had the lowest possible score of 0 for rectal 
symptoms. This value did not reach the threshold of 20% indicative of marked floor 
effects. 
Number of patients with Number of patients with the 
the minimum possible maximum possible domain 
domain score (%) score (%) 
Overall PAC-SYM 0 (0) 0 (0) 
Abdominal symptoms 2(1.6) 4 (3.3) 
Rectal symptoms 12 (9.8) 1 (0.8) 
Stool symptoms 1 (0.8) 5 (4.1) 
Table 16. Ceiling and floor effects for PAC-SYM. 
The distributions of responses for each domain are displayed in frequency histograms 
(Figure 7, Figure 8, Figure 9). Distributions of responses were uni-modal. For the 
rectal domain there was a positively skewed distribution. Normal distributions were 
observed for abdominal and stool domains. 
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Figure 7. Histogram of responses for abdominal symptoms score of PAC-SYM. 
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Figure 8. Histogram of responses for rectal symptoms score of PAC-SYM. 
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Figure 9. Histogram of responses for stool symptoms score of PAC-SYM. 
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5.6.1 Internal consistency for PAC-SYM 
Internal consistency of PAC-QOL was assessed using Cronbach's a coefficient. 
Cronbach's a coefficient values were all above 0.7 suggesting adequate internal 
consistency for each domain (Table 17). 
The coefficients for item-total correlations are also shown in Table 17. The range of 
correlations was 0.48 to 0.79. All items met the criteria for item-total correlation with 
their own domain (coefficient > 0.4). 
Table 18 compares Cronbach's a coefficients from our study with those obtained by 
Frank et al and Slappendel et al. Our values for stool and abdominal symptoms were 
similar to those from the two previous studies, but our values for the rectal subscale 
were lower. 
Cronbach's a Item-total correlations 
Total score 0.93 0.67- 0.19 
Abdominal symptom domain 0.85 0.69-0.79 
Rectal symptom domain 0.77 0.57-0.68 
Stool symptom domain 0.78 0.48-0.62 
Table 17. Cronbach's a values and item-total correlations for each domain of PAC- 
SYM. 
Cronbach's a Cronbach's a Cronbach's a 
Frank et al 125 Slappendal et al 144 Current study 
Total score 0.89 0.91 0.93 
Abdominal symptom 0.80 0.83 0.85 domain 
Rectal symptom domain 0.87 0.90 0.77 
Stool symptom domain 0.80 0.78 0.78 
Table 18. Comparison of Cronbach's a values for PAC-SYM from current and previous 
studies. 
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5.6.2 Construct validity of PAC-SYM 
The correlation coefficients are shown in Table 19 and the expected and actual 
associations displayed in Table 20. As expected, there was a moderate negative 
association between PAC-SYM abdominal symptoms and the bodily pain domain of 
SF-36 (r = -0.40). As hypothesised, weak negative associations existed between 
PAC-SYM scores and SF-36 physical functioning, role physical, general health, 
vitality, social functioning, role emotional and mental health (r -0.39 to -0.04). 
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PAC-SYM domain 
SF-36 domain Abdominal Rectal Stool 
Physical functioning -0.04 -0.15 -0.19 
Role physical -0.18 -0.12 -0.15 
Bodily pain -0.40 -0.11 -0.08 
General health -0.22 -0.17 -0.17 
Vitality -0.27 -0.15 -0.20 
Social functioning -0.29 -0.06 -0.23 
Role emotional -0.19 -0.15 -0.19 
Mental health -0.28 -0.09 -0.24 
Table 19. Pearson correlation coefficients between PAC-SYM domains and SF-36 
domain scores. 
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5.7 Discussion 
The results provide preliminary evidence of the reliability and validity of the PAC- 
SYM as a measure of symptom severity in patients with chronic idiopathic 
constipation. Satisfactory internal consistency has been demonstrated and the pattern 
of correlations between PAC-SYM and SF-36 scores provides evidence of construct 
validity. 
Completeness of data was high with 92% of subjects responding to all items. This 
reflects the fact that PAC-SYM was constructed for ease of self-administration, with 
minimal respondent burden and contains items that were readily understood and 
acceptable to patients. The fact that the study group was highly motivated to take part 
may have also contributed to the high response rate. 
The overall PAC-SYM scores are higher then those reported by Frank et al. This 
suggests severity of constipation in the current study is greater then that previously 
evaluated by other authors 125. 
In our study no significant ceiling effects were demonstrated. Furthermore, marked 
floor effects were not found. Although 9.8% of patients recorded the lowest score on 
the rectal sub-scale score (suggesting mild rectal symptoms), this percentage did not 
reach the threshold value of 20% that is widely used to define a significant floor 
effect 113. The observation that 9.8% of patients scored at the best possible level on 
this single administration is nonetheless worth noting particularily if an intervention 
study was to be performed in this patient population. On the assumption that the 
intervention would improve symptoms, post intervention PAC-SYM scores would be 
expected to fall. However, patients with floor effects at baseline in the rectal domain 
would not be able to score any "better" than their pre-intervention PAC-SYM. 
The floor and ceiling effects observed in our study were less marked than in the 
validation study in patients with opioid induced constipation 144. For example, in 
patients requiring opiate analgesics, the percentage reporting the lowest scores (floor 
effect) were 30%, 25% and 50% for the abdominal, stool and rectal sub-scales 
respectively. In comparison, in our study, floor effects in the abdominal, stool and 
rectal sub-scales were lower; 1.6%, 9.8% and 0.8% respectively. Patients with opioid 
induced constipation represent a different etiological group to those with idiopathic 
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constipation and this may explain differences in perception of symptom severity and 
lead to a different pattern of floor effect. 
The Cronbach's a coefficients in the current study were slightly lower than those 
demonstrated by Frank et al in the original validation study. However, the 
requirements for confirming adequate internal consistency are met. Item-total 
correlations also support the reliability of the measure. 
The strength and direction of associations demonstrated between PAC-SYM and SF- 
36 domains were all as hypothesised. This supports the construct validity of PAC- 
SYM. These findings are in keeping with those reported by Slappendel et al who also 
assessed the psychometric properties of the measure and confirmed validity144 . 
PAC-SYM was administered once in the main study. Therefore, only those 
psychometric properties pertaining to a single administration were evaluated. 
Evaluation of test-retest reliability and responsiveness to change in this patient 
population remains to be established. 
Known group analysis was not undertaken. This analysis would have involved 
comparing the PAC-SYM scores from two groups where symptom severity in one 
group was known to be significantly different to that in the other group. Frank et al 
showed that PAC-SYM scores were significantly higher in constipated patients who 
did not respond to fibre and laxatives. The design of the current study did not involve 
assessment of response to a treatment regime. Consequently, known groups that are 
similar to those described by Frank et al are not available to replicate the analyses 
previously performed. Furthermore, we did not analyse validity with respect to 
patient and/or clinician rating of severity of condition. Further study of test-retest 
reliability could be performed in this cohort of patients in the future. 
5.8 Conclusion 
The results of the psychometric analyses provide preliminary evidence of the 
reliability and validity of PAC-SYM for evaluating symptoms in the current 
population of constipated patients. These results support the findings of the previous 
12s , iaa. validation study in idiopathic and opioid induced constipation 
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6 EVALUATION OF THE PSYCHOMETRIC 
PROPERTIES OF SF-36 
6.1 Abstract 
Introduction The psychometric properties of the Short Form Medical Outcomes 
Survey (SF-36) have previously been evaluated in the general population and in a 
variety of disease states. Psychometric analyses were performed on data obtained 
from the current study population to confirm reliability and validity in patients with 
idiopathic constipation. 
Methods A single self-administration of SF-36 was undertaken by 122 patients. 
Item-total correlations and Cronbach's a coefficient were calculated to test reliability 
and internal consistency. 
Results Cronbach's a coefficients and item-total correlations were high. 
Conclusions The psychometric evaluations suggest that SF-36 is reliable and valid 
generic measure of QOL in patients with idiopathic constipation. The use of the 
measure for analysing data from the main study is supported. 
Data collection SRC, YY 
Data entry SRC 
Data Analysis SRC (advice from EM) 
Data interpretation SRC, EM 
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6.2 Introduction 
The Short Form Medical Outcomes measure (SF-36) is an established measure of 
generic quality of life. In the studies described in the preceding sections, SF-36 has 
been used as a standard to compare PAC-SYM and PAC-QOL against so that their 
psychometric properties can be evaluated. This approach has been adopted by other 
authors who have validated condition-specific measures 125.144 An assumption here 
is that SF-36 itself has robust psychometric properties. This assumption is supported 
by the results of validation studies in the general population and in diverse disease 
states (hypertension, congestive heart failure, type II diabetes etc) 145. SF-36 has also 
previously been employed in studies of constipated patients although data regarding 
the psychometric properties of the measure are not reported 146. The purpose of the 
following study was not to undertake an exhaustive revalidation of the measure in 
patients with chronic constipation. Rather, it was to assess some key psychometric 
properties using the available data so that the use of SF-36 in the main study could be 
supported. 
6.3 Aims 
To evaluate psychometric properties pertaining to SF-36 using data from the current 
population of constipated patients. 
6.4 Patients and methods 
6.4.1 Subjects 
One hundred and forty-eight patients with idiopathic constipation were identified as 
potential participants and 122 provided consent and completed the questionnaires 
(section 3.6). 
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6.4.2 Psychometric analysis 
Missing data 
As previously stated, the accuracy of a measure depends on the completeness of 
responses. If a patient does not answer a SF item, no response code can be entered 
for that item. The response is therefore treated as "missing". If all items have 
missing responses, no domain scores can be calculated for that patient. 
QualityMetric provide an online scoring system that employs scoring algorithm 
software. These algorithms can still score many records if only some item responses 
are missing. The algorithm substitutes a patient specific estimate for missing items 
when the subject has answered at least half of the items in any domain. The average 
score across completed items in the same domain for that patient is used as the 
substitute response. This approach is considered to be a psychometrically sound way 
of estimating the substitutions 121. The QualityMetric online scoring system also 
provides a missing data estimator (MDE) that can be employed to maximise the data 
available for analysis. This makes it possible to calculate domain scores for many 
respondents who do not answer every survey item but for whom scores would be 
missing if only the substitution method described above was used. 
Ceiling and floor effects 
The techniques described in section 4.4.2 were used to assess ceiling and floor 
effects. 
Internal consistency and Item-total correlation 
Cronbach's a coefficient and corrected correlations between the SF items and 
domain totals were calculated, as described in section 4.4.2. 
Known-group validity 
Brazier et al measured QOL in 1980 general practice patients of different ages via a 
postal survey. The patients were selected at random from the lists of practices in 
South Yorkshire. In the physical functioning domain there were statistically 
significant differences in SF-36 scores were found between young and old patients. 
Patients in the 16-24 years age category reported a better QOL in these domains than 
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those in the 65-74 age groups. Furthermore, males scored significantly higher than 
females in all domains except general health'47 
These observations allowed us to evaluate known group validity of SF-36 in the 
current study population. It was hypothesised that significant differences in SF scores 
will be demonstrated in patients of different sex and age. Student's t Test (and Mann 
Whitney Test for non-normally distributed data) were used to compare domain 
scores between known groups defined by age and sex. 
Ideally, known group analyses in our study would have been informed by 
observations reported from previous studies of constipated patients that used SF-36. 
Unfortunately, studies that report clear differences in SF-36 scores between groups 
defined by sex and age in populations similar to our own are lacking. 
SPSS® version 12 for Windows (SPSS, Chicago, Illinois, USA) was used to analyse 
data. A value p<0.05 was considered statistically significant. 
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6.5 Results 
There was no significant difference between those patients who agreed to participate 
in the study and those who did not give consent for inclusion in the study in terms of 
age, sex distribution or duration of constipation (Table 6). 
6.5.1 SF-36 scores 
The mean SF-36 domain scores are displayed in Table 21. Figure 10 shows the norm 
based domain scores. In norm based scoring each of scale or domain is scored to 
have the same general population mean (50) and the same standard deviation (10 
points). 
Domain Mean sd 
Physical functioning PF 71.3 26.8 
Role physical RP 61.1 32.4 
Bodily pain BP 40.6 21.2 
General health GH 48.4 22.8 
Vitality VT 35.3 22.6 
Social functioning SF 53.9 31.8 
Role emotional RE 62.1 32.6 
Mental Health MH 53.6 24.6 
Table 21. Mean SF-36 domain scores. 
103 
Best 
health 
Norm 
poorest 
health 
'hy, n. 31 Role Bodily pain General Vitality Social Role Mental 
functioning physical health functioning emotional health 
Figure 10. Norm based scores for SF-36 domains. 
In norm based scoring each domain is scored to have the same general population 
mean (50) and the same standard deviation (10 points). Therefore, a domain score 
below 50 represents health status that is below average for the general population. 
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6.5.2 SF-36 completion 
Data completeness was high. The number of patients that fully completed SF-36 was 
104 (85%). Missing item rates were uniformly low; ranging from 0.8% to 4.1% (item 
GH03 of the general health domain). Although some items were missing, it was still 
possible to calculate domain and summary scores because the extent to which 
responses were missing did not invalidate the scoring algorithms. The missing data 
estimator (MDE) did not have to be utilised because of the satisfactory level of 
completeness. 
6.5.3 Floor and ceiling effects for SF-36 
The number of patients that recorded the minimum score of 0 in each domain was 
low and no appreciable floor effects were demonstrated (Table 22). Modest ceiling 
effects were seen for the physical functioning (18%), role physical (21.3%), social 
functioning (14.8%) and role emotional (27.9%) domains. There was no appreciable 
ceiling effect in the other domains. Table 23 shows a comparison of the floor and 
ceiling effects of the current study with the findings reported by Ware et al 148 
The distributions of responses for each domain are shown by frequency density 
histograms (Figure 11 and Figure 12). Distributions of responses were uni-modal. 
For the physical functioning domain there was a negatively skewed distribution. 
Normal distributions were observed in the other domains. 
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Number of patients with 
the minimum possible 
domain score (%) 
Number of patients with 
the maximum possible 
domain score (%) 
Physical functioning PF 3 (2.5) 22 (18) 
Role physical RP 8 (6.6) 26 (21.3) 
Bodily pain BP 5 (4.1) 3 (2.5) 
General health GH 3 (2.5) 1 (0.8) 
Vitality VT 11 (9.0) 0 (0.0) 
Social functioning SF 10 (8.2) 18 (14.8) 
Role emotional RE 10 (8.2) 34 (27.9) 
Mental health MH 1 (0.8) 3 (2.5) 
Table 22. Ceiling and floor effects for SF-36. 
The minimum possible score for SF-36 domains (not using norm based scoring) is 0 
and the maximum possible score is 100. 
Floor effect (%) Ceiling effect (%) 
Current study Ware et al148 Current study Ware et al148 
Physical functioning PF 32.5 1.0 18.0 25.6 
Role physical RP 6.6 2.1 21.3 47.4 
Bodily pain BP 4.1 1.0 . 2.5 22.0 
General health GH 2.5 0.0 0.8 6.0 
Vitality V 9.0 1.1 0.0 2.1 
Social functioning SF 8.2 1.0 14.8 55.7 
Role emotional RE 8.2 1.0 27.9 60.2 
Mental health MH 0.8 0.1 2.5 5.1 
Table 23. Comparison of ceiling and floor effects from the current study with previous 
studies. 
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Figure 11-Histogram of responses for physical functioning, role physical, bodily pain 
and general health domains of SF-36. 
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Figure 12. Histogram of responses for vitality, social functioning, role emotional and 
mental health domains of SF-36. 
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6.5.4 Item-total correlation for SF-36 
The coefficients for item-total correlations are shown in Table 24. The range of 
correlations was 0.42 to 0.93. All items met the criteria for item-total correlation with 
their own domain (r > 0.4). 
6.5.5 Internal consistency for SF-36 
Internal consistency of SF-36 was assessed using Cronbach's a coefficient. The 
coefficients were above 0.7 suggesting adequate internal consistency for group 
comparisons for each domain (Table 24). Table 25 shows a comparison with 
Cronbach's a coefficients obtained by Ware et altos. 
Cronbach's a Item-total correlations 
Physical functioning 0.94 0.60-0.80 
Role physical 0.96 0.89-0.93 
Bodily pain 0.74 0.58 
General health 0.83 0.42-0.70 
Vitality 0.80 0.54-0.72 
Social functioning 0.86 0.76 
Role emotional 0.95 0.86-0.91 
Mental health 0.88 0.64-0.80 
Table 24. Cronbach's a coefficients and item-total correlations for SF-36 domains. 
Cronbach's a 
current study 
Cronbach's a 
Ware JE et al 148 
Physical functioning 0.94 0.94 
Role physical 0.96 0.95 
Bodily pain 0.74 0.85 
General health 0.83 0.83 
Vitality 0.80 0.85 
Social functioning 0.86 0.88 
Role emotional 0.95 0.93 
Mental health 0.88 0.85 
Table 25. Comparison of Cronbach's a coefficients for SF-36 from current and 
previous studies. 
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6.5.6 Known-groups analysis 
The results of the known group analyses are summarised in Table 26 and Table 27. 
There were 12 patients in the age category 16-24 years and 14 patients in the 65-74 
age category. No significant differences were demonstrated in the domain scores 
between the two age groups except in the PF domain. Here, the physical functioning 
score was significantly lower in the 65-74 age category (p=0.02). 
Female patients accounted for 97% of the study population. In male patients, scores 
were significantly higher in the physical functioning and bodily pain domains (Table 
27). 
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Age category 
16-24 years 65-74 years 
n=12 n=14 
Mean score sd Mean score sd p value 
Physical functioning 84.1 17.8 60.2 28.1 0.02 * 
Role physical 60.4 37.5 58.57 30.6 0.89 
Bodily pain 36.3 24.4 36.0 22.1 0.98 
General health 41.2 18.9 49.1 19.6 0.35 
Vitality 32.2 21.3 40.8 22.1 0.33 
Social functioning 51.3 36.7 52.9 32.9 0.98 
Role emotional 62.5 39.1 61.9 35.1 0.92 
Mental Health 51.7 22.7 56.5 23.9 0.60 
* Mann Whitney test 
Table 26. Mean differences in SF-36 domain scores between age categories. 
Mean domain scores 
Female Male p value 
n=119 n=4 
sd sd 
Physical functioning 70.7 26.9 90.0 7.1 0.003 
Role physical 60.8 32.8 85.9 16.4 0.120 
Bodily pain 39.7 20.8 67.8 11.2 0.009 
General health 48.0 22.9 62.0 15.8 0.227 
Vitality 35.0 22.7 46.9 19.4 0.303 
Social functioning 53.0 31.8 81.3 16.1 0.080 
Role emotional 61.3 32.7 83.3 20.4 0.185 
Mental health 52.1 24.9 68.8 8.6 0.212 
Table 27. SF-36 domain scores for male and female patients. 
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6.6 Discussion 
The results suggest that SF-36 is a reliable and valid measure of QOL in patients 
with chronic idiopathic constipation. Satisfactory internal consistency, item total 
correlation and construct validity have been demonstrated. 
The detrimental impact of constipation on QOL is demonstrated by the norm based 
scores; in all domains scores are less than 50. This suggests that QOL is lower than 
in the normal general population. 
Although completeness of data was high (85% of subjects responding to all items), 
this was less than for PAC-SYM and PAC-QOL. SF-36 contains more items than 
these other measures. Completing it fully may have been a greater burden for 
respondents leading to lower completeness. Another issue relating to the reduced 
completeness compared to PAC-SYM and PAC-QOL is patient perception of the 
relevance of the SF-36 items. Since the PAC items were specific to constipation (the 
reason that the subjects had been referred to the clinic) the patients may have had a 
greater motivation to answer these fully compared to the SF-36 items that appear less 
relevant to their primary complaint. 
No significant floor effects were demonstrated. Modest ceiling effects were seen for 
the physical functioning, role physical, social functioning and role emotional 
domains. This suggests that despite suffering constipation, a proportion of patients 
are still able to perform with maximum ability in these domains. As a result of this 
ceiling effect it would be difficult to detect "improvement" post intervention in these 
domains if a treatment study was performed. These subjects would unable to score 
any "better" than their pre-intervention domain score. The ceiling effects reported by 
Ware et al were greater than demonstrated in the current study. Ware et al evaluated 
SF-responses from the US normal general population where we would expect higher 
proportions of subjects displaying maximal QOL in any given domain (and therefore 
. 
148 greater ceiling effect) , 
149 
The Cronbach's a coefficients in the current study were comparable to those 
previously reported except in the bodily pain domain (0.74) 148. However, adequate 
internal consistency was achieved in this and all other domains. Item-total 
correlations also suggest reliability. 
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The known group analyses were based on the observation made by Brazier et al who 
found that QOL measured by SF-36 was higher in males than females and higher in 
young patients than older patients 147. In the current study there were only 4 male 
patients. Consequently, the results of known group validity analyses regarding the 
effect of sex must be interpreted with this in mind. It was possible to reproduce the 
analyses undertaken by Brazier with regard to age categories. In their study no 
difference was found in QOL between the young an old, except in the physical 
functioning domain. A similar pattern emerged in our study with young patients 
reporting a better QOL for physical functioning compared to the older patients. No 
other differences were found in the domains with regard to age. Although these 
findings support the known group validity of SF-36, the fact that the known groups 
contained relatively small numbers and a female preponderance must be born in 
mind as a limitation of these particular analyses. 
6.7 Conclusion 
The results of the psychometric analyses confirm the reliability and validity of SF-36 
for evaluating symptoms in the current population of constipated patients. 
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7 PREDICTORS OF QUALITY OF LIFE IN 
REFRACTORY IDIOPATHIC CONSTIPATION. 
7.1 Abstract 
Introduction Determining predictors of disease specific QOL in refractory 
constipation could enable clinicians to identify patients in whom the impact and 
severity of constipation is greatest. Predictors could be used to target therapies to 
those with greatest need. The aim was to establish whether disease specific QOL 
depends on: demographics, symptoms assessed by clinician, symptoms assessed by 
the patient, results of objective tests, and / or the patient's perception of health. 
Methods 122 patients were evaluated by; clinician led assessment of demographics 
and symptoms; self-administration of PAC-SYM, PAC-QOL and SF-36; colonic 
transit study and defecating proctography. Multiple linear regression analyses were 
used to identify predictors of disease specific QOL (PAC-QOL). 
Results Symptom severity (expressed through PAC-SYM) and patient perception of 
mental health were the main explanatory variables for disease specific QOL. Mental 
health scores (indicating psychological morbidity) were lower compared to those in 
the general population. There was little association between demographics, symptom 
intensity assessed by clinician, colonic transit or proctography and disease specific 
QOL. 
Conclusions Therapeutic strategies that reduce abdominal and stool symptoms and 
address problems with psychological wellbeing may offer a way of improving QOL 
in refractory idiopathic constipation. 
Data collection SRC, YY 
Data entry SRC 
Data Analysis SRC (advice from TH) 
Data interpretation SRC, TH, YY 
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7.2 Introduction 
Idiopathic constipation can be a severe chronic refractory illness that has a 
significant impact on a patient's life. Measuring the impact of this condition has 
traditionally been undertaken by clinicians assessing symptom severity (through 
history taking at consultation) or by performing objective investigations. As 
previously stated, there may be inaccuracy and bias inherent in the use of symptom 
evaluation by clinician as the main measure of severity (section 2.1.2). Furthermore, 
the role of objective tests for assessing severity in constipation is not fully explored. 
As with other chronic diseases it is possible that measuring quality of life (QOL) 
provides a more meaningful insight into the complete experience of the affected 
individual. 
Identifying factors associated with poor QOL may help anticipate the problems faced 
by patients and allow effective targeting of therapy to those with the greatest need. 
The objective of this element of the research study was to explore empirically the 
relationship between potential predictor variables and constipation specific QOL. 
7.3 Aims 
The aim was to explore the relationship between disease specific quality of life and 
several key factors including: demographics, symptoms assessed by clinician, 
constipation related variables evaluated by objective tests, symptoms assessed by 
patient and the patient's perceived health status. The objective was to identify 
predictors of disease specific quality of life. 
The findings of previous studies were used to guide the selection of variables for 
inclusion in regression analysis to identify predictors of QOL. For example, Damon 
et al have previously shown a relationship with QOL (measured by GIQLI) and 
symptom intensity expressed as a cumulative score (Cleveland Constipation score) 
and, Grotz and Wald have shown greater psychological distress in subjects with 
2,37,135 transit constipation compared to slow transit constipation. '37'135 . These 
variables were included in the regression analyses. For other variables, the literature 
does not suggest extensive study of their relationship with disease specific QOL. 
However, there is a held belief that these factors are important for assessing 
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constipation (section 1.5 and section 2.1.8). Therefore, variables such as the presence 
of coexisting medical conditions, psychiatric illness, history of child birth, surgery 
and proctographic parameters were also included in the regression analysis based on 
pragmatic grounds and our desire to investigate their relationship with QOL. 
In our study no a priori assumptions were made regarding the relationships between 
the variables. Consequently, no specific hypotheses were tested regarding 
determinants of disease specific QOL. 
7.4 Materials and methods 
7.4.1 Study design 
This was a cross-sectional observational study of individuals attending a district 
general hospital in the North East of England. Appropriate ethical approval was 
obtained (section 7.7). Subjects were recruited from the constipation clinic at 
University Hospital North Durham. Data were collected by patient self- 
administration of questionnaires and by clinician led interview. Data obtained from 
the results of objective tests were also analysed (proctography and colonic transit 
study). 
7.4.2 Patients 
Patients with idiopathic constipation were identified at the constipation clinic at the 
University Hospital of North Durham. The criteria used to define constipation are 
summarised in Figure 13. All subjects were clinically assessed in a consultant led 
clinic and had undergone investigation to exclude organic causes for their 
constipation. Inclusion and exclusion criteria are summarised in section 3.4. 
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At least 12 weeks, which need not be consecutive, in the preceding 12 
months of two or more of; 
(1) Fewer than 3 defecations /week 
(2) Straining in more than 25% of defecations; 
(3) Lumpy or hard stools in more than 25% of defecations; 
(4) Sensation of incomplete evacuation in more than 25% of defecations; 
(5) Sensation of anorectal obstruction/blockade in more than 25% of defecations; 
(6) Manual manoeuvres to facilitate in more than 25% of defecations 
e. g. (digital evacuation, support of the pelvic floor) 
Figure 13. Diagnostic criteria for constipation used in the study. 
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7.5 Data collection 
Information regarding several essential themes was gathered: 
Patient demographics; 
The results of an evaluation by the clinician of salient symptoms and 
characteristics of constipation; 
The results of a patient self-assessment of symptoms; 
The results of a patient self-assessment of perceived health status; 
The results of a patient self-assessment of disease specific QOL. 
7.5.1 Patient demographics, characteristics and salient symptoms 
Data were gathered at face to face interview with the clinician including age, sex and 
duration of constipation for each subject. Standardised questions regarding salient 
symptoms and characteristics were asked during the clinician led interview from a 
questionnaire format. A two week period of recall was used to answer the questions. 
The content of the questions was based on the Cleveland Clinic Score 36. 
The 11 questions evaluated bowel frequency, frequency of laxative use, frequency of 
unsuccessful defecatory attempts, time spent attempting to defecate, straining during 
defecation, defecatory pain, sensation of incomplete evacuation, digital manoeuvres 
to assist defecation, vaginal manoeuvres to assist defecation, abdominal pain and 
abdominal bloating. Likert scales were used with higher scores indicating a greater 
intensity or severity of the symptom or characteristic assessed by the question. In 
keeping with the Cleveland Clinic Score, the scores for each individual question 
were combined to calculate a cumulative constipation score. Higher scores indicated 
a greater intensity or severity of constipation. The range of possible scores in the 
cumulative constipation score is from 0 to a maximum of 44. 
In addition, data were obtained regarding the duration of constipation and the age at 
onset. Details regarding a subject's exposure to childbirth, exposure to abdominal / 
pelvic surgery, presence of coexisting medical conditions and psychiatric history 
were gathered. Details of the variables that were evaluated at the clinician led 
interview are summarised in Appendix A, Table 6. 
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Data regarding the patients' perception of their constipation specific symptoms were 
gathered using the PAC-SYM questionnaire (section 2.1.3 and section 5) 125 . PAC- 
SYM assesses 3 domains (stool symptoms, rectal symptoms and abdominal 
symptoms). Individual domain and totals are scored from 0 to 4, with a high score 
indicating increasing severity of symptoms. The psychometric properties have been 
125 
confirmed in our own population (section 5) and by other authors 
7.5.2 Quality of life assessment 
Disease-specific and generic measures of quality of life were included. PAC-QOL 
was used to evaluate disease specific quality of life. It comprises 4 domains 
(constipation related worries and concerns, physical discomfort, psychosocial 
discomfort and satisfaction). Individual domain and totals are scored from 0 to 4. 
High domain or overall PAC-QOL scores indicate poor quality of life. The 
psychometric properties of the measure have been evaluated in our population 
(section 4) and by other authors studying patients with constipation 119,144 . 
The SF-36 is a generic measure of general health status 117 and as such should 
capture the impact on functioning and well-being of co existing conditions in 
addition to the effect of the index condition (constipation). The SF-36 domains 
include; physical functioning, social functioning, mental health, role limitations due 
to physical problems, role limitations due to emotional problems, vitality, bodily pain 
and general health perception. Scores in the eight domains can be combined to 
produce standardised norm referenced summary scores: physical and mental 
component summary scores (PCS and MCS). High component summary scores 
indicate better health and QOL. 
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7.5.3 Colonic transit 
Total and segmental colonic transit time was determined using radio-opaque marker 
53 
studies based on a method described by that Metcalf et al . The protocol involves 
the ingestion of capsules containing 24 radio-opaque markers (Konsyl, Easton, USA) 
on each of days 1,2 and 3 with a plain abdominal x-ray taken on day 4. Subjects are 
instructed to discontinue laxative therapy or treatments that could interfere with 
intestinal motility for the duration of the investigation. 
The method is a multiple bolus single x-ray model. To determine the colonic transit 
time (CTT) time in a given segment the following equation is applied; 
CTT; =n; (AT/N) 
CTTi represents the colonic transit within segment ; and n; is the number of markers 
seen on the x-ray in segment ;. N is the number of markers ingested each day (24 in 
this current study) and AT is the time interval between ingestion of markers (24 
53 hours in the present study) . 150. 
This technique works under the assumptions that marker transit has achieved a 
steady state on the day of the abdominal x-ray and that the patient has not deviated 
from the study protocol or taken their radio-opaque markers incorrectly 151. Subjects 
who have been unable to discontinue their laxative therapy, who are taking agents 
that affect motility or who have diarrhoeal states may have colonic segments with 
Aso few or no markers on the day of the abdominal x-ray 
To validate the technique, Metcalf et al studied normal non-constipated individuals. 
They demonstrated mean total colonic transit times in men of 30.7 hours (sd 3.0) and 
38.8 hours (sd 2.9) in women 53. In the absence of normal controls obtained from a 
cohort in the North East of England, these results can be used as a guide for arbitrary 
definitions of slow colonic transit. 
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7.5.4 Proctographic assessments 
The technique for radioisotope defecating proctography was based on that developed 
by Papachrysostomou et al 139. 
The radiopharmaceutical used was 99'Tc-methylene diphosphonate (99'Tc-MDP). 
This was mixed with re-hydrated porridge oats to form a thick paste that could be 
inserted into the rectum to simulate stool. The volume of the porridge/radioisotope 
mixture inserted was detennined by a balloon inflation study in the rectum to 
determine rectal capacity. The radiopharmaceutical was prepared by adding 
approximately 200MBq of 99mTc-MDP to a volume of warm water determined by the 
results of the rectal capacity study for each individual patient. The dehydrated 
porridge mixture was slowly added and stirred constantly to produce a smooth thick 
paste. A foley catheter filled with approximately 20 MBq 99mTc-MDP was positioned 
to act as a marker of the anal canal. 
If necessary the rectum was cleared using phosphate enema (Forest Laboratories, 
Kent, UK) prior to the study. To introduce the radiopharmaceutical, a tube (E-Z-EM, 
NY, USA) was positioned in the distal bowel 10cm from the anal verge. The paste 
was injected into the rectum using a 50ml syringe. During this procedure the patient 
was positioned in the left lateral position. 
The patient was then sat upright on a screened commode with a collection pan. 
Dynamic acquisition of data with 2 second images was performed during the study. 
images were acquired during the patient's attempt to defecate. The images were 
recorded using a small field Starcarn 300 A/M Gamma Camera (General Electric 
Medical Systems, Chalfont, UK). Data and images were processed using Xeleris TM 
workstation software (General Electric Medical Systems, Chalfont, UK). At the 
termination of the study, if evacuation was incomplete, the residual paste was 
evacuated by administration of a phosphate enema (Forest Laboratories, Kent, UK). 
An advantage of this technique over barium defecating proctography is a reduced 
radiation exposure. Exposure is limited and the effective dose equivalent (EDE) is 
low (EDE <0.3mSv/min) irrespective of the duration of the study. Furthennore, 
absorption of radioactive material from the rectum is minimal 152 . EDE for 
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fluoroscopy in the left lateral position (as used in video barium defecating 
153 proctography is significantly greater (lmSv/min) 
Radioisotope defecting proctography allows quantitative data (such as rectocoele 
size, evacuation time, % evacuation, evacuation rate) and qualitative data regarding 
the patient's evacuatory efforts during defecation to be gathered. By convention, a 
rectocoele that retains 25% or more of the radioisotope is described as being 
radiologically significant. Hutchinson et al have undertaken radioisotope isotope 
proctography in normal subjects 1 52 .. In the absence of normal controls obtained from 
a cohort in the North East of England, their results can be used as reference data for 
constipated individuals. 
7.6 Statistical analysis 
Normality of data was assessed by the Kolmogorov-Smirnov test. For comparisons 
between groups defined by salient characteristics (e. g. colonic transit time), normally 
distributed data were analysed with Student's t test for unpaired samples and non- 
normally distributed data were analysed with the Mann-Whitney U test. Categorical 
data were compared using Fisher's exact test. 
To evaluate the relationships between the dependent variable of disease specific 
QOL (overall PAC-QOL score) and the independent (predictor) variables, bivariate 
analysis was initially performed. To further examine the relationship between 
predictors and the dependent variable, Multiple Linear Regression was used. 
Although it is possible to pre-select variables for regression modelling by using 
bivariate analyses (to identify variables that show a statistically significant 
association) this approach was not used because it has been suggested that pre 
selection can exclude variables that otherwise would contribute to the regression 
model in unforeseen ways 154 . Furthermore, we were interested in analysing the 
relationships between all the variables that we had chosen as potentially important 
explanatory variables. 
Multiple Linear Regression is an extension of the simple linear regression model that 
allows researchers to investigate more than one variable at a time. In essence, the 
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aim is to construct a hierarchy of predictive values for variables remaining in the 
model at the end of the exercise. 
There were five core areas that we were interested in investigating as to possible 
relationships with the primary outcome (overall PAC-QOL). These comprised: 1) 
demographic factors 2) patient characteristics, 3) constipation related variables 
evaluated by objective tests, 4) symptoms assessed by patient (PAC-SYM) and 5) the 
patient's perceived health status (SF-36). 
To measure perceived health status, SF-36 Physical Component Summary (PCS) and 
Mental Component Summary (MCS) scores were chosen rather than the individual 
domains scores of SF-36. The reason for this was to reduce error caused by multiple 
comparisons. 
In multiple regression several assumptions exist: that for each value of the 
independent (predictor) variable, the distribution of the response or dependent 
variable is normal and that the relationship between the independent and dependent 
variables should be linear. It is also assumed that the effects of each variable are 
independent, i. e. the effect of one variable is the same regardless of the values of 
other variables. This latter assumption might not be satisfied with regard to some 
variables that share a common theme and maybe interrelated (i. e. where there is 
multicollinearity). This is a recognised limitation of the technique. 
The initial regression model used was the forward selection method. This strategy 
starts with an empty model and attempts to determine the best combination of 
variables by starting with a single variable and increasing the number of variables 
used, step by step. The independent variable that has the highest correlation with the 
dependent variable is entered first. Each subsequent step adds the variable that has 
the highest correlation in the presence of the predictors already in the equation. The 
procedure stops when there are no variables that meet the entry criterion. 
Stepwise regression was used to confirm the findings of the forward selection 
strategy. Stepwise regression is similar to forward selection except that independent 
variables can be removed from the model if they become non-significant as other 
independent variables are added. The method terminates when no more variables are 
eligible for inclusion or removal. 
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Additional confirmation was undertaken by performing a backwards elimination 
regression strategy. In this method, all variables are entered into the equation and 
then sequentially removed. The variable with the smallest partial correlation with the 
dependent variable is considered first for removal. After the first variable is removed, 
the next variable remaining in the equation with the smallest partial correlation is 
considered. The procedure stops when there are no variables in the equation that 
satisfy the removal criteria. 
Data were analysed using the SPSS'ý version 12 for Windows (SPSS, Chicago, 
Illinois, USA). A value p<0.05 was considered statistically significant. 
7.7 Ethical considerations 
The study was carried out in accordance with the 2004 Declaration of Helsinki and 
approval was granted by the local research ethics committee. All participants gave 
written informed consent. 
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7.8 Results 
7.8.1 Group characteristics 
One hundred and forty eight patients were identified in the constipation clinic as 
potential participants. Informed consent was obtained from 122 patients. There were 
118 females (97%) and 4 males (3%). In view of the female preponderance it was 
decided that the male patients would be removed from the analyses. 
The patients who decided not to participate were not significantly different from the 
responders in terms of age, sex distribution or duration of constipation (Table 28). 
The mean age of the 118 females was 42.5 years (sd 13.9). The mean duration of 
constipation was 17.7 years (sd 15.5). The characteristics of the female subjects are 
shown in Table 29. Of these, 81 (68.6%) have been exposed to childbirth. Forty two 
subjects (35.6%) had a history of exposure to pelvic-abdominal surgery. All subjects 
had a history of laxative use prior to attendance in the constipation clinic. At the 
point of assessment, 96.6% were using laxative therapy. Common reasons for not 
taking laxatives were that they were ineffective or that side effects had limited their 
use. A history of a psychiatric disorder was found in 14 subjects (11.9%). None of 
these subjects were receiving active input from psychiatric services because of 
persistent psychiatric symptoms. Forty five subjects (38.1%) had coexisting medical 
conditions. These conditions are displayed in Table 30. 
The results of the evaluation of the intensity of salient symptoms and characteristics, 
performed by the clinician at interview, are shown in Table 3 1. The cumulative 
constipation score is the sum of the scores for each individual evaluation of symptom 
or characteristic. Higher scores indicate greater severity of constipation. There was 
no missing data for the individual questions or the cumulative constipation score. 
The high degree of data completeness was possible because the questions were 
administered by the clinician (SC or YY). 
125 
Study participants Non-participants p value 
Mean age (years) 43 (sd 14.0) 44 (sd 15.1) 0.73 
Sex distribution Female = 118 Female = 23 
0.10§ 
Male =4 Male =3 
Duration of constipation (years) 17.6 ( sd 15.5) 19.8 ( sd 14.5) 0.37 
Table 28. Comparison of participants and non-participants. 
§ Fisher's Exact test. 
Number of subjects Percentage 
Exposed to childbirth 81 68.6 
Exposed to pelvic-abdominal surgery 42 35.6 
Co-existing medical conditions 45 38.1 
History of psychiatric disorder 14 11.9 
Currently using laxatives 114 96.6 
Table 29. Characteristics of the study population. 
(118 female subjects) 
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Co-existing medical history 
Nil 
Osteoarthritis 
Asthma 
Hypertension 
Rheumatoid arthritis 
Chronic Renal Failure 
Hypothyroidism (treated) 
Angina 
Epilepsy 
Endometriosis 
Primary Biliary Cirrhosis 
Non Ulcer Dyspepsia 
Chronic back pain 
Diabetes 
Migraine 
Oesophagitis 
GORD 
Dysmenorrhoea 
Table 30. Co-existing medical conditions in the study population. 
(118 female subjects) 
Number of subjects 
74 
4 
2 
4 
1 
1 
7 
3 
5 
1 
1 
4 
2 
4 
1 
1 
1 
2 
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Symptom / characteristic 
Range of 
possible scores 
Mean sd 
Days between defecations with 0-5 2.18 1.46 laxative 
Laxative use 0-3 2.20 0.81 
Unsuccessful defecatory attempts 0-4 2.35 1.20 
Time spent attempting to defecating 0-4 1.62 0.98 
Straining during defecation 0-4 3.25 0.81 
Painful defecation 0-4 1.96 1.17 
Sensation of incomplete evacuation 0-4 2.16 1.21 
Digitation to assist defecation 0-4 0.97 1.28 
Vaginal pressure to assist defecation 0-4 0.52 1.12 
Abdominal bloating 0-4 3.03 0.74 
Abdominal pain 0-4 2.52 0.98 
Cumulative constipation score 0-44 22.78 4.94 
Table 31. Cumulative constipation score obtained from clinician evaluation of 
symptoms and characteristics. 
I High scores indicate greater Intensity of symptoms. The cumulative constipation 
score is the sum of scores for each item and was studied as a predictor variable In the 
Multiple Regression Analyses. 
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All 118 of the female patients had radio-opaque marker transit studies. Inspection of 
the transit studies revealed five subjects who had unexpected aberrant results. 
Subjects 29,39,76,97 and 107 all had total colonic transit times of 9 hours or less 
(Table 32). Appendix B, Table I shows data from the transit studies of all 118 
subjects (aberrant results highlighted). The most likely explanation for these aberrant 
results is that either the subjects did not discontinue their laxatives or mistimed the 
ingestion of their radio-opaque markers. 
Colonic transit (hours) 
Subject Right Left Rectosigmoid Total 
identification 
29 6 3 0 9 
39 0 4 0 4 
76 2 0 0 2 
97 7 1 0 8 
107 3 0 5 8 
Table 32. Aberrant colonic transit study results. 
These subjects were removed form further analyses pertaining to colonic transit. 
Therefore, the mean total colonic transit time for the remaining group of 113 subjects 
group was 59.4 (sd 13.8) hours (Table 33). Using a cut off value of ý: 40 hours to 
classify patients as slow transit constipation (STC); one hundred and two patients (90 
%) had slow transit constipation according to this definition (Table 34). 
There was no difference between patients with NTC and STC (cut off 2: 40 hours) 
with respect to age, sex, duration of constipation, exposure to childbirth, exposure to 
surgery, presence of co-existing medical conditions or psychiatric history (Table 35). 
These findings are comparable to those of Grotz et al and Wald et al who likewise 
found no differences with respect to age or duration of constipation between STC 
and NTC constipated patients 2,135. Comparison of mean PAC-QOL scores between 
NTC and STC showed no differences (Figure 14 and Table 36). 
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Colonic transit (hours) Mean sd 
Right colon 21.13 15.45 
Left colon 25.33 13.21 
Rectosigmoid colon 12.97 11.50 
Total colonic 59.43 13.84 
Table 33. Total and segmental colonic transit time. 
(113 female subjects) 
Colonic transit Number of subjects 
Normal < 40 hours 11 
Slow Z 40hrs 102 
Table 34. Subjects with normal and slow transit constipation 
(113 female subjects) 
NTC STC 
Parameter p 
16 subjects 
102 value 
subjects 
Mean age years (sd) 42.5(15.9) 42.5(14.0) 0.861 
Duration of constipation years (sd) 14.0 (12.8) 18.2 (15.6) 0.431 
Exposure to childbirth number of 
subjects 
exposed 
Exposure to pelvic abdominal number of subjects 
surgery exposed 
Coexisting medical conditions number of subjects 
8 71 1.0011 
5 36 0.52 " 
3 41 0.5211 
History of psychiatric illness number of subjects 1 13 1.00 H 
Table 35. Characteristics of normal and slow transit constipation subjects. 
NTC: Normal Transit Constipation, STC: Slow Transit Constipation. §Student's T test. 
§§ Fisher's Exact Test. 
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Figure 14. Overall PAC-QOL in slow and normal transit constipation. 
*p0.71 
Slow transit Normal transit 
constipation constipation 
n=102 n=11 
p value 
mean sd Mean sd 
overall PAC-QOL score 2.45 0.74 2.53 0.62 0.71 
Table 36. PAC-QOL in slow and normal transit constipation. 
Cut off for slow transit ? 40hrs 
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Overall PAGQOL 
Additional analyses, at a cut off of 2: 50 hours to define STC, did not show a 
difference between overall PAC-QOL in STC or NTC (Appendix B, Table 2). 
Furthermore, there were no differences in PAC-QOL between patient groups defined 
by different categories of transit time (Appendix B, Figure I and Appendix B, Table 
3). 
From the group of 118 female subjects, 114 underwent radioisotope defecating 
proctography. Table 37 summarises the proctographic results and includes reference 
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values for normal subjects 
Number of Normal 
Proctographic parameter subjects with 
Study results reference 
complete 
data Mean sd Mean sd 
% Evacuation N 113 68.3 20.9 67 15.0 
Evacuation time (sec) 107 70.6 87.8 31 14.0 
Evacuation Rate (% / sec) 109 2.9 3.0 2.5 0.9 
Table 37. Proctogram results. 
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A rectocoele was demonstrated in 88 patients. The mean size of these was 2.49cm 
(sd 1.26, range 0.90 - 5.90 cm). Fifteen (13%) of these rectocoeles were deemed to 
be significant on proctographic grounds (Radiologically significant rectocoele, RSR). 
There was no difference between patients with RSR and Non-RSR with respect to 
age, duration of constipation, exposure to childbirth or exposure to surgery (Table 
38). Furthermore, there was no difference between PAC-QOL scores between 
subjects with RSR and Non-RSR (Table 39). 
Radiologically Non Radiologically 
p Significant Rectocoele Significant Rectocoele 
value (RSR) (Non-RSR) 
Mean age (years) 40.1 (sd 11.7) 42.9 (sd 14.3) 0.50 
Exposedto Exposed =12 Exposed =71 556 0 
childbirth Not exposed =3 Not exposed = 32 . 
Exposedto Exposed =6 Exposed =36 
abdominal / pelvic 0.785 
surgery Not exposed =9 Not exposed = 67 
Duration of 
constipation (years) 
23.7 ( sd 11.8) 17.2 (sd 15.7) 0.12 
Table 38. Radiologically significant rectocoele and Non-Radiologically significant 
rectocoele. 
6 Fisher's Exact test 
RSR Non RSR p value 
n= 15 n= 73 
mean sd Mean sd 
Overall PAC-QOL score 2.56 0.69 2.54 0.67 0.91, 
Table 39. Effect of radiologically significant rectocoele on PAC-QOL. 
I Student's T test 
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Results of the patient self assessment of disease specific QOL (PAC-QOL) and 
symptoms (PAC-SYM) symptoms are shown in Table 40. The subject's perception 
of mental and physical general health is also displayed in Table 40. 
The mean overall PAC-QOL score was 2.43 (sd 0.73) and mean overall PAC-SYM 
score was 2.13 (sd 0.68). Regarding specific PAC-SYM domains: stool score 2.34 
(sd 0.90), abdominal score 2.43 (sd 0.86) and rectal score 1.42 (0.97). 
The mean physical component summary (PCS) score of SF-36 was 42.07 (sd 8.62). 
Mean mental component summary (MCS) was 35.87 (sdl4.80). 
Table 41 shows the correlation coefficients between the variables and overall PAC- 
QOL score. Although the strength of association was weak in several instances, 
many of the correlations achieved statistical significance. 
Possible scores mean sd 
PAC QOL 
Overall PAC-QOL 
PAC SYM 
Overall PAC-SYM 
Abdominal symptoms 
Rectal symptoms 
Stool symptoms 
SF-36 
04 
0-4 2.13 0.68 
0-4 2.43 0.86 
0-4 1.42 0.97 
0-4 2.34 0.90 
2.43 0.73 
Physical component score 0-100 42.07 8.62 
Mental component score 0-100 35.87 14.80 
Table 40: Mean scores for OOL, symptom and health perception measures. 
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Overall PAC-QOL score 
Variable mean sd 
Correlation Strength of p 
coefficient association value 
Age (years) 42.54 13.08 -0.267 Weak 0.010 
Cumulative constipation score 22.81 4.85 0.358 Moderate 0.011 
Total colon transit time (hours) 57.20 17.30 0.050 Weak 0.601 
%Evacuation 
Evacuation time (seconds) 
Rectoccele size (cm) 
68.30 20.90 -0.106 
70.60 87.80 0.168 
2.49 1.26 0.169 
Weak 0.266 
Weak 0.083 
Weak 0.068 
Physical Component Summary 42.07 8.62 -0.265 Weak 0.010 
Mental Component Summary 35.87 14.80 -0.509 Moderate 0.010 
PAC-SYM stool symptom score 2.34 0.90 0.466 Moderate 0.012 
PAC-SYM Abdominal symptom 2.43 0.86 0.553 Moderate 0.006 score 
PAC-SYM Rectal symptom 1.42 0.97 0.243 Weak 0.013 score 
Table 41. Correlation between variables and overall PAC-QOL 
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Disease specific QOL (overall PAC-QOL) was no different between groups of 
patients defined by exposure to child birth, exposure to abdominal-pelvic surgery, 
presence of a coexisting medical condition, or a psychiatric history (Table 42 and 
Table 43). 
Parameter Overall PAC-QOL score 
Mean (sd) Mean (sd) p value 
Exposed (n = 81) Not exposed (n = 37) 
Childbirth 
2.42(0.76) 2.57(0.68) 
0.33 
Abdominal-pelvic 
surgery 
Exposed (n = 42) Not exposed (n = 76) 
2.62 (0.75) 2.37 (0.71) 0.08 
Table 42. PAC-001- scores and exposure to childbirth and surgery. 
Student's T test 
Parameter Overall PAC-QOL score 
Mean (sd) Mean (sd) p value 
Coexisting medical No coexisting medical 
medical conditions 
condition (n = 45) condition (n = 73) 
0.91 
2.43(0.67) 2.45(0.86) 
History of No history of 
psychiatric illness psychiatric illness 
Psychiatric illness (n = 14) (n = 104) 0.28 
2.56 (0.82) 2.49 (0.72) 
Table 43. PAC-QOL scores and presence of medical conditions and psychiatric 
history. 
Student's T test 
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7.9 Regression analyses 
The variables that were entered in to the regression model comprised: 
Clinician assessment of symptoms; 
- expressed as the cumulative constipation score (higher score indicative 
greater severity of constipation). 
Demographics and patient characteristics; 
- including age, onset age of constipation, duration of constipation, 
exposure to surgery, exposure to childbirth, presence of coexisting 
medical problems and presence of psychiatric history. 
Proctography results; 
- including evacuation time, % evacuation, rectocoele size and presence of 
radiologically significant rectocoele. 
Colonic transit; 
- total colonic transit time and classification into STC / NTC. 
Perceived health; 
- expressed as the MCS and PCS (higher score indicates better QOL). 
Patient self assessment of symptoms; 
- PAC-SYM Stool score, PAC-SYM Abdominal symptom score and 
PAC-SYM Abdominal symptom score (higher score indicates more 
severe symptoms). 
Details of the methods for coding and units for continuous variables are included in 
Appendix B, Table 4. Descriptive statistics for the variables used in the regression 
analyses are displayed in Appendix B, Table 5. The data from subjects 29,39,76,97 
and 107 were not included in the regression analyses because of the aberrant nature 
of their transit study results (Table 32). 
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Forward regression models 
The forward regression produced three models (Table 44). The descriptive data 
regarding the variables and a summary of the model are displayed in Appendix B, 
Table 6. 
The third model accounted for 55% of the variance in the overall PAC-QOL score 
(Rý = 0.56, adjusted Rý = 0.55). 
Model RR2 Adjusted R2 Standard error 
of the estimate 
1 0.61 0.40 0.39 0.60 
2 0.71 0.50 0.49 0.55 
3 0.75 0.56 0.55 0.52 
Model Predictor variables in each model 
1 PAC-SYM Abdominal symptom score 
2 PAC-SYM Abdominal symptom score, Mental Component Summary 
3 PAC-SYM Abdominal symptom score, Mental Component Summary, PAC-SYM 
stool symptom score 
Table 44. Forward regression models. 
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Table 45 describes model 3 of the forward regression. The variables have highly 
significant p values (p < 0.01) suggesting that they all contribute significantly to the 
model. 
Variable Unstandardized Coefficients 
B 
Standard 
error 
Standardized 
Coefficients 
Beta 
t statistic p value 
Constant 1.69 0.27 6.12 < 0.01 
PAC-SYM Abdominal 0.38 0.06 0.44 5.85 < 0.01 
symptom score 
Mental Component 
-0.02 0.00 -0.32 -4.30 < 0.01 Summary 
PAC-SYM stool 0.21 0.06 0.25 3.48 < 0.01 
symptom score 
Summary of variance 
Sum of Degrees of Mean Square F statistic p value Squares freedom 
Regression 31.57 3 10.52 39.40 < 0.01 
Residual 24.83 93 0.26 
Total 56.30 96 
Table 45. Forward regression analysis (model 3). 
Forward regression analysis of overall PAC-QOL score on PAC-SYM Abdominal 
symptom score, Mental Component Summary and PAC-SYM stool symptom score. 
The unstandardised regression coefficients (B) can be used to produce the regression 
equation for disease specific QOL; 
Overall PAC-QOL 1.69 + 0.38 x (PAC-SYM Abdominal symptom score) - 
0.02 x (Mental component summary score) + 0.21 x (PAC- 
SYM stool symptom score) 
As expected, the regression coefficient for Mental Component Summary (MCS) has 
a negative value because a high MCS score suggests better psychological wellbeing 
(associated with better generic QOL) whilst a high PAC-QOL suggests worse 
constipation specific QOL. The standardised coefficients (Beta) suggest that the 
PAC-SYM abdominal symptom score is the main contributor to PAC-QOL followed 
by Mental Component Summary (MCS), and PAC-SYM stool symptom score. 
The values of the unstandardised regression coefficients (B), reflect the original units 
in which the variables were measured. In regression modelling the units for each 
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variable are not always the same. The standardized coefficients (Beta) are an attempt 
to make the regression coefficients for each variable more comparable. They can 
provide more information about the relative importance and contribution of each 
predictor to the dependent variable than the unstandardised coefficients (B). The 
standardized coefficients (Beta) represent the change in response in dependent 
variable for a change of one standard deviation in a predictor variable. 
Therefore, a change of one standard deviation in PAC-SYM Abdominal score will 
produce a change of 0.44 of a standard deviation in overall PAC-QOL, whilst a 
change of one standard deviation in PAC-SYM Stool score produces a change of 
only 0.25 of a standard deviation in PAC-QOL. 
Since PAC-SYM Abdominal score has the largest Beta weight, it also has the largest 
correlation with the dependent variable (PAC-QOL). 
Table 46 displays collinearity diagnostics for the forward regression. Overall, model 
3 performs well although the eiganvalues for dimensions 3 and 4 could be considered 
close to zero. This could suggest that the variables are highly inter-correlated. The 
Condition Index for Dimension 4 is 11.57, but not of a large enough magnitude to 
suggest a series problem with multi-collinearity. 
Residual statistics for the model are summarised in Appendix B, Table 7. Appendix 
B, Figure 2, Appendix B, Figure 3 and Appendix B, Figure 4 confirm that the 
residuals follow a normal distribution and have the same variance throughout the 
range. 
Overall it appears that model 3 offers the best model under the circumstances 
explaining 55% of the variance in the overall PAC-QOL score. The contributory 
variables are PAC-SYM abdominal symptom score, Mental Component Summary 
(MCS) and PAC-SYM stool symptom score, in order of their relative contribution to 
disease specific QOL. 
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Stepwise regression models 
The stepwise regression also produced three models that confirmed the results of the 
forward regression strategy. The third stepwise model accounted for 55% of the 
variance in the overall PAC-QOL score (W = 0.56, adjusted R2 = 0.55) (Table 47 and 
Table 48). 
Again, the standardised regression coefficients (Beta) in this model, suggest that 
PAC-SYM abdominal symptom score is the main contributor followed by Mental 
Component Summary (MCS) and PAC-SYM stool symptom. 
A summary of the stepwise regression is displayed in Appendix B, Table 8. 
Collinearity diagnostics and residual statistics for the stepwise regression are 
displayed in Appendix B, Table 9 and Appendix B, Table 10. The residuals follow a 
nonnal distribution and have the same variance throughout the range. 
Model RR2 Adjusted R2 Standard error of the estimate 
1 0.61 0.40 0.39 0.60 
2 0.71 0.50 0.49 0.55 
3 0.75 0.56 0.55 0.52 
Model Predictor variables in each model 
1 PAC-SYM Abdominal symptom score 
2 PAC-SYM Abdominal symptom score, Mental Component Summary 
3 PAC-SYM Abdominal symptom score, Mental Component Summary, PAC-SYM 
stool symptom score 
Table 47. Stepwise regression models. 
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Variable Unstandardized Coefficients 
B 
Standard 
error 
Standardized 
Coefficients 
Beta 
t statistic p value 
Constant 1.69 0.27 6.12 <0.01 
PAC-SYM Abdominal 0.38 0.06 0.44 5.85 <0.01 
symptom score 
Mental Component 
-0.02 0.00 -0.32 -4.30 <0.01 Summary 
PAC-SYM stool 0.21 0.06 0.25 3.48 <0.01 
symptom score 
Summary of variance 
Sum of 
Squares 
Degrees of Mean Square F statistic p value freedom 
Regression 31.57 3 10.52 39.40 <0.01 
Residual 24.83 93 0.26 
Total 56.30 96 
Table 48. Stepwise regression analysis (model 3). 
Stepwise regression analysis of overall PAC-001- score on PAC-SYM Abdominal 
symptom score, Mental Component Summary and PAC-SYM stool symptom score. 
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Backwards regression models 
The backwards regression strategy produced seventeen models. The seventeenth 
model accounted for 55% of the variance in the overall PAC-QOL score (Rý = 0.56, 
adjusted R2 = 0.55) (Table 50). The same three predictor variables were identified 
(PAC-SYM Abdominal symptom score, Mental Component summary and PAC- 
SYM Stool symptom score), confirming the findings of the forward and stepwise 
regression strategies. 
Model R R2 Adjusted R2 
Standard error 
of the estimate 
1 0.79 0.62 0.53 0.53 
2 0.79 0.62 0.53 0.52 
3 0.79 0.62 0.54 0.52 
4 0.79 0.62 0.54 0.52 
5 0.79 0.62 0.55 0.51 
6 0.79 0.62 0.55 0.51 
7 0.79 0.62 0.56 0.51 
8 0.78 0.61 0.56 0.51 
9 0.78 0.61 0.56 0.51 
10 0.78 0.61 0.56 0.51 
11 0.78 0.60 0.56 0.51 
12 0.77 0.60 0.56 0.51 
13 0.77 0.60 0.57 0.50 
14 0.77 0.59 0.57 0.50 
15 0.76 0.58 0.56 0.51 
16 0.76 0.57 0.55 0.51 
17 0.75 0.56 0.55 0.52 
Model Predictor variables in final model 
17 Mental Component Summary, PAC-SYM stool symptom score, PAC-SYM Abdominal symptom score 
Table 50. Backwards regression models. 
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The regression equation from the final model in the backwards strategy expressed 
constipation specific QOL as; 
Overall PAC-QOL 1.67 + 0.44 x (PAC-SYM Abdominal symptom score) + 
0.21 x (PAC-SYM stool symptom score) - 0.02 x (Mental 
component summary score) 
The standardised coefficients (Beta) suggest that PAC-SYM Abdominal symptom 
score is the main contributor to PAC-QOL (Beta 0.44), followed by Mental 
Component Summary (Beta -0.32), followed by PAC-SYM Stool symptom score 
(Beta 0.25). These results are displayed in Table 5 1. 
Collinearity diagnostics and residual statistics for the stepwise regression are 
displayed in Appendix B, Table II and Appendix B, Table 12. The residuals follow a 
normal distribution and have the same variance throughout the range. 
Variable Unstandardized Standard Standardized t statistic p value Coefficients error Coefficients 
B Beta 
Constant 1.67 0.27 6.19 <0.01 
Mental Component 
-0.02 0.00 -0.32 -4.30 <0.01 Summary 
PAC-SYM stool 0.21 0.06 0.25 3.48 <0.01 symptom score 
PAC-SYM Abdominal 0.38 0.06 0.44 5.85 <0.01 symptom score 
Summary of 
variance 
Sum of 
Squares 
Degrees 
of Mean Square F statistic p value 
freedom 
Regression 31.57 3.00 10.52 39.42 <0.01 
Residual 24.83 93.00 0.27 
Total 56.40 96.00 
Table 51. Backwards regression analysis (model 17). 
Backwards regression analysis of overall PAC-001- score on Mental Component 
Summary, PAC-SYM stool symptom score and PAC-SYM Abdominal symptom score. 
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7.10 Discussion 
This study has used a larger group of patients in comparison to all but one of the 
previous studies that have examined the relationship between QOL in constipation 
and the results of objective tests. In contrast to previous studies, it has utilised well 
validated QOL measures that are specific to idiopathic constipation, rather than 
relying on more generic measures. Furthermore, the disease specific measures of 
QOL and symptom assessment have been validated in our own study population. 
The population studied represents an extreme part of the spectrum of idiopathic 
constipation. It is made up of subjects who have remained refractory to medical 
therapy in both primary and secondary care who were referred to a dedicated clinic. 
Consequently, these subjects are not representative of the majority of patients who 
can manage symptoms themselves or through consultation with their GP. There was 
a female preponderance in the cohort. Female gender is associated with a higher 
prevalence of constipation and has also been associated with increased health seeking 
24 behaviour compared to males with constipation . These influences result in a 
predominant female population being referred to the constipation clinic. Our 
convenience sample only contained 4 male subjects. These were removed from the 
analyses and our findings only relate to female patients with severe refractory 
idiopathic constipation. 
The majority within the cohort had no coexisting medical conditions. Despite this the 
Physical Component Summary PCS (a measure of the physical effect of the 
condition) was less than norm referenced values for the general population. In 
addition, the Mental Component Summary MCS (a measure of the psychological 
effect of the condition) was less than norm referenced values. It is recognised that 
constipation is a problem in patients with a formal diagnosis of psychiatric illness, 
such as depression 41 . It might be expected that MCS would be low in subjects with 
known depression. However, only a minority of subjects (14) in our cohort had any 
history of psychiatric illness. The diminished MCS in our subjects suggests that a 
hidden or undiagnosed psychological burden exists within the constipation clinic. 
The deleterious affects of constipation, evidenced by a diminished MCS, has also 
been noted by Wald et al in a multinational survey of general populations. In UK 
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subjects, the norm referenced MCS was 46.4 in the constipated and 49.9 in the non- 
constipated 155. 
The proctographic investigations performed show that rectocoele is common in our 
cohort but again selection bias exists. Only a small proportion of subjects had a 
radiologically significant rectocoele. Suggested risk factors for the development of 
significant rectocoeles include exposure to childbirth and increasing age. However, 
we found that patients exposed to childbirth or surgery were no more likely to have a 
significant rectocoele than a non significant rectocoele. There was no difference in 
age between the groups. 
The main aim of the study was to consider which of several parameters would be 
predictors of disease specific QOL. These parameters included a clinician assessment 
of symptom severity (expressed as a cumulative score) and the results of transit study 
and proctography. Traditionally, these have been held as important for assessing 
severity in constipation. Patient perception of health and symptoms were also 
studied. 
The major findings are that: disease specific QOL in idiopathic constipation is 
associated with the intensity of symptoms assessed by the patient rather than 
assessed by the clinician; patient perception of their own mental health is associated 
with QOL; and proctography and transit study results are not associated with QOL. 
Forward and stepwise regression strategies, suggested that the predictors of disease 
specific QOL (in order of contribution) were PAC-SYM abdominal symptom score, 
Mental Component Summary (MCS) and PAC-SYM stool symptom score. The 
backward regression strategy confirmed that these variables accounted for the 
variance in PAC-QOL. 
The PAC-SYM abdominal discomfort domain contains 4 items that consider the 
severity of abdominal discomfort, pain, cramping and bloating. The domain is scored 
0 to 4 with a higher score representing more severe symptoms. The PAC-SYM stool 
symptom domain contains 5 items. Subjects are asked to score how severe the 
following symptoms are; passage of bowel movements that require straining, bowel 
movements that are too hard, too small, that result in a sensation of incomplete 
evacuation and the feeling of having to pass a bowel movement but being unable 
(false alarm). Interestingly, frequency of defecation is not explicitly considered in the 
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PAC-SYM. In the development process of the PAC system, item deletion regarding 
stool frequency occurred in the psychometric validation of the measure. Although 
bowel frequency has long been held as an important marker of disease severity by 
clinicians, in the rigorous patient driven development process of the PAC-SYM it did 
not remain as a variable. 
The rectal symptom domain for PAC-SYM was not found to be a significant 
predictor of disease specific QOL. This domain considers symptom intensity related 
to the passage of painful bowel movements, rectal burning, bleeding or tearing 
during or after bowel movements. Of all of the domains of PAC-SYM, the rectal 
domain scored the lowest (less severe symptoms). This suggests that rectal 
symptoms were not a significant problem for the patients and consequently did not 
affect disease specific QOL. 
The MCS is a psychometrically validated score that summarises the SF-36 domains 
of Vitality, Social functioning, Role emotional and Mental Health 148. The MCS 
measures the impact of a disorder on the subject's psychological wellbeing. MCS 
was lower compared to norm references in the healthy population suggesting that 
constipation was causing psychological morbidity. Mason et al also encountered 
psychological morbidity in female patients with idiopathic constipation4o. That 
reduced QOL in constipation is associated with impaired psychological wellbeing is 
an important observation since in addition to managing symptoms of constipation, 
tackling psychological morbidity may provide an additional route for ameliorating 
the effects of this condition. In our subjects, what is not yet clear is whether the 
presence of psychological morbidity is a consequence of constipation or a trigger 
leading to constipation or whether psychological morbidity is a separate 
phenomenon. These issues require ftu-ther study. 
Previous studies have shown an association between symptoms intensity (measured 
by a cumulative score) and QOL. Damon et al found a moderate correlation (r = 
0.45) between symptoms assessed by the clinician (Cleveland Clinic Score) and 
GIQLI but ultimately concluded that symptom scoring alone was insufficient to 
37 provide a precise assessment of the impact of constipation on QOL 
in our study the clinician assessment of symptoms, expressed as a cumulative score, 
was rejected from the models as a predictor of disease specific QOL. Ile assessment 
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was based on the Cleveland Clinic Score that evaluates symptoms traditionally held 
to be important markers of severity. Higher scores equate with worse symptom 
intensity. A criticism of using a system like the Cleveland Clinic Score is that the 
items were chosen by clinicians rather than through a patient centred approach (as 
used in PAC-SYM). It could be argued that a patient developed symptom measure 
has more meaning since it evaluates symptoms that are important to the patient 
themselves. 
A ftirther criticism of the Cleveland Clinic Score is that although statistical testing 
was used to select items for the final system, item development, item reduction and 
psychometric validation was not as rigorous as that employed in the PAC system. In 
addition, the Cleveland Clinic Score was not validated against QOL measures to 
confirm that increasing symptom intensity was associated with a worse QOL. These 
criticisms also apply to our own constipation score that was based on the Cleveland 
Clinic system. Certainly the results of our regression analyses would suggest that 
PAC-SYM, rather than the cumulative constipation score, is more appropriate for 
evaluating symptoms with regard to their affect on QOL. 
A limitation of our regression models is that they tell us little about the association of 
individual clinician assessed symptoms and QOL. For example, we cannot comment 
specifically on whether stool frequency predicts PAC-QOL because this factor was 
not included as an individual variable in the regression models but formed part of the 
cumulative constipation score. Regarding the decision to include the cumulative 
symptom assessment rather than individual symptoms, a compromise had to be 
reached to avoid problems of multiple testing in a small data setI54 and problems of 
variable overlap. In the latter, where variables share similarities and overlap with 
other variables they may not be entered into the regression model. For example, the 
individual clinician assessed symptoms of straining during defection, painful 
defecation, sensation of incomplete evacuation abdominal pain, abdominal bloating 
etc potentially overlap with the individual items in the PAC-SYM questionnaire. 
Once one of these variables is in the regression model it is unlikely that other 
variables that overlap will be entered. Entering in the cumulative score, a single 
variable, avoided this problem. However, to investigate the relative importance of 
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each individual clinician assessed symptom on PAC-QOL, ftu-ther regression 
analyses using only these as the predictor variables would need to be performed. 
The other problem alluded to was multiple-testing large numbers of variables (from a 
small data set) that has the potential to produce an over optimistic model. To limit 
this problem it has been suggested that n1IO should be the number of variables 
included (where n is the sample size) 154 . In our current study 19 variables were 
examined (all of which were felt to be worthy of study). If all of the individual 
clinician assessed variables had been included in addition, then more than 30 
variables would have been studied. This would have potentially led to inaccuracy 
from over optimistic models and problems with overlap. 
Demographic factors such as age, duration of constipation, age of onset were studied. 
These variables did not explain variance in the overall PAC-QOL score. Damon et al 
also found that duration of constipation was not associated with QOL 37 . Two thirds 
of our patients had been exposed to childbirth and a third exposed to surgical 
intervention. However, bivariate analyses showed no differences in QOL between 
groups of patients defined by whether they had been exposed to surgery or child- 
birth. Furthermore, neither of these factors was found to be an independent predictor 
of QOL. In their paper, Damon et al did not explore whether age, gender, history of 
37 
surgical intervention or delivery predicted QOL 
The importance of demographic factors in relation to QOL in constipation has been 
highlighted by Wald et al. QOL was lower in unemployed subjects and singles living 
with their parents 155. A limitation of our current study is that the effect of marital 
status, household size, education status and employment on PAC-QOL was not 
studied. 
Slow colonic transit was demonstrated in 86.4% of the subjects, using a cut off limit 
of greater than 40 hours. Glia et al have previously shown that patients with normal 
transit constipation have a poorer QOL- Our results do not support this observation. 
Firstly, simple comparisons of disease specific QOL showed no differences between 
subjects with NTC and STC and secondly, through regression modelling, neither 
colonic transit time nor classification according to transit time explained variance in 
PAC-QOL. 
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The results of transit study were aberrant in five subjects with disproportionately low 
numbers of radio-opaque markers retained. The most likely explanation for this is 
that the capsules containing the markers were not taken according to protocol. 
Results for these subjects were not used in the regression analyses. Transit studies 
may also be inaccurate in patients who inadvertently take laxatives or continue 
medications that alter colonic transit. These issues illustrate the problems inherent in 
the use of this investigation. Since transit studies do not predict QOL, their role in 
assessing severity is questionable. Further criticisms can be levelled regarding the 
use of arbitrary cut offs for defining slow transit and whether the studies accurately 
reflect colonic physiology. However, there may still be a role for radio-oPaque transit 
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studies for diagnosing pseudo-constipation 
No previous studies have examined proctographic parameters as predictors of QOL. 
In our study, neither evacuation time or % evacuation were independent predictors. 
The presence of a significant rectocoele and the size of the rectocoele were not 
associated with QOL. Bivariate analysis did not show differences in QOL between 
those with a radiologically significant rectocoele and those without. Overall, these 
results do not support the use of proctography for assessing severity. Proctography 
should be reserved for those patients with severely disordered defecation in which 
surgery for anatomical abnormalities would be contemplated. Considered wisdom is 
that surgery should only be offered to patients with radiologically significant 
rectocoele have also use manual manoeuvres to defecate. Pigot et al have shown that 
disease specific QOL can be improved after surgery in such selected patients 134 . 
It is clear that multi-factorial elements are at play when the effect of constipation on 
QOL is considered. Previous studies of QOL have looked for associations between 
variables (such as symptom scores or colonic transit) in isolation without considering 
the effect of coexisting variables. To overcome this problem, Multiple Linear 
Regression was used to evaluate the relationships between the dependent variable 
(overall PAC-QOL score) and several predictor variables. The variables for inclusion 
were chosen on pragmatic grounds, based on clinical experience of managing 
constipation. Variables involving colonic transit and proctography were included 
because they have long been accepted as important objective assessments of 
constipation. This is despite the fact that their utility has not been proven formally. 
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Some of the variables included were shown to have significant association with 
PAC-QOL in bivariate analyses. However, bivariate analysis was not used as a strict 
method of selecting variables. This is because we were keen to include variables of 
interest considered to be worthy of study. Although, pre-selection of variables by 
bivariate analysis is a common approach, a potential problem is that excluded 
variables may contribute to a multiple regression model in unforeseen ways because 
of the presence of complex interrelationships. 
Ultimately, the results of a regression model are reliant on the variables entered. We 
have identified independent predictors of disease specific QOL but it will be 
desirable to undertake further study to look at the predictive influence of the 
demographic and socioeconomic variables not already studied in our models. In 
addition, it will be interesting to study the individual clinician based symptoms to 
evaluate their association with PAC-QOL. Importantly, this should include stool 
frequency as well as frequency of laxative use, frequency of unsuccessful attempts, 
time spent attempting to defecate, straining, pain on defecation, sensation of 
incomplete evacuation, use of manual manoeuvres, frequency and intensity of 
abdominal pain and bloating. 
7.11 Conclusion 
An understanding of predictors of disease specific QOL will hopefully enable 
targeting of interventions to improve overall QOL in patients with refractory 
constipation. Our findings suggest that symptoms (abdominal and stool symptoms) 
and the impact of constipation on mental health are important predictors. Therapeutic 
strategies that reduce abdominal and stool symptoms may offer a way of improving 
QOL in constipation. Addressing problems in mental health with psychiatric and 
psychological interventions may also be beneficial. 
The results of transit studies and proctography are unhelpful for identifying subjects 
who are suffering the most from their constipation. In addition, it would appear that 
if symptom intensity is used to evaluate the impact on QOL, it is preferable to use the 
psychometrically validated, patient administered PAC-SYM, rather than using a 
cumulative clinician based assessment of symptoms. 
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7.12 Future directions 
The search for predictors of disease severity is important so that interventions can be 
targeted and best use be made of limited resources. Confirmation of our findings will 
be an important further step. The impact of additional demographic details needs to 
be studied within our population. 
Our findings present us with avenues for prospective studies to test hypotheses 
regarding QOL and natural history in groups defined by symptom patterns, 
demographics and treatments. Studies of therapies that specifically deal with 
abdominal and stool symptoms would be interesting. Data has emerged suggesting 
that Tegaserod can ameliorate symptoms of abdominal discomfort, pain, cramping, 
and bloating in patients with IBS and functional constipation 70,157,1 58. A study of 
Tegaserod in our cohort would add to the understanding of the efficacy of this drug 
in severe refractory idiopathic constipation. Despite the fact that Tegaserod is 
effective in treating some of the predictors we have identified (abdominal 
symptoms), because of safety concerns (increased risk cerebrovascular and 
cardiovascular events) a study in our subjects seems unlikely 73 . 
Other emergent therapies such as Lubiprostone and Linaclotide have been shown to 
improve stool frequency and consistency 159,160 . However, their effectiveness in 
treating abdominal symptoms such as Pain and bloating is less certain. 
Lubiprostone is a member of a class of compounds called prostones. It activates 
type-2 chloride channels (CIC-2) thus increasing the chloride concentration of 
intestinal fluid. This increases intestinal fluid secretion (without disturbing serum 
electrolyte balance) facilitating intestinal transit. Johanson et al studied 129 patients 
in a randomized, double-blind, placebo-controlled trial of Lubiprostone versus 
placebo for treatment of idiopathic constipation. Frequency of spontaneous bowel 
movements was higher with Lubiprostone than with placebo. Severity of straining 
and stool consistency improved in the treated patients. However, results for 
abdominal discomfort and bloating were less encouraging. Although the intensity of 
abdominal pain and bloating did improve with Lubiprostone, the differences 
compared to placebo did not achieve statistical significance 159. It would be 
interesting to study the affects of Lubiprostone in our own population to determine 
whether it improved any of the predictor symptoms we have identified. 
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The other potential candidate for future study is Linaclotide, a guanylate cyclase-C 
(GC-C) receptor agonist. Activation of the GC-C receptor (present on the luminal 
membrane of enterocytes) results in increased chloride and bicarbonate secretion into 
the intestinal lumen. Anderson et al studied the pharmacological effects of 
Linaclotide in 36 female patients with IBS-C 160 . There was a significant decrease in 
colonic transit time with Linaclotide compared to placebo. Stool frequency, stool 
consistency and ease of passage were improved by treatment. However, the affects of 
Linaclotide on abdominal symptoms (bloating, pain etc) were not specifically 
studied. 
Data is emerging in the literature regarding therapies that enhance intestinal motility, 
such Methylnaltrexone and Alvimopan (peripherally acting mu-opioid antagonists). 
These drugs have been studied in a limited way for the management of opiate-related 
constipation and post operative ileus 161,162 . These treatments could form the basis of 
future studies in our population. 
The issue of psychological wellbeing in patients referred to the constipation clinic 
deserves further attention. It is possible that an unrecognised burden of psychological 
morbidity exists, evidenced by low MCS scores (the MCS is a summary of SF-36 
domains dealing with mental well being). The Mental Health (MH) domain contains 
5 questions that have previously been combined to form the Mental Health Inventory 
(MHI-5). The raw scores (0-30) are transformed to a score of 0 to 100, where 100 
represents good mental health. A cut off score of less than 52 has been shown to 
163-165 
accurately predict the presence of depression and other psychiatric conditions 
In this way, SF-36 could be used as an initial screening tool to identify those patients 
who may benefit from psychiatric or psychological treatment. A further future study 
would be to assess the impact of psychological wellbeing on QOL, prognosis and 
response to treatment in severe refractory idiopathic constipation. 
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8 EXPLORING THE PATHOPHYSIOLOGY OF A 
REDUCED URGE TO DEFECATE IN IDIOPATHIC 
CONSTIPATION 
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8.1 Abstract 
Introduction Patients with idiopathic constipation can be separated into groups 
depending on their urge to defecate. Approximately 60% of patients have a reduced 
rectal urge to defecate. These patients perceive the urge as abdominal sensations or 
have no urge at all. It is possible that these patients represent a distinct group 
defined by differences in the sensation, motility or physical properties of the 
anorectum compared to those with a normal urge. 
The role of the sampling reflex has not been studied in these patient groups. The 
sampling reflex describes relaxation of the anal sphincter that allows rectal contents 
to come into contact with sensory receptors in the proximal anal canal. This event is 
thought to have a role in appreciation and discrimination of rectal contents prior to 
evacuation and therefore may have a role in creating a rectal urge to defecate. 
Patients with a reduced rectal urge may have less frequent episodes of the sampling 
reflex compared to those with a normal urge. 
To test this hypothesis a technique for measuring the frequency of sampling events 
was developed and a comparative study of patients with reduced urge and normal 
urge was performed. 
Methods Semi-ambulatory continuous anorectal manometry using solid state 
transducers was performed in 5 subjects to test the feasibility and tolerability of the 
technique. The 5 subjects were heterogeneous group with a variety of gastrointestinal 
disorders. A prospective study was then performed in patients with idiopathic 
constipation to compare the frequency of the sampling reflex in II with a normal 
rectal urge and II patients with a reduced rectal urge to defecate. Comparisons of 
symptom severity, anorectal sensation and colonic transit were also made. 
Results The developmental study demonstrated the feasibility of semi-ambulatory 
anorectal manometry. The duration of recording that was acceptable to subjects was 
4 hours. Three distinct types of events were identified. A reproducible method with 
satisfactory inter-observer agreement was developed to analyse the manometry 
results. 
In the prospective study of constipated patients, the frequency of sampling events 
was 8.71/hr in the nonnal rectal urge group and 8.95/hr in the reduced urge group 
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(NS). There were no differences in type of events occurring in the two groups. Also 
no differences in anorectal sensation, colonic transit time were found. 
Conclusion The frequency of the sampling reflex can be studied using semi- 
ambulatory continuous anorectal manometry. The cause of a reduced rectal urge in 
constipated patients was not infrequent sampling events. The factors determining the 
urge to defecate remain unclear. Further study is required to evaluate the role of 
rectal compliance, rectosigmoid motility and central processing of sensory 
perceptions. 
The frequency of the sampling response does not determine urge to defecate in 
patients with constipation: A study using semi-ambulatory anorectal physiology. 
Cowlam S, Saunders P, Wooff D, Yiannakou Y. 
Neurogastroenterology and Motility. 2006.18 (8); 676 
Oral presentation at the European Society of Coloproctology. 
Lisbon, Portugal, September 2006. 
Data collection 
Data entry 
Data Analysis 
Data interpretation 
SRC, PS 
SRC 
SRC (advice from TH) 
SRC, YY 
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8.2 Introduction 
Patients with idiopathic constipation can be separated into distinct groups depending 
on their perception of the urge to defecate. One group experience the urge to defecate 
as a sensation in the rectum. This group can be described as having a normal rectal 
urge to defecate (NRUD). In contrast, the other group experience the urge to defecate 
as sensations in the abdomen (abdominal fullness, bloating or pain) or do not 
perceive any urge to defecate at all. This group can be described as having a reduced 
rectal urge to defecate (RRUD). Some patients lose their normal rectal urge at the 
same time as the onset of constipation. The explanation for this phenomenon is not 
known. Harraf et al found that 61% of patients with constipation had no rectal urge 
to defecate, instead describing abdominal sensations 166 . Hawkes et al studied patients 
with chronic constipation and found that 58% had a RRUD 
167 whilst in the 
constipation clinic at Durham, 63% of patients with idiopathic constipation were 
found to have a RRUD 168 . The 
fact that constipated patients can be separated into 
groups raises the possibility that distinct pathophysiological processes exist that may 
have an impact on prognosis and outcome. 
Rectoanal sampling is part of a sensory pathway that appears to be involved with 
perception of the rectal urge to defecate. The possibility that the frequency of 
sampling is different in patients with a normal urge compared to those with a reduced 
urge has not been studied. 
It is postulated that sampling occurs when faeces distends the distal rectum and 
initiates a reflex relaxation of the anal sphincter. Faeces enters the rectum as a result 
of propulsive forces in the colon, sigmoid and rectum. Reduced motor activity has 
been found in some patients with constipation and it is interesting to speculate 
whether a reduced urge to defecate (occurring because of infrequent sampling) is a 
surrogate marker of this dysmotility 
169 
. 
It is known that some patients with slow transit constipation have a poor outcome 
(pain, bloating, rectal discomfort) following colectomy and ileorectal anastomosis 
(IRA)170 . This might 
be related to disordered rectal motility so that despite removal 
of the colon, rectal abnormalities contribute to ongoing distressing symptoms. if it 
was shown that a reduced urge to defecate was associated with a clinical marker of 
rectal dysmotility (reduced urge) this would have implications for patient selection 
for colectomy and IRA. 
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8.3 The urge to defecate 
In normality, a sensation of rectal fullness generally precedes the act of defecation. 
The perception of this rectal urge depends on a sensory pathway (Figure 15). In this 
process there is activation of sensory apparatus in the rectum, initiation of local 
inhibitory and activation of sensory receptors in the anus. Sensory afferents carry 
information via the spinal cord to the brain for processing. Centres in the brain 
dictate the behaviour of the individual in terms of how they deal with the rectal 
content (e. g. whether they choose to defecate). 
Propulsive contractions in the colon move material into the rectum which leads to 
rectal distension 171,172 . This activates stretch receptors and an 
intrinsic inhibitory 
reflex is initiated. This causes relaxation of the internal anal sphincter (IAS). This 
rectal anal inhibitory reflex (RAIR) can be induced by balloon inflation in the 
rectum. Interstitial cells of Cajal and nitric oxide have been implicated in the 
173,174 relaxation of the IAS Other neurotransmitters may have a role such as 
175 vasoactive intestinal peptide and adenosine triphosphate 
Relaxation of the IAS allows rectal material to come into contact with the proximal 
part of the anal canal. This allows sampling to occur to discriminate faeces from 
flatus and has been described as the "sampling reflex" 176 . During this process, 
continence is maintained by simultaneous contraction of the external anal sphincter 
(EAS) in normal subjects. The proximal part of the anal canal is sensitive to touch, 
pain, temperature and movement. Sensory nerve endings identified in this area 
include Meissner corpuscles, Pacinian corpuscles and corpuscles of Golgi and 
Mazzoni 177 . Sensation from the anus and rectum 
is carried by afferent fibres 
running via the pelvic and sacral nerves and through the spinal cord to the cortical 
brain for processing. 
The urge to defecate can therefore be influenced by factors affecting this pathway at 
several points. Possible factors include mechanical changes in the anus and rectum 
or disruption of the inhibitory reflex. Aside form "local" disturbances in the 
anorecturn, disruption may occur in the spinal column. Injury to the spinal column 
has been associated with diminished rectal sensory responses and changes to 
RAIR 178 . Such changes may affect the urge to 
defecate. 
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Central processing of the sensory information in the brain can also influence whether 
an urge to defecate is perceived. For example, central control can allow urge to be 
suppressed or disregarded. In this situation, accommodation within the rectum 
allows faeces or flatus to be stored until a convenient time for evacuation. During 
this time, continence is maintained by a combination of voluntary contraction of the 
EAS, the efforts of the puborectalis muscle, the effect of the ano-rcctal angle and 
179 rectal compliance It is possible that learned behaviour in childhood or 
adolescence (such as volitional stool retention due to painful defecation 180,181) leads 
to a diminished call to stool. Here the sensation of a rectal urge is suppressed or lost. 
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Behaviour: 
Defecation or 
suppression of urge 
1. Propulsive contractions in the sigmoid and proximal rectum move faeces Into the 
distal rectum. 
2. Rectal distension activates mechano receptors in the rectal wall and initiates an 
intrinsic inhibitory reflex via the myenteric plexus. 
3a & 3b. Relaxation of the internal anal sphincter occurs. 
4. As the anal sphincter relaxes, faeces enters the proximal anal canal and activates 
sensory receptors. 
S. Afferent nerve fibres carry sensory information to the spinal cord. 
6. Processing of sensory afferent information occurs In the brain. 
7. A sensation of rectal fullness is perceived as an urge to defecate. 
8. A behavioural response is triggered; either the act of defecation or the suppression 
of the urge so that defecation is delayed to until a more convenient time. 
Figure 15. Sensory perception of the normal urge to defecate. 
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8.4 The Rectoanal Inhibitory Reflex (RAIR) 
Both the RAIR and the sampling reflex refer to transient decreases in anal sphincter 
pressure. Lowry defined the RAIR as "the transient decrease in resting anal pressure 
by ý: 25% of basal pressure in response to rapid inflation of a rectal balloon with 
182 subsequent return to baseline" . It is likely that both reflexes share common 
physiological features. Several situations affect the RAIR (including Hirschsprung's 
disease, rectal capacity, faecal incontinence and pelvic surgery) that may also 
influence sampling. 
In Hirschsprung's disease there is aganglionosis in the mucosal and sub mucosal 
plexuses. As a consequence, the RAIR is absent (a pathognomonic finding). This is 
in keeping with the theory that the RAIR is mediated locally by the intramural 
neuronal plexus in the anorecturn. In megarectum, the large rectal capacity means 
that larger volumes then normal are required to distend the rectum to illicit the RAIR. 
This can lead to false negative results. Localised surgery such as low anterior 
resection, trans-anal microsurgery and ileoanal pouch formation can abolish the 
RAIR. However, regeneration of the reflex has been demonstrated after surgery in 
some patients 183,184 . The effects of pelvic trauma on the reflex (such as childbirth or 
gynaecological surgery) have not been extensively studied. Abnormalities of the 
RAIR have been noted in faecal incontinence. Sun et al found that the RAIR was 
185 
absent or impaired in a subgroup of patients . Pudendal neuropathy has been 
detected in some patients with faecal incontinence 186 and it is interesting to speculate 
whether this also effects the RAIR and likewise sampling. 
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8.5 Defining the Sampling Reflex 
Duthie et al demonstrated reflex lowering of anal pressure caused by balloon 
distension and postulated that this mechanism was involved in sampling of rectal 
content. During the "sampling reflex" resting anal sphincter pressure dropped with or 
without a rise in rectal pressure and returned quickly to basal values over the 
following 30-60 seconds 176 . 
Miller also studied spontaneous sampling events and identified two situations; firstly 
a fall in anal sphincter pressure occurring with or without the patient being aware and 
secondly, a fall in pressure associated with the sensation of the presence or passage 
of flatus 187 . 
In the first situation, he described ". Jalls in sphincter pressure to such an extent that 
it was equal or less then rectal pressure" and also "falls in pressure that did not result 
in equalisation with rectal pressure". In the second situation, " where flatus was noted 
it was associated with a fall in sphincter pressure of 30mmHg (20-50mmHg) and a 
rise in rectal pressure of only 7 mmHg (0-15 mmHg). Sphincter pressure was equal 
to or lower then rectal pressure in 80% of these (flatus) cases". The work of Duthie 
and Miller has provided definitions for sampling events that include quantitative and 
qualative elements. These descriptions have been used by other authors studying 
169,188,189 these phenomena 
8.6 Previous studies regarding the sampling reflex 
Duthie studied 19 normal male subjects and mapped out a sensitive area in the 
proximal anal canal using a fine bristle 176 . Rectal distension with a balloon was 
performed whilst anal sphincter pressure was measured with a non-perfused water 
filled manometric system. They demonstrated relaxation that produced equalisation 
with rectal pressure that they postulated would allow the sensitive anal mucosa to be 
exposed to the rectal contents. 
Miller and Bartolo found that the spontaneous sampling reflex occurred in 89% of 
controls but only in 35% of incontinent patients 187 . They suggested that defective 
anorectal sampling might be an important factor in the control of continence. 
Manometric measurements in this study were made over short periods of time in the 
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left lateral position in a laboratory and therefore cannot be assumed to mirror natural 
physiological conditions. In an attempt to address these limitations, the authors 
developed an ambulatory technique of anorectal manometry. A micro transducer was 
inserted into the anal canal and rectum and secured at the anal verge. A portable 
device was carried by the subjects to record pressure changes over a3 hour period. In 
15 normal subjects sampling occurred 7 times per hour. The subjects did not perceive 
60% of these events. In one subject the rectum filled with stool during recording 
producing a characteristic pressure trace. The authors concluded that several times an 
hour, the anal sphincter relaxes allowing entry of rectal contents into the anal canal 
187 
so that its presence and nature can be determined 
Waldron et al studied 12 control subjects and 8 patients with intractable idiopathic 
constipation with slow colonic transit 
169 
. Ambulatory anorectal manometry was 
performed using a micro transducer attached to a portable recorder. A mean of 23.25 
hours of recorded activity per subject was available for analysis. The portable nature 
of the equipment meant that recording could occur in the patients own home rather 
than in a laboratory. Sampling occurred 2.4 times per hour in the constipated 
patients and 7.4 times per hour in the controls. 
Farouk et al studied 48 patients with faecal incontinence and 44 controls. The median 
88 
length of recording was 8 hours' . The median 
frequency of sampling during the 
daytime was 4 per hour in controls. Sampling occurred in all of the incontinent 
patients at a frequency of 9 per hour. This result is in contrast to those reported by 
Miller 187 (sampling in only 35% of incontinent patients) and Sun et al (only 18% of 
patients) 190. These studies however, were non-ambulatory with short periods of 
recording performed in a laboratory rather then in the patients' natural environment. 
Another explanation for these differences is patient selection; Farouk's subjects had 
neurogenic faecal incontinence and were theoretically dissimilar to the patients with 
idiopathic faecal incontinence studied by Miller and Sun. 
An attractive explanation for why patients with faecal incontinence sample more then 
controls or constipated individuals is that the increased frequency allows a greater 
appreciation of rectal content so that episodes of incontinence are reduced. 
Ronhalt et al performed ambulatory manometry using solid state equipment in 10 
normal subjects (3 women) 
189 
. Recordings 
for 20 to 24 hours were made. Analysis 
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of anorectal. activity was made by a computer programme and by visual inspection of 
the pressure traces. The frequency of sampling events was 14.5 /hr whilst awake and 
4.3 / hr during sleep. 
8.7 Previous studies regarding the urge to defecate 
The pathophysiological explanation for why some patients have abdominal urge and 
others a rectal urge remains unclear. There are few reports comparing subjects from 
the two groups. 
Harraff et al studied 44 consecutive patients with constipation attributable to IBS and 
evaluated symptoms, colonic transit and rectal sensation 166 . Included were 17 
patients with an abdominal urge and 27 patients with a rectal urge. There were no 
differences between groups defined by urge with respect to age, sex, stool frequency, 
passage of pellet like stools or laxative use. There was no difference in psychological 
symptoms between the groups. However, a greater proportion of patients with a 
rectal urge rated their symptoms of constipation as "severe" in comparison to 
abdominal urge patients. 
Sensation was assessed by balloon distension using ramp and phasic inflation 
protocols to test for the sensations of "stool" and "discomfort". Perceptual responses 
to phasic distension were no different between the two groups. However, both urge 
groups displayed hypersensitivity for discomfort thresholds compared to normal 
controls. Responses to continuous ramp distension were different between groups. 
Stool and discomfort thresholds were significantly higher in abdominal urge 
compared to the rectal urge group and controls. The results suggest a degree of rectal 
hyposensitivity to ramp distension in patients with abdominal urge compared to those 
with rectal urge. With regard to colonic transit, Harraff found no difference in total 
166 
or segmental transit between the groups 
Hammonds et al tested sensory perceptions to distension in the oesophagus, 
jejeunum, ileum, colon and rectum'91. Patients with IBS constipation were studied. 
Comparisons were made between 10 patients with urge, 21 patients with no urge and 
31 normal controls. For all regions of the bowel, the constipated patients had 
hypersensitivity to distension compared to controls. This finding was irrespective of 
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their urge. The no urge patients showed diminished sensitivity to distension in the 
rectum compared to those with urge but there were no differences in sensation in the 
other regions of the bowel. 
Yiannakou et al studied 23 constipated patients with rectal urge and 33 patients with 
a reduced urge. The groups were well matched for age and duration of symptoms. 
Sensory perceptions to rectal distension were comparable in the domains of initial 
sensation, desire to defecate and maximum tolerated volume. Rectal compliance was 
not assessed. 
Mertz et al commented on 26 patents obtained from a convenience sample of patients 
with idiopathic constipation who described rare or no urge. Total colonic transit time 
was slower in patients with no urge group (85 hours) compared to patients with urge 
(60 hours, p <0.05). Rectal compliance was comparable in the two groups as was 
192 rectal sensation to balloon distension 
8.8 Summary 
Patients with constipation can be separated into groups dependent on their urge to 
defecate. The pathophysiological determinants of whether a patient has a RRUD or 
NRUD are not fully explained. Demographics, symptoms, psychological state, and 
colonic transit appear to be comparable. Conflicting results exist regarding rectal 
sensation; some authors reporting no differences between the two groups and others 
reporting hyposensitivity in RRUD. The role of the sampling reflex in determining 
the urge to defecate has not been studied. In the following two sections, a technique 
for recording sampling events using semi-ambulatory anorectal manometry and a 
study comparing the frequency of sampling events in RRUD and NRUD patients, are 
described. 
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9 DEVELOPMENT OF A SEMI-AMBULATORY 
TECHNIQUE FOR CONTINUOUS ANORECTAL 
MANOMETRY 
9.1 Abstract 
Introduction It is postulated that the sampling reflex is involved in determining the 
urge to defecate in patients with constipation and that in those with a reduced urge, 
the frequency of sampling is less compared to patients with a normal urge. The 
frequency of sampling events has not previously been measured in groups of patients 
defined according to whether they have a normal or reduced urge to defecate. 
Aims The primary aim was to develop a semi-ambulatory technique for performing 
continuous anorectal manometry to measure the frequency of the sampling reflex. 
The secondary aim was to evaluate the tolerability and acceptability of the technique 
to patients with gastrointestinal conditions. 
Method An explorative study of semi-ambulatory anorectal manometry was 
undertaken. Semi-ambulatory anorectal manometry was performed using a catheter 
with 2 solid-state transducers positioned at I cm and 5cm (Gaeltec). This was inserted 
so that the distal transducer was placed in the rectum and the second transducer 
positioned in the proximal anal canal. Subjects were ambulatory within the 
department during recording and were closely supervised. A detailed diary was 
completed by each patient. Subjects were interviewed after the recording to ascertain 
they views on the tolerability and acceptability of the procedure. The recordings were 
analysed independently by two different observers. 
Results Five subjects with a gastrointestinal conditions were studied (alternating IBS 
=3, functional abdominal pain =1, idiopathic constipation =1). The mean age was 
38.5 years. Four subjects were female. The mean duration of recording was 4.4 hours 
(range 3.7 hrs - 5.7 hrs). Mean sampling event frequency 7/hr (range 2-17/hr). Only 
6% of sampling events were perceived by the subjects. Three distinct types of 
sampling events were identified (defined by the variation in anal sphincter pressure). 
All of the subjects found the procedure to be acceptable and felt that a recording time 
of 4 hours was tolerable. Good agreement was found between the two observers for 
reporting the frequency and type of sampling event. 
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Conclusion Scmi-ambulatory continuous anorcctal manometry is a tolerable and 
acceptable technique that can be used to measure the frequency of sampling events in 
patients with gastrointestinal conditions. Tluee distinct types of sampling events have 
been identified. 
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9.2 Introduction 
Patients with constipation can be split into two groups depending on their urge to 
defecate. The pathophysiology of why one patient may have a rectal urge whilst 
another has a reduced rectal urge is not known. Although rectal sensation and 
compliance have been studied in patients with differing urges, the role of the 
sampling reflex has not been examined. Sampling events can be studied using 
anorectal manometry performed in a static patient in the left lateral position or by 
using ambulatory manometry. In the former method sampling events are not studied 
in the normal physiological state of the patient. Fully ambulatory study allows 
prolonged recording that can be undertaken in the subjects own home. However, 
outside of the supportive environment of the physiology laboratory, there is a risk 
that artifactual measurements are recorded due to probe displacement. 
Semi-ambulatory continuous recording using solid state transducer technology in a 
dedicated environment represents a compromise. Recordings can be made in a 
physiological state that closely mirrors that of the natural condition. Close 
supervision of the subject can be provided to identify the problem of probe 
displacement so minimising recording artefact. Furthermore, detailed symptoms and 
sensation diaries can be recorded by the patients. 
To address the question of whether there are differences in sampling reflex frequency 
in patients with RRUD and NRUD it was first necessary to develop a technique for 
semi ambulatory anorectal manometry that was acceptable to patients. 
9.3 Aims 
The primary aim was to develop a technique of continuous anorectal manometry that 
could be used to study the role of the sampling reflex in the determination of the urge 
to defecate. The secondary aim was to evaluate the tolerability of semi ambulatory 
anorectal manometry to determine the length of recording that would be acceptable 
to subjects. The third aim was to determine whether reproducible analysis could be 
performed of the manometry recordings. 
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9.4 Hypothesis 
A solid state micro transducer catheter can be used to perform semi ambulatory 
continuous measurement of anal and rectal pressure so that the frequency of the 
sampling reflex can be calculated. 
9.5 Materials and methods 
9.5.1 Study design 
Prospective explorative study of the tolerability and feasibility of performing semi 
ambulatory anorectal manometry. Appropriate ethical approval was sought (section 
9.7). 
9.5.2 Subjects 
Five patients referred to a dedicated clinic for investigation of gastrointestinal 
disorders were studied. The subjects were invited to undergo semi ambulatory 
anorectal manometry in addition to their routine investigations. 
9.5.3 Semi-ambulatory anorectal manometry 
Recordings for all subjects began at 10am. No special dietary restrictions were 
imposed and subjects were advised to adhere to their normal diet and eating patterns 
in the evening and morning prior to investigation. Subjects were allowed to continue 
their normal prescribed medications. No bowel preparation was used although 
subjects were given the opportunity to empty their bowels before starting the study. 
A soft, flexible transducer catheter, 2mm diameter was used (I 6C, Gaeltec Ltd, Isle 
of Skye, UK). The catheter carries two pressure sensitive transducers, one close to 
the tip and one 5cm proximally (Fig I& 2). It was connected to a Flexilog 
3000/Flexisoft III (Oakfield Instruments Ltd) data acquisition system by a 4m 
flexible umbilical cable (4mm diameter). The system allowed an extended recording 
of pressure from the two channels that was displayed simultaneously on a visual 
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display unit. Pressure data were recorded and stored for later analysis. Events can be 
marked by the operator or patient and stored along with the pressure data (Fig 3,4,5) 
Before insertion, per rectum examination was performed to confirm whether the 
rectum was empty. The distal transducer was positioned in the rectum and the other 
within the anal canal. The position of the transducers was confirmed by a manual 
pull through the rectum and anal sphincter to identify their characteristic pressure 
traces and to determine the length of the anal sphincter and location relative to the 
anal verge. The catheter was positioned so that the second transducer was situated in 
the middle part of the sphincter. The transducer catheter was secured externally to 
the natal cleft up to the anal verge with adhesive tape. The transducer catheter was 
initially inserted with the patient in the left lateral position. In this position, anal 
sphincter squeeze pressure was measured on three occasions. The patient was then 
allowed to move from the left lateral position. The flexible umbilical cable enabled 
the patient to dress normally and adopt comfortable, natural sitting or lying postures. 
In addition, participants were able to mobilise around the department and were 
encouraged to act naturally during the recording. A standard light meal was provided 
at lunchtime. 
Subjects recorded a symptom diary during recording and were assessed on an hourly 
basis by an investigator. Recordings were continued until subjects felt unable to 
continue or a maximum of six hours of recording had elapsed. 
At the end of the recording the subjects were interviewed to ascertain their views of 
the procedure. Subjects we asked to state their views regarding tolerability and 
acceptability of the test using the following descriptors; "tolerable", "intolerable", 
66an acceptable test" or "an unacceptable test". 
172 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
Figure 16. Transducer catheter 
cm 
Figure 17. Solid state pressure transducers 
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Figure 18. Umbilicus connection to data acquisition system 
Figure 19. Flexilog 3000/Flexisoft III (Oakfield Instruments Ltd) data acquisition 
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Rectal I 
Flexilog data 
acquisition 
system 
Figure 20. Illustration of semi-ambulatory anorectal manometry. 
(1) Catheter with solid state pressure transducers inserted in the anorecturn so that 
the proximal transducer is positioned in the mid point of the anal sphincter. The distal 
transducer is positioned in the rectum. (2) Catheter attached securely at the anal 
verge with adhesive tape to prevent displacement during recording. (3) 4m umbilical 
cable. (4) Flexilog 3000/Flexisoft III (Oakfield Instruments Ltd) data acquisition system 
that allows continuous measurement and recording of anal and rectal pressure. (5) 
Simultaneous display of pressure traces. 
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Figure 21. Simultaneous pressure recording. 
Anal sphincter pressure (top) and rectal pressure (bottom). 
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9.5.4 Analysis of semi-ambulatory anorectal manometry 
The traces were analysed on two separate occasions using Flexisoft III software 
(Oakfield Instruments Ltd). The analyses were performed independently of each 
other by different observers (PS and SQ. Reported endpoints included, mean anal 
sphincter pressure, mean anal squeeze pressure, mean rectal pressure in the left 
lateral position. The frequency of sampling events was recorded. The descriptions of 
sampling events previously reported by Duthie and Miller were used to identify the 
176,187 
sampling events in each recording 
9.6 Statistical analysis 
Inter-observer variation was assessed using weighted Kappa statistic to assess 
agreement between PS and SC for reporting the frequency of sampling events. 
Data were analysed performed using SPSS* version 12 for Windows (SPSS, 
Chicago, Illinois, USA). A value p<0.05 was considered statistically significant. 
9.7 Ethical considerations 
The study was carried out in accordance with the 2004 Declaration of Helsinki and 
approval was granted by the local research ethics committee. All participants gave 
written informed consent. 
-177- 
9.8 Results 
The clinical characteristics of the patients are summarised in Table 52. Mean age of 
all patients was 35.8 (sd 12.6) years. The group comprised I male (diagnosis of 
alternating IBS) and 4 females (2 cases of alternating IBS, one idiopathic 
constipation and one case of functional abdominal pain). 
9.8.1 Anorectal manometry in the left lateral position 
The mean anal sphincter pressure was 75.8 cmH20 (sd 28.5) and mean rectal 
pressure was 26.6 cmH20 (sd 8.9). The mean anal squeeze pressure for the group 
was 141.80 CMH20 (sd 52.0). 
9.8.2 Semi-ambulatory anorectal manometry 
The mean duration of recording was 4.4 hrs; (sd 0.87) with a range of 3.7 hours to 5.7 
hours (Table 52). The pressure recordings were analysed in conjunction with the 
patient diaries by two investigators (SC and PS) on separate occasions. Pressure 
changes compatible with sampling events, were identified. The mean sampling event 
frequency was 7 per hour (range 2-17 per hour). Three distinct patterns of events 
were identified and classified as Type 1, Type 2 and Type 3 (summarised in Table 
53, Figure 22, Figure 23 and Figure 24). 
Correlation with the diaries allowed artifactual pressure changes (for example caused 
by cough or movement) to be disregarded (Figure 25, Figure 26 and Figure 27). 
A total of 169 events were identified by PS. Very good agreement (weighted Kappa 
statistic 9.3) was demonstrated between the observers for identifying all types of 
events. 
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Parameter 
Number of patients 5 
Mean age (scl) 35.8 (scl 12.6) 
Male 
Sex (number of patients) 
Condition (number of patients) 
Mean anal sphincter pressure cmH20 (sd) 
Mean anal squeeze pressure cmH20 (sd) 
Mean rectal pressure cmH20 (sd) 
Mean duration of recording (hours) (sd) 
Minimum duration of recording (hours) 
Female 4 
IBS alternating 3 
Idiopathic constipation 1 
Functional abdominal pain 1 
75.8 (sd 28.5) 
141.80 (sd 52.0) 
26.6 (sd 8.9) 
4.40 (sd 0.87) 
3.7 
Maximum duration of recording (hours) 5.7 
Table 52. Patient characteristics. 
Type of event Description of anal sphincter pressure 
Type 1 Anal sphincter pressure falls below rectal pressure 
Anal sphincter pressure falls and equals rectal pressure 
Type 2 (equality of pressure sometimes achieved by simultaneous 
elevation of rectal pressure) 
Type 3 
Anal sphincter pressure falls and but remains greater than rectal 
pressure 
Table 53. Description of sampling events. 
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Figure 22. Type I sampling event 
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Figure 23. Type I and type 2 sampling events 
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- 181 - 
Movement artefact 
AI 
Anal sphincter pressure 
pressure 
Figure 25. Movement artefact 
la. 39AM 10 45 AAA 10.4i AM 
movement 
cmH20 AR2 
Crosslegs 
15000 
Anal sphincter pressure 
100.00- 
%oo 
A. -.!. ý ý ý2 -, 
", I'll -ý-`"ý, .ýII)II 
ti, 
Rectal pressure 
0.00 
10: 52 AM 10 54 AM 10 56 AM 10 58 AM 11,00 AM 11 02 AM 1104 AM 1106 AM 1106 
Figure 26. Specific movement artefact 
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Figure 27. Cough artefact 
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9.8.3 Tolerability and acceptability of semi-ambulatory anorectal 
manometry 
All 5 subjects felt that semi-ambulatory anorectal manometry was "an acceptable 
test" and that the procedure was "tolerable". The maximum tolerated length of 
recording was 5.7 hours. The subjects felt that the procedure became less tolerable 
and less acceptable after 4 hours. 
9.9 Discussion 
The results of this exploratory study demonstrate that anorectal manometry can be 
performed using a semi-ambulatory technique to measure the frequency of sampling 
events. Three distinct patterns of events were observed that could be distinguished 
from the background anorectal pressure recordings. The use of patient diaries to 
record activities meant that pressure variations caused by movement or coughing 
could be accurately recognised and not n-iisreported as sampling events. The diaries 
also ensured meant that sampling events associated with the sensation or passage of 
stool could be identified. 
This technique using solid state transducers was an effective way of observing the 
phenomena of sampling. It allowed the events to be studied in a more "natural" state 
then would have been possible using a water perfused pressure catheter in the left 
lateral position. The semi-ambulatory approach in conjunction with accurate patient 
diaries added a dimension of control so that artefact in the recordings could be 
readily distinguished from physiological changes in anal pressure. 
Clearly, the longer the period of recording the more likely sampling evens are to be 
recorded. Fully ambulatory anorectal manometry using solid state transducers over 
24 hours has been performed but this increases the likelihood of catheter 
displacement and movement artefact being included in the recording. The semi- 
ambulatory technique represents a compromise between recording anorectal pressure 
changes in a state that is close too "normal" as possible and ensuring accuracy of 
data collection. 
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The maximum time tolerated by patients was 5.7 hours although their opinion was 
that 4 hours represented the limit of overall tolerability and acceptability for the 
technique. Good agreement was shown between the two observers for identifying 
sampling events and classifying them into one of three different patterns. 
9.10 Conclusion 
This study has shown that semi-ambulatory simultaneous measurement of anorectal 
pressure can be used to identify and classify sampling events in patients with lower 
gastrointestinal disorders. The technique allows the recordings to be analysed and 
reported by different observers with a satisfactory level of agreement. The period of 
recording that is acceptable to patients appears to be 4 hours. 
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10 SAMPLING EVENTS IN IDIOPATHIC 
CONSTIPATION: A COMPARISON OF PATIENTS 
WITH NORMAL RECTAL URGE AND PATIENTS 
WITH REDUCED RECTAL URGE. 
10.1 Abstract 
Introduction Patients with constipation can be separated into groups depending on 
their urge to defecate. Approximately 60% of patients have a reduced rectal urge to 
defecate (RRUD). It is possible that these patients represent a distinct group defined 
by differences in the frequency of sampling events, sensation, motility or physical 
properties of the anorecturn compared to those with a normal rectal urge to defecate 
(NRUD). A technique for measuring the frequency of sampling events using 
continuous semi ambulatory manometry was used to test the hypothesis that the 
frequency of sampling is less in patients with a reduced rectal urge to defecate. 
Aims The primary aim was to compare the frequency of sampling events in two 
groups of constipated patients defined by their urge to defecate. Secondary aims were 
to establish whether anorectal sensation, symptom severity and colonic transit were 
involved in determining the urge to defecate. 
Method Prospective study comparing frequency of sampling events in NRUD 
constipated patients with RRUD constipated patients. Subjects with idiopathic 
constipation were recruited. Each subject underwent a period of semi-ambulatory 
anorectal manometry using a catheter with 2 solid-state transducers at lcm and Scm 
(Gaeltec). The catheter was attached at the anal verge with the transducers in the 
rectum and anal canal. The subjects were ambulatory within the department during 
recording. The duration of recording (4 hours) was dictated by the results of a prior 
tolerability study. Analysis of recordings was made by an investigator blinded to 
whether the subject had NRUD or RRUD. Resting anal pressure, anal squeeze 
pressure, rectal pressure and anal electro-mucosal sensation were also assessed. 
Rectal balloon distension was performed to assess the RAIR. Rectal sensation was 
tested using barostat controlled inflation. Colonic transit was measured by radio- 
opaque marker studies 
Results 22 female patients were studied; II RRUD and II NRUD. There were no 
differences between groups regarding age, duration and severity of symptoms or 
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mean duration of recording - NRUD group 3.95 hrs, RRUD 3.86 hrs (NS). All 
subjects had evidence of slow colonic transit. Mean sampling event frequency: NUD 
group 8.71/hr (range 2-20/hr), RUD 8.95/hr (range 0-21/hr) (NS). NRUD patients 
perceived 6% of sampling events; RRUD patients perceived 9% of events (NS). 
There was no difference in total or segmental (left, right, rectosigmoid) colonic 
transit time between the groups. No association between frequency of sampling 
events and segmental or total colonic transit time. No differences in resting anal 
pressure, anal squeeze pressure, rectal pressure or anal electro mucosal sensation 
were detected between the two groups. 
Conclusion The cause of a reduced rectal urge to defecate is not infrequent sampling 
events. The factors determining whether constipated patients have RRUD or NRUD 
remain unclear. Further study is required to evaluate rectal compliance, rectosigmoid 
motility and higher cerebral function in determining the urge to defecate. 
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10.2 Introduction 
In constipated patients a reduced rectal urge to defecate may be caused by 
differences in anorectal sensation or infrequent sampling events. It is postulated that 
sampling events occur as a result of faeculant material entering the rectal ampulla. 
Therefore, infrequent events may be associated with dysfunction of rectal motility. 
Studies have not been performed to determine whether urge is dictated by the 
frequency of sampling events or whether a RRUD is a surrogate marker for rectal 
dysmotility. Rectal dysmotility may influence outcome following colectomy and 
ileorectal anastomosis performed to treat refractory slow transit constipation. The 
identification of a simple clinical parameter such as a reduced urge (caused by 
infrequent sampling) that was a surrogate marker of rectal dysmotility may have 
relevance for patient selection for surgery. 
A technique for continuous semi ambulatory manometry was developed to test the 
hypothesis that the frequency of sampling is less in patients with a reduced rectal 
urge compared to patients with a normal rectal urge to defecate. 
10.3 Aims 
The primary aim was to compare the frequency of sampling events in two groups of 
with idiopathic constipation defined by their urge to defecate. Secondary aims were 
to establish whether other parameters (such as anorectal sensation, symptom severity 
and colonic transit) were involved in determining the urge to defecate. 
10.4 Hypothesis 
In idiopathic constipation the frequency of sampling events is less in patients with a 
reduced rectal urge to defecate compared to patients with a normal rectal urge to 
defecate. 
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10.5 Materials and methods 
10.5.1 Study design 
This was a prospective study of constipated patients meeting inclusion and exclusion 
criteria. Subjects were recruited from a dedicated clinic dealing with constipated 
patients. The planned duration of semi-ambulatory anorectal manometry was 4 hours 
(based on the results of the exploratory study described in section 9.8.3). Group size 
was determined on the assumption that constipated individuals with NRUD would 
experience a mean of 28 sampling events in 4 hours and a conservative assumption 
that RRUD is associated with a reduction of sampling events to 20 in 4 hours. 
Tberefore, eleven patients per group would give 90% power at 5% significance to 
detect a difference. 
10.5.2 Subject recruitment 
Potential candidates for study were identified at the constipation clinic at the 
University Hospital of North Durham. 
10.6 Inclusion criteria 
only patients with a diagnosis of idiopathic constipation (according to the definitions 
described in section 3.4) were considered for inclusion. In such patients systemic, 
biochemical, pharmacological, primary neurological, structural abnormalities of the 
colon or endocrinological explanations for symptoms of constipation had been 
excluded by appropriate investigation. 
The affects of gender on the prevalence of constipation and healthcare seeking 
behaviour means that the majority of patients referred to the constipation clinic are 
female. This meant that the convenience sample for potential candidates was likely to 
be female. Tberefore, it was decided to limit inclusion to women only. Patients over 
the age of 18 were considered. 
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To classify the subjects according to their urge to defecate a series of standardised 
descriptors were used at face to face clinician led interview (SQ. These comprised; 
1. In the last three months, the main reason that I go to the toilet to pass a 
motion is because of a feeling of fullness in my rectum. 
2. In the last three months, I have not experienced any urge or feeling to pass a 
motion, in my rectum. 
3. In the last three months, the main reason that I go to the toilet to pass a 
motion is because of a feeling of fullness or bloating in my abdomen. 
10.7 Exclusion criteria 
The presence of any of the criteria disqualified the patient for inclusion. 
a) Age less than 18 years 
b) Severe psychiatric disease 
c) Known pregnancy, suspected pregnancy or patient trying to conceive. 
d) Uncontrolled cardiac, respiratory, endocrine, metabolic, renal or hepatic diseases 
e) Incapacity of higher mental function such that informed consent could not be 
achieved 
f) Evidence of diarrhoea predominant Irritable Bowel Syndrome OBS-D) according 
to Rome II criteria. 
g) Previous ano rectal surgery 
10.7.1 General assessment 
In addition to details regarding urge to defecate, information regarding 
demographics, symptoms and history of constipation were assessed in all recruited 
patients using a standardised questionnaire based proforma. Severity of constipation 
was measured in terms of symptoms and QOL, assessed using the Patient 
Assessment of Constipation - Quality of Life (PAC-QOL) and the Patient 
Assessment of Constipation - Symptoms (PAC-SYM) 119,125. 
The subject's description of their urge to defecate was recorded at the time that they 
were identified as potential study candidates and at the time that they attended for 
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semi-ambulatory manometry. Therefore, the description of urge was assessed on two 
occasions using the same descriptor questions (section 10.6) by the same clinician 
(SC). This provided an opportunity to determine whether the the description of urge 
remained constatnt with time. 
10.7.2 Semi ambulatory anorectal manometry 
Semi ambulatory anorectal. manometry was performed using the technique described 
in section 9. 
Recordings for all subjects began at l0arn after a 15 minute running in period 
performed in the left lateral position. No special dietary restrictions were imposed. 
Subjects were advised to adhere to their normal diet and eating patterns in the 
evening and morning prior to investigation. Subjects discontinued laxative therapy 
for 3 days before the study. No bowel preparation was used although subjects were 
given the opportunity to empty their bowels before starting the study. A per rectum 
examination was performed to confirm that the rectum was empty. The protocol 
allowed for the administration of an enema to clear the rectum if needed, however, 
this was not necessary in any of the subjects. 
The transducer catheter (16C, Gaeltec Ltd, Isle of Skye, UK) was inserted with the 
patient in the left lateral position. It was connected to the Flexilog 3000/Flexisoft III 
(Oakfield Instruments Ltd) data acquisition system by a 4m flexible umbilical cable 
(4mm diameter). The catheter was positioned so that the distal transducer was 
positioned in the rectum and the second transducer was situated in the middle part of 
the anal sphincter. 
A standard light meal was provided at lunchtime. Each subject completed a diary of 
their activities, movements, symptoms and sensations (including times). Information 
regarding abdominal symptoms, sensation or passage of flatus and sensation of urge 
were recorded. Defecation was not prohibited. Subjects were able to pass urine with 
the transducers in situ. 
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10.7.3 Resting anal pressure and anal squeeze pressure 
Following the period of semi-ambulatory anorectal manometry a 10 min period of 
recording was performed in the left lateral position to record mean resting anal 
pressure. Following this mean anal squeeze pressure was determined by performing 
3 episodes of volitional squeezing up to a maximum of 30 seconds with 2 minutes of 
rest between attempts. 
10.7.4 Rectoanal inhibitory reflex (RAIR) 
To test for the RAIR, a thin latex balloon was used for rectal distension (Mediplus, 
MED2301, Anorectal response catheter, 3cm. by 5cm). This was inserted into the 
rectum so that the proximal part of the balloon was 10 cm from the anal verge. It was 
inflated rapidly via a short 141'r catheter. The balloon was inflated with 10ml of air. 
If the RAIR did not occur the balloon was deflated and the process repeated using 
incrementally larger volumes of air (increasing by 10ml) or until 60ml of air was 
inflated. Anal sphincter pressure was measured continuously using a soft, flexible 
transducer catheter (2mm diameter) (16C, Gaeltec Ltd, Isle of Skye, UK). 
10.7.5 Anal mucosal electro sensitivity 
A 5mm. diameter bipolar ring electrode was inserted into the proximal part of the 
anal canal 193 . The electrodes were spaced 
lcm, apart. Current pulses at 3Hz were 
passed between the electrodes from a constant current source (Medtronic, Keypoint) 
and increased linearly until the patient felt a sensation of tingling or pulsation. 
Averages of three recordings were taken to obtain a threshold value. The procedure 
was performed in both the right and left aspects of the anal canal. 
10.7.6 Rectal sensation to distension 
A latex rectal balloon was attached to a silastic tube (external diameter 4mm) and 
tied at the distal end with fine cord. The balloon was inflated and deflated prior to 
insertion to exclude leaks. Lubrication was used to insert the balloon so that the distal 
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tie attachment was Scm from the anal verge. A barostat (volume displacement 
device) (Distender series II, G&J Electronics Inc. Toronto, Canada) was used to 
inflate the balloon continuously at a constant volume rate of 50ml/min (ramp 
distension). The device records pressures and volumes simultaneously. The subject 
was instructed to indicate their sensations to distension using the descriptors "first 
sensation of distension", "sensation of desire to defecate" and "maximum tolerated 
sensation or discomfort" (equating with maximum tolerated volume). At this point 
inflation was terminated and the balloon deflated and removed. To determine the 
sensory thresholds to distension, the indicated volume was corrected to find the true 
inflation volume by using Boyle's law at the indicated pressure. 
10.7.7 Colonic transit 
A validated method of assessing total and segmental colonic transit was performed in 
all subjeCtS53 . This 
is described in detail in section 7.5.3. 
10.8 Analysis of semi-ambulatory anorectal manometry 
The anorectal pressure recordings were analysed by an investigator (PS) blinded as 
to whether the subject had RRUD or NRUD. Sampling reflexes were reported using 
the definitions described in section 9.8.2. These included type I events (anal 
sphincter pressure falls below rectal pressure), type 2 events (anal sphincter pressure 
falls and equals rectal pressure) and type 3 events (anal sphincter pressure falls but 
remains greater than rectal pressure). 
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10.9 Statistical analysis 
Normality of data was assessed by Kolmogorov-Smirnov tests. Normally distributed 
data were analysed with Student's t test for unpaired samples. Non-normally 
distributed data were analysed with the Mann-Whitney U test. Categorical data were 
compared using Fisher's exact test. 
Reproducibility was evaluated by testing inter and intra-observer variability. The 
pressure recordings were re-analysed by SC and agreement between PS and SC was 
tested using weighted Kappa statistic to evaluate inter-observer variability. PS 
performed a second analysis (again blinded to the description of urge) of the traces 
two months after the original evaluation. Agreement between the first and second 
analyses made by PS was tested by weighted Kappa statistic to assess intra-observer 
variability. 
Data were analysed using the SPSSO version 12 for Windows (SPSS, Chicago, 
Illinois, USA). A value p<0.05 was considered statistically significant. 
10.10 Ethical considerations 
The study was carried out in accordance with the 2004 Declaration of Helsinki and 
approval was granted by the local research ethics committee. All participants gave 
written informed consent. 
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10.11 Results 
10.11.1 Patient characteristics 
The mean age of all patients was 40 years (scl 11) with a mean duration of 
constipation of 17 years (sd 14.7). All patients were female. 
The description of urge remained stable with time. In all cases, the description of the 
urge to defecate recorded at the time of recruitement and at the time of semi 
ambulatory manometry was comparable. For the total group the mean time between 
recruitment and study was 4.3 weeks (sd 2.1). For NRUD, a mean of 4 weeks (sd 
1.5) elapsed between recruitment and semi ambulatory manometry, for RRUD, a 
mean of 4.5 weeks (sd 2.6) elapsed (p = 0.56). 
Semi-ambulatory anorectal manometryfor the whole group 
Regarding the whole group of 22 patients, the mean number of all types of sampling 
events was 34.82 (sd 25.3). The range was wide; one patient with zero events 
occurring in a4 hour recording to 84 events occurring in another patient. The 
frequency of all types of sampling event in this group of patients with idiopathic 
constipation was 8.8 (sd 6.4) / hour. 
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10.11.2 Group comparisons 
Clinical characteristics 
Table 54 shows the characteristics of the two groups. The RRUD and NRUD groups 
were matched with regard to age, duration and severity of constipation (expressed as 
PAC-QOL and PAC-SYM score). There was no difference between the groups in 
terms of those exposed to labour or abdominal / Pelvic surgery. 
Parameter Normal Rectal Urge to defecate d s 
Reduced Rectal 
Urge to defecate sd 
p 
value 
Number of patients 11 11 
Mean age (years) 44.5 12.4 36 8.2 0.07 
Mean Duration of 17 14.6 16.9 15.5 0 99 
constipation (years) . 
PAC-SYM score 1.93 0.61 2.32 0.72 0.18 
PAC-QOL score 2.5 0.68 2.55 0.54 0.86 
Table 64. Group characteristics. 
Group sizes, age, duration and severity of constipation. 
196 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
Semi-ambulatory anorectal manometry 
In the whole group of 22 patients, the mean number of all types of sampling events 
was 34.82 (sd 25.3). The range was wide, from zero events in 4 hour period of 
recording to 84 events occurring in one of the patients. 
The mean number of sampling events (all types) was 32.9 (scl 24.9) in NRUD and 
32.6 (sd 27.4) in RRUD. There was no significant difference between the groups 
(p=0.98). Figure 28 shows a boxplot of all types of sampling events. 
The frequency of sampling events in the two groups was comparable: 8.9/hr NRUD 
and 8.8/hr RRUD (p=0.96). Type 1, Type 2 and Type 3 events were recorded in both 
RRUD and NRUD patients. Type 3 events (anal sphincter pressure falls but remains 
greater than rectal pressure) accounted for 81% of all events recorded. 
Figure 29 shows the frequency of each type of event in the two groups. There were 
no statistical differences in the frequency of Types 1,2 or 3 events between NRUD 
and RRUD subjects. 
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Figure 28. Boxplot of sampling events (all types). 
The box plots include median bars. There was no difference between the mean 
number of events in NRUD 32.9 (sd 24.9) and RRUD 32.6 (sd 27.4) (p = 0.98). 
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Figure 29. Frequencey of Types 1,2 and 3 sampling events. 
There were no differences between NRUD and RRUD regarding the frequency of 
Types 1,2 and 3 events. 
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Periodic episodes of rectal motor activity - Rectal Motor Complexes (RMC)172 _ 
were identified in 9 patients (4 NRUD and 5 RRUD). These were characterised by 
contractile activity of a frequency of 2-7 /minute with duration between I and 15 
minutes. The amplitude of the complexes was between 3- 39cm H20. Examples of 
the RMC are displayed in Figure 30. 
There were no differences in the number of times RMC activity occurred, the total 
duration of RMC episodes, frequency or amplitude of the complexes (p, > 0.15). 
Table 55 shows data regarding the RMC. 
Rectoanal inhibitory reflex (RAIR) 
The RAIR was present in all subjects. 
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Figure 30. Examples of the Rectal Motor Complex. 
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Normal Rectal Reduced 
Urge to sd Rectal Urge sd p 
defecate to defecate value 
Number of patients 45 
Mean number of episodes 2.00 1.00 2.2 1.21 0.99 
of RMC activity 
Incidence of RMC 0.18 0.28 0.26 0.57 0.57 
episodes per hour 
Mean total duration of 
RMC activity per 3.54 2.11 8.5 1.74 0.26 
recording (min) 
Mean RMC frequency 6.32 0.81 4.9 2.10 0.15 
Mean RMC amplitude (cm 6.31 8.14 2.4 3.23 0.25 H20 ) 
Table 55. RMC activity in RRUD and NRUD. 
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Inter and intra observer variability 
Very good agreement (weighted Kappa statistic 9.3) was demonstrated between PS 
and SC for identifying all types of events in the recordings. This result suggests 
minimal inter observer variability. Very good agreement (weighted Kappa statistic 
9.1) was demonstrated between the first analysis by PS and the second analysis by 
PS (2 months later). This suggests minimal intra observer variability. 
A norectal physiology performed in the left lateral position 
Figure 31 and Figure 32 show the results of anorectal physiology testing performed 
in the left lateral position. There were no differences between groups regarding mean 
anal sphincter pressure; 91.5cm H20 (sd 26.0) in NRUD and 94. Ocm H20 (sd 21.5) 
in RRUD (p = 0.81). There were no differences regarding mean anal squeeze 
pressure; 129.4cm H20 (sd 35.1) in NRUD and 143.7cm H20 (sd 20.2) in RRUD (p 
= 0.26). 
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Figure 31. Resting anal sphincter pressures. 
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Figure 32. Anal squeeze pressures. 
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Anal mucosal electro sensitivity 
Figure 33 and Figure 34 show the results of electro, mucosal sensory testing. There 
were no differences in mean left sided anal mucosal sensitivity between NRUD and 
RRUD groups; 6.5 niA (sd 2.9) and 5.5 mA (sd 2.0), p=0.26. 
There were no differences in mean right sided sensitivity between NRUD and 
RRUD; 6.8 mA (sd 3.4) and 5.1 mA (sd 1.7), p=0.15. 
Rectal sensation to distension 
The results of rectal sensory testing to distension are summarised in Figure 35. No 
significant differences were detected between NRUD and RRUD with regard to 
volumes required to elicit sensations of "first sensation", "desire to defecate" or 
"maximum tolerated volume". Table 56 shows the mean volumes in the two patient 
groups. 
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Figure 34. Right sided anal mucosal sensation. 
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Figure 35. Rectal balloon distension in RRUD and NRUD. 
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Normal Rectal 
sd 
Reduced Rectal 
sd p Urge to defecate Urge to defecate value 
Number of patients 11 11 
Volume at first 0.4 58.1 66.6 43.4 0.78 
sensation 
Volume at desire to 94.8 54.5 108.6 43.0 0.52 defecate 
Maximum tolerated 137.6 12.6 161.6 67.0 0.35 
volume 
Table 56. Rectal sensation to distension. 
Colonic transit 
The mean total colonic transit for the total group was 50 hours (sd 11.9) suggesting 
prolonged colonic transit in the subjects compared to reference values for normal 
females (upper limit of normal 38.9 hours) 53 . 
The mean total colonic transit time was comparable in the two groups; 47.5 hours (sd 
15.1) inNRUD and 52.6 hours (sd 7.5) inRRUD patients (p = 0.33). Therewereno 
differences between the groups with regard to right colonic, left colonic and 
rectosigmoid transit time (p > 0.4). Results of total and segmental colonic transit in 
NRUD and RRUD are summarised in Figure 36. 
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Figure 36. Colonic transit in NRUD and RRUD. 
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10.12 Discussion 
The primary aim of this study was to confirm whether sampling was less frequent in 
RRUD. This was not the case. No differences in the mean number or frequency of 
events were seen between groups. During the recording period there was a great 
variation in the number of events occurring in the total group; ranging from 0 events 
to more than 80 in some patients. Within the two groups, there was again a large 
range for the number of events; 0-84 in RRUD (sd 27.6) and 2-81 events in NRUD 
(sd 24.5). These large degrees of variation suggest that RRUD and NRUD are not 
distinct patient groups, in terms of the frequency of sampling. 
Power calculations based on these results suggest that sample sizes of at least 174 
would be required to detect statistically significant differences in the number of 
events in RRUD and NRUD (using four hour recordings). If the frequency of 
sampling was truly an important clinical determinant, it would be expected that even 
with the small sample sizes available for this study, some difference would have 
been shown. 
It can be concluded that sampling is not clinically important for dictating urge to 
defecate. However, sampling represents only one possible mechanism and the effect 
of other anorectal parameters remain unclear. 
The secondary aim of our study was to determine if there were variations in anorectal 
sensation and colonic motility that dictated urge. No differences in anal electro 
mucosal sensation or rectal sensation (ramp balloon distension) were found. This 
raises the possibility that urge to defecate is not dictated by abnormalities occurring 
locally in the anorecturn but due to altered perception of sensory afferents at a higher 
level. Positron emission tomography (PET) and dynamic MRI scanning have shown 
that visceral perception of bowel sensations (such as distension and pain) is 
associated with activation of different parts of the brain in IBS patients compared to 
194"196 controls . The possibility that a reduced urge 
is associated with different 
patterns of brain activation compared to normal urge is intriguing. However, 
dynamic imaging comparing the two groups has not been performed. 
The role of rectal sensation in urge has not been fully established and published 
results of sensory testing vary. In contrast to our findings, Harraf found greater 
-209- 
sensitivity to ramp distension in patients with rectal urge compared to those with 
abdominal urge 166 . No 
differences in sensation to phasic distension were 
demonstrated. Hammonds et al studied constipated patients with urge and no urge 
and also found increased rectal sensitivity in the urge group'91. Although these two 
groups could be separated from each other by rectal sensory testing, it was more 
difficult to separate urge and no urge patients from controls. Hammonds et al found 
that 50% of urge patients were hypersensitive and 50% normosensitive compared to 
control values. Regarding no urge pateints, 33% were hypersensitive, 57% 
normosensitive and 10% hyposensitive compared to controls. In keeping with our 
results, Yiannakou et al found no differences in rectal sensation between reduced and 
normal rectal urge patients 197 . To 
definitively study rectal sensation in RRUD and 
NRUD, it will be necessary to study larger patient groups using validated distension 
protocols that assess reproducible endpoints and that can be compared to normative 
data 199 . 
Another factor that might influence rectal sensation and therefore urge to defecate is 
compliance. A highly compliant rectum may need large volumes of stool to achieve 
sufficient rectal pressure to activate sensory receptors. Gladman et al have 
demonstrated rectal hyposensitivity in patients associated with increased compliance 
199. It is possible that a reduced urge to defecate is similarly due to increased 
compliance. However, Mertz et al found no differences in compliance in patients 
with urge and patients in whom urge was rare 
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. Further study of rectal compliance 
and the urge to defecate would be interesting but it must be remembered that rectal 
hyposenitivity can occur in the presence of normal compliance suggesting that this is 
199 
not the only factor that could influence the urge to defecate . 
It was postulated that a RRUD might be associated with colonic dysmotility 
manifesting as prolonged total colonic transit or right sided delay. However, there 
were no differences in either total or segmental transit times in RRUD and NRUD 
patients. This finding is in keeping with the findings of Harraf et al who also found 
no difference in transit time in urge and non-urge patients 166 . In contrast, Mertz et al 
found that total colonic transit time was slower in patients with no urge compared to 
those with urge. They postulated that absent urge could be due to reduced delivery of 
stool to the rectum (occurring because of slower colonic transit) rather than 
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abnormalities of perception in the rectum. This suggestion was supported by the fact 
that they demonstrated no difference in rectal sensation in patients with normal urge 
or no urge 192 . 
It has been suggested that diminished Rectal Motor Complex (RMC) activity is a 
marker of colonic dysmotility in constipation 169 . RMC activity can 
be propulsive and 
it is possible that this initiates sampling by moving faeces through the rectum. It 
might be expected that reduced RMC activity would be associated with RRUD. In 
our study, RMC was observed in both groups. However, no differences were 
detected in terms of the duration, amplitude or interval between the RMC in the two 
groups. However, there are limits to the strength of the conclusions that can be drawn 
from the results of a4 hour of recording. To fully test the hypothesis that rectal 
dysmotility (evidenced by changes in RMC) dictates urge, larger sample sizes would 
be required. Ambulatory manometry for at least 24 hours would be needed since it is 
recognised that RMC activity varies in intensity according to the time of day 
200. To 
assess the propulsive characteristics of the rectosignioid, a catheter with multiple 
transducers fixed in the splenic flexure would be preferable to the single rectal 
transducer used in our Stud y 201,202. The development of impedance planimetry may 
also allow more detailed assessment of motility and the urge to defecate 
60 
. 
The above issues highlight the main limitation of our study; namely that only a4 
hour period of semi ambulatory recording was possible (using a catheter with only 2 
transducers), as opposed to a 24 hour fully ambulatory recording with multiple 
transducers. Our use of a2 transducer catheter was dictated by the availability of 
equipment. The duration of the recording was dictated by the tolerability of the semi 
ambulatory manometry equipment. Patients were only able to tolerate 4 hours of 
recording. An advantage of this was that subjects could be studied in a controlled and 
secure environment and that the symptom diaries of the recordings were completed 
comprehensively. Another limitation is that the study relates to females only. Gender 
issues regarding the urge to defecate have not been studied in depth. 
Our results suggest that the description of urge remains static with time. At 
recruitment, subjects were specifically asked descriptor questions regarding their 
urge in the preceding three month period. During that time frame, the description of 
the urge to defecate (either RRUD or NRUD) was constant. Furthermore, the 
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description at the time of recruitment was the same as that recorded 4 weeks latter 
when they attended for their manometry. However, fixther study is required to 
confirm the clinical impression that the description of urge remains constant in the 
longer term. 
We have demonstrated sampling events occurring at a frequency of 8.8 (sd 6.4) per 
hour in constipated individuals. Waldron et al, studying 8 patients with slow transit 
constipation, found sampling occurring 2.4 (sd 0.3) per hour 169 . Ambulatory solid 
state manometry was performed without the use of a patient diary over a 24 hour 
period. In their study, normal controls sampled at a frequency of 7.4 (sd 2.0) per 
hour. Waldron et al demonstrated a lower frequency of sampling compared to our 
study with a smaller standard deviation. 
One explanation for these discrepant results relates to the use of patient diaries. Our 
experience suggests that without correlation with diaries, some events are 
misinterpreted as movement artefact and mistakenly ignored. It is possible that 
Waldron under reported events because no diary was used. 
Another explanation relates to the criteria used to define sampling during analysis. 
Events can be identified by quantitative definitions (that use the amplitude of anal 
sphincter relaxation) or qualitative definitions (based on characteristic patterns of 
pressure change). In our study all events with characteristic pressure changes were 
included without the use of predetermined amplitude criteria. A quantitative 
approach may underestimate the frequency of sampling because small amplitude 
changes that still fit the descriptions of sampling are ignored. Likewise, computer 
analysis using definitions set by predetermined amplitudes may underestimate 
sampling 189 . There 
is an element of subjectivity associated with visual analysis 
using qualitative definitions. This may lead to inter observer variation and over 
estimation of sampling. Existing studies have used the descriptions suggested by 
176,187 Duthie and Miller as a broad definition of sampling . Specific details regarding 
whether qualitative or quantitative definitions were also used for analysis in these 
studies are not clearly described. These issues may explain why discrepant results 
have been reported between units. For example, Ronhalt reported sampling in 
normal subjects as 14.5/hr whilst Waldron and Farrouk reported 7.4/hr and 4/hr 
169,198 respectively 
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There is a need to develop agreed methods for analysis that use both quantitative and 
qualitative definitions of sampling. Computer analysis should not be performed 
alone and should be supported with visual reporting. By adopting agreed analysis 
protocols reproducibility between centres could be assessed and inter and intra unit 
variability evaluated. 
On the whole we believe that our method of reporting the manometry traces is 
robust. We have demonstrated good intra and inter observer reliability as well as 
reproducibility and do not believe that the number of events has been overestimated. 
What is not known is whether the insertion of a manometer catheter into the anal 
canal and rectum will actually trigger sampling events, increasing the natural 
frequency. Furthermore, the question of whether the diameter or the materials used in 
a catheter could increase frequency by an irritant effect has not been studied. 
Differences in catheter design are unlikely to explain why our sampling frequency 
was higher than that reported by Waldron et al since the catheters were of identical 
dimensions and produced by the same manufacturer. 
With regard to the wide range of sampling seen in this study it is not clear why one 
constipated patient should sample more than 80 times in the recording whilst another 
does not sample at all. Clearly, further study with large numbers of patients with 
recordings for a minimum of 24 hours compared against controls would improve our 
understanding of the physiology of sampling. However, this would be a great 
undertaking which may not produce clinically relevant findings. Further analysis of 
our data looking for differences between groups of patients at the extremes of the 
sampling range (i. e. those who sample the least and those that sample the most) 
would involve comparisons between small numbers of patients, such that the 
meaning of the results would be questionable. 
10.13 Future directions 
The explanation of why some patients have RRUD remains unclear. The perception 
of rectal urge involves a complicated pathway that has been described in section 8.3 
and summarised in Figure 15. The current study results (using 4 hours of semi 
ambulatory recording) suggest that the frequency of sampling does not dictate urge. 
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Further studies arc required to examine each part of the pathway to look for 
differences between those with RRUD, those with a NRUD. Comparison with 
normal controls will also be needed. Areas for future study include; rectosigmoid 
motility and ftu-ther assessment of anorcctal properties (sensation and compliance). 
These studies will require sufficient sample sizes to identify differences and use 
reproducible and validated protocols. Studies involving functional brain imaging 
may also be interesting. 
More study could be performed, specifically examining the frequency of sampling, in 
constipated patients, in normal and reduced urge subjects and in normal healthy 
controls. However, it could be argued that using the current protocol of 4 hours 
recording in such studies would potentially limit the ability to examine the 
phenomena of sampling and motility. The duration of 4 hours was dictated by our 
use of semi ambulatory recording in a secure environment and the results of the 
tolerability study. The advantage of this was that it facilitated accurate completion of 
diaries. However, our experiences of this technique would suggest that in future 
studies, a minimum of 24 hours recording (necessitating ambulatory recording) 
would be preferable. 
Further study of rectal motility in RRUD and NRUD may still be of value. It is 
recognised that poorer outcomes after colectomy and IRA are associated with pre 
203,204 
operative anismus, proximal bowel dysmotility and elevated rectal compliance 
Despite selecting out such patients, surgery may still not be universally successful 
98,170 
. It is possible that some patients 
have persistent abnormalities of rectal function 
that contribute to impaired evacuation leading to persistent troublesome symptoms. If 
it could be shown that urge was a surrogate marker for dysmotility and reduced 
propulsive contractions, this could help refine selection further. Again, larger sample 
sizes will be required and fully ambulatory manometry for a minimum of 24 hours 
would be desirable. 
There has been increased recognition that constipated patients can be separated into 
groups according to urge and that this division may reflect the presence of distinct 
166,167,197 
pathophysiological processes . Despite this, there has been little or no 
assessment of the effect of RRUD on severity, prognosis or response to treatment. 
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Further study of these issues will be important and may influence the design of future 
treatment trials. 
10.14 Conclusion 
A description of the urge to defecate can be used to separate constipated patients into 
two distinct groups, those with a normal rectal urge and those with a reduced rectal 
urge. This description appears to remain static with time. 
The role of sampling in dictating urge was examined using semi-ambulatory 
simultaneous measurement of anorectal pressure. The results did not support the 
hypothesis that a reduced urge to defecate is caused by infrequent sampling events. 
To detect significant differences in sampling, unfeasibly large sample sizes would be 
required. Further study of the frequency of sampling in these patients is not 
recommended using the current technique. 
Fully ambulatory recording for a minimum of 24 hours may give us the opportunity 
to learn more about RRUD and NRUD. Further study is also required to definitively 
examine the anorecturn in these two groups, including assessment of rectal sensation, 
compliance and rectosigrnoid motility. 
It is possible that urge is determined by the way sensory afferent information is 
processed in the brain rather then because of differences in anorectal properties. This 
aspect has not previously been evaluated. Developments in dynamic imaging of 
parts of the brain involved in the sensory perception may make this possible. 
The effect that RRUD has on prognosis has not been studied. This represents an 
important area for future work, to determine the true clinical significance of the 
observation that constipated patients can be separated according to their urge to 
defecate. 
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I EVALUATION OF A NOVEL THERAPY FOR THE 
MANAGEMENT OF IDIOPATHIC CONSTIPATION: 
PERCUTANEOUS ENDOSCOPIC COLOSTOMY 
(PEC). 
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11.1 Abstract 
Background: Percutaneous Endoscopic Colostomy (PEC) in the left colon is a 
minimally invasive endoscopic technique that can be used to irrigate the left colon 
and relieve constipation. The efficacy of the technique in the management of 
refractory idiopathic constipation has not been studied in depth. 
Aim: To evaluate efficacy and safety of PEC insertion for the management of 
refractory idiopathic constipation. The initial step was a retrospective data collection 
of all patients who had PEC inserted at the unit. The results were to be used to 
inforrn the design of a prospective study. 
Methods: Retrospective data collection 
Rcsults: Between 2001 and 2005,31 patients attended for PEC. Insertion was 
possible in 27. Indications included idiopathic constipation, recurrent sigraoid 
volvulus, colonic pseudo-obstruction and neurological constipation. 
Although symptoms were improved in the majority of patients and recurrent sigmoid 
volvulus prevented, complications were common. Infection and abdominal pain 
necessitated the removal of PEC in the majority of patients. Patients with refractory 
idiopathic constipation were particularly susceptible to these complications. Two 
deaths occurred due to faecal peritonitis occurring after insertion. 
Conclusion: Insertion was associated with significant morbidity and mortality. 
Recurrent infection was a common problem necessitating removal. The findings did 
not support the initiation of a prospective study to assess efficacy in patients. 
Consequently the aim of the project could not be fulfilled. 
The widespread use of PEC is not recommended and insertion should be restricted to 
specially selected cases. 
Percutaneous Endoscopic Colostomy (PEC) of the left colon is effective at preventing 
sigmoid volvulus and treating symptoms of constipation but insertion is associated 
with morbidity and mortality. 
S Cowlam, C Watson, M Elltringharn, I Bain, P Barrett, S Green, Y Yiannakou 
Gastrointestinal Endoscopy, 2007,65(7): 1 7-14 
Data collection SRC 
Data entry SRC 
Data Analysis SRC (advice from TH) 
Data interpretation SRC, YY 
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11.2 Overall aims 
The overall aim of the study was to evaluate the efficacy and safety of PEC in the left 
colon to treat patients with idiopathic refractory constipation. The initial step was a 
retrospective data collection of all patients who had undergone PEC insertion. 
It was intended that the results of this assessment would inform the feasibility of a 
prospective study of the effectiveness of PEC. However, the findings suggested that 
a prospective study in patients with refractory idiopathic constipation was not 
feasible. 
11.3 Design 
The prospective study of PEC was to involve constipated patients meeting inclusion 
and exclusion criteria. Subjects were to be recruited from a dedicated clinic dealing 
with constipated patients. The primary endpoint for assessing efficacy was to be 
colonic transit time pre and post insertion of PEC. Previous unpublished data from 
the unit had shown that colonic transit was reduced on average by 24 hours following 
insertion. This result was used in a power calculation to determine sample size. A 
conservative assumption was made that following insertion would be a reduction of 
transit time by 10 hours. Therefore, 28 patients would need to be assessed pre and 
post insertion to give 80% power at 5% significance to detect a difference in colonic 
transit after PEC. 
Secondary endpoints were to be symptom severity assessed using the Patient 
Assessment of Constipation - Symptoms (PAC-SYM) 125 and a subjective global 
assessment made by both patients and clinician. Quality of Life was to be evaluated 
pre and post insertion using the Patient Assessment of Constipation - QOL (PAC- 
QOL) questionnaire' 19. Assessments after insertion were to occur at 1,3 and 6 
months. 
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11.4 Introduction 
Percutaneous Endoscopic Colostomy (PEC) is a minimally invasive endoscopic 
procedure in which a plasticised tube is inserted in the left colon. Through this, the 
bowel can be irrigated or decompressed. Percutaneous insertion of a tube into the 
colon has in the past been undertaken radiologically 
205,206. In 1986 Ponsky et al 
described an endoscopic technique in the caecum; Percutaneous Endoscopic 
Caecostomy 207 . 
Endoscopic methods have also been used for insertion in the left 
colon, where the technique has been termed PEC; Percutaneous Endoscopic 
Colostomy 208-211. PEC has been used to treat a variety of conditions including 
colonic pseudo-obstruction, functional constipation and patients with constipation 
and faecal incontinence caused by neurological disorders 
209-213 
. PEC 
insertion has 
also been used to fix the sigmoid colon to the abdominal wall in recurrent sigmoid 
213-216 
volvulus, so offering an alternative to surgical sigmoidopexy or resection 
11.5 Historical perspective 
The formation of a conduit into the colon can be undertaken percutaneously by 
radiological and endoscopic means or directly by surgery. Traditionally the site for 
undertaking such procedures was the caecum. 
Malone described a surgical procedure in which a conduit was created by 
appendicocaecostomy fashioned in such a way to prevent reflux 
93 
. Through this 
irrigation could be performed and the concept of antegrade colonic enema (ACE) 
irrigation was developed. Percutaneous insertion using conscious sedation and 
radiological techniques have also been performed. Casola et al used Computed 
Tomography (CT) guidance to perform percutaneous caecostomy in colonic pseudo- 
obstruction in 1986 205 . More recently, 
Chait et al. reported the use of fluoroscopy for 
217 the procedure 
In 1986 Ponsky described an endoscopic method for insertion in the caecum that was 
termed Endoscopic Percutaneous Caecostomy 207 . Further case reports 
followed 218,219. Ganc et al used a gastrostomy tube to create the caeCoStOMY2 18 . 
Insertion was under direct vision. The technique had an advantage over the 
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radiological approach because the problem of inadvertent insertion into the terminal 
ileum could be avoided. 
Following on from these early attempts in the right colon, endoscopic methods have 
been used for insertion in the left colon, where the technique has been termed PEC; 
Percutaneous Endoscopic Colostomy. Review of the existing literature suggests that 
percutaneous endoscopic insertion in the left colon (including left and right colon) 
has been performed in approximately 80 adults and 33 children (Table 57, Table 58, 
Table 59, Table 60). 
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11.6 The technique of Percutaneous Endoscopic Colostomy in the left 
colon 
The approach favoured by most operators is full bowel preparation 24 hours before 
insertion. Intravenous antibiotics are administered before the procedure as 
prophylaxis against infection. The procedure is performed under conscious sedation. 
Colonoscopy is performed to identify a site for insertion. This site is the point of 
maximal transillumination and indentation on the abdominal wall suitable for 
placement of the tube. The area is infiltrated with local anaesthetic. A ScIdinger 
needle is passed through the abdominal wall and its entry into the lumen of the colon 
observed endoscopically. A guide wire can then be passed grasped by a 
polypectomy snare. The guide wire is then pulled through the anus by withdrawing 
the colonoscope. The PEC tube is attached to the guide wire and pulled through the 
abdominal wall via the anus. This method is termed the "pull through" technique. 
The type and diameter of tube is dictated by the clinical situation. Typically, 20 Fr 
gastrostomy tubes (Merck Pharmaceuticals, UK) or specifically designed 12 Fr PEC 
tubes (Merk Pharmaceuticals, UK) are used. The latter tubes utilise a plasticised 
guide wire to reduce the risk of "cheese wiring" the colon and abdominal wall during 
"Pull through". In addition, the diameter of the internal bumper (or bolster) is 
increased in comparison to standard tubes to reduce the risk of the bumper becoming 
buried in the colon wall. 
The colonoscope is reinserted to check the position of the internal bumper and adjust 
the tension on the tubing. Finally, the tube is attached to the abdominal wall to avoid 
inadvertent dislodgement. Patients are generally admitted after the procedure for 
observation and antibiotic therapy continued. Figure 37 shows schematic diagrams 
illustrating the technique. Figure 38 shows images taken during PEC insertion. 
The "pull through" technique has been used for insertion in both the right and left 
colon. An "introducer" method of percutaneous endoscopic caecostomy insertion has 
222 
also been described 
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Figure 37. Schematic diagrams of the technique for PEC Insertion 
i. Colonoscope passed into left colon. Seldinger needle inserted into left colon (under 
colonoscopic vision). 2. Guide wire passed through Seldinger needle into left colon 
and grasped with polypectomy snare. Colonoscope is withdrawn so that the guide 
wire is pulled out through the anus. 3. PEC tube attached to the guide wire and 
pulled back into the left colon. 4. PEC tube fixes left colon to the inner surface of the 
abdominal wall and held in place by the internal and external bolsters. 
1 
3 
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Insertion site demonstrated by 
maximal transillumination. 
18-gauge Seldinger needle passed 
into lumen of the colon. 
Guide wire passed into the lumen 
of the colon. 
Position of the internal bolster 
checked endoseopically 
PEC tube secured to the 
abdominal wall 
Figure 38. Images of PEC Insertion. 
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11.7 PEC and the management of recurrent sigmoid volvulus 
Sigmoid volvulus is a potentially life-threatening condition that may occur in elderly 
patients who often have other comorbidities. An overall mortality of 7% has been 
reported 228 . 
Decompression by colonoscopy can be performed but maybe associated 
with a recurrence rate of approximately 40%. A mortality of 10% has been observed 
for operative reduction. In the presence of colonic ischaernia mortality can rise to 
60%229. PEC provides an alternative to surgical intervention in a potentially high- 
risk, frail and elderly population. 
Daniels et a, 214 reported on 14 patients with a mean age of 78 years with recurrent 
volvulus. Colonoscopy was performed to reduce the acute volvulus and PEC was 
inserted. Two tubes were used to fix the sigmoid to the inner surface of the 
abdominal wall (inserted in the proximal and distal sigmoid). There were no deaths 
associated with the procedure. In five patients the tubes were left in situ and 
volvulus did not reoccur (mean follow up 12.6 months). Tubes were removed at an 
early stage in 8 patients; in 3 of these volvulus reoccurred. It was concluded that 
PEC was safe and effective for treating RSV and had a role in those patients in 
whom "conventional surgery was considered unsafe or inappropriate". Baraza et al 
reported on 19 patients with recurrent sigmoid volvulus in whom there were no 
further episodes of volvulus with tubes in situ. In 6 of these patients tubes were 
removed between 5 and 26 months with no subsequent recurrence 223 - The authors 
again concluded that PEC had a role for the management of RSV particularly in 
patients who were unfit for surgical intervention. 
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11.8 PEC and the management of colonic pseudo-obstruction 
Colonic pseudo-obstruction describes a clinical syndrome characterised by clinical 
and radiographic appearances suggestive of mechanical obstruction of the colon but 
where no physical obstruction can be demonstrated. Acute colonic pseudo- 
obstruction; often termed Ogilvie's syndrome 230 can be associated with systemic 
conditions (metabolic derangements, systemic infection, electrolyte disturbance, 
trauma or surgery)23 1. The chronic form may be a feature of intestinal pseudo- 
obstruction. In this pan-intestinal disorder neuropathic or myopathic changes in the 
bowel wall can occur as a primary illness or in association with other conditions 
232 
(scleroderma, bronchial carcinoma and amyloidosis) as a secondary phenomena 
The most feared complication of acute pseudo-obstruction is caecal perforation. 
Conservative and supportive treatments may not be effective. Prokinetics including 
neostigmine have been used with variable results 
233-236 
. Decompression by 
colonoscopy can be considered but the rate of recurrence ranges from 20% to 40% 
236,237 
. 
Furthermore, colonoscopy in the presence of pseudo-obstruction, is associated 
235 
with an increased risk of perforation and complications . 
Surgical caecostomy or 
colectomy may be indicated in cases of emergency perforation or threatened 
perforation. Surgery is however associated with significant mortality rates of 
between 26-36% 238. 
Treatment of chronic intestinal pseudo-obstruction is difficult with no guarantees of 
success. Overall, the effect of medical treatment is disappointing. Surgical options 
for managing chronic CPO include resection, stoma formation or decompression 
with enterostomy tubes. However, after reviewing the prognosis and response to 
treatment in 20 patients Mann et al concluded that the role of surgery was poorly 
defined. The authors suggested that the main aims of management included avoiding 
unnecessary surgery, symptom control and commitment to the long-term care of 
239 patients . Percutaneous Endoscopic Colostomy of the left colon can be used to 
provide decompression in both acute and chronic CPO. PEC offers an alternative to 
surgery. 
Acute colonic pseudo-obstruction 
Brown et al, reported their experience of using PEC to treat acute Cp0208 . They 
presented two cases. The first was a retired miner with severe Chronic Obstructive 
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Pulmonary Disease who suffered episodes of recurrent abdominal distension. 
Conservative management was successful in the initial episodes but subsequent 
presentations required colonoscopic decompression. On the final admission PEC 
was inserted in the sigmoid colon. This allowed decompression of the bowel. The 
patient remained symptom-free and avoided re-admission during a 12 month follow 
up period. The second case was 73-year-old patient with ischaernic heart disease. 
Ten days following aortic valve replacement and coronary artery bypass grafting, 
they developed CPO. Repeated colonoscopic decompression was unsuccessful. 
PEC was inserted, allowing decompression of the bowel. The tube was removed 28 
days later and the patient remained well at three months. 
The "pull through" technique was used to perform percutaneous endoscopic 
caecostomy in 5 patients with acute CPO in a Japanese series 222. Decompression 
was achieved in these patients but the duration that tubes were in situ was not stated. 
Chronic colonic pseudo-obstruction 
Thompson et a12 10, reported three consecutive cases of chronic CPO treated with 
PEC. In all cases, diagnosis of chronic colonic pseudo-obstruction was confirmed by 
contrast enema and treatment had included flatus tube. After PEC placement in the 
left colon, all three patients noted symptom improvement. In each case PEC allowed 
decompression of the colon and relieved symptoms of bloating and discomfort. 
There were no PEC related complications in any of the cases. The period of follow- 
up ranged from five weeks to 2.5 years. Four patients with CPO were studied 
prospectively by Baraza et al. These patients with a median age of 75 had not 
responded to medical management. Three had a satisfactory result with resolution of 
symptoms 223 . 
Both sets of authors concluded that PEC is an effective treatment in 
selected patients with chronic CPO. 
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11.9 PEC and the management of constipation and faecal incontinence 
Chronic constipation and faecal incontinence are significant problems for clinicians, 
patients and carers. These conditions can have a detrimental effect on the physical, 
social and psychological well-being of patients with significant impairment of 
quality of life. Although many patients can be treated successfully with laxative 
therapy, some do not respond. Behavioural therapy with biofeedback and rectal 
irrigation has been used with variable degrees of success to manage these 
conditions 240,241 . 
Experience with sacral nerve stimulation is so far limited to 
relatively small numbers 242 . In patients who 
do not respond, surgical intervention 
can be considered. The type of surgery is dictated by the cause of the chronic 
constipation. The functional results of rectocoele repair and internal anal 
243,244 
sphincterotomy can vary with no guarantee of long-term success . 
Subtotal 
colectomy and ileorectal anastomosis is accepted as a definitive procedure for 
managing slow transit constipation. Functional improvement of up to 90% has been 
reported 245 . 
Further detailed long-term follow up is required to fully appreciate the 
role of invasive surgery in patient management. However, for patients with proximal 
intestinal dysfunction and slow colonic transit or patients with obstructed defecation 
such surgery is unlikely to be beneficial. Irrigation via an appendicocaecostomy - 
antegrade colonic enema (ACE) - is another surgical option. Although encouraging 
long term results are reported 246 the procedure is again, invasive and requires 
general anaesthesia. The long length of colon that must be irrigated could 
theoretically compromise the efficacy of ACE. This maybe of relevance in those 
247,248 patients with predominantly left sided colonic dysfunction . It is plausible that 
antegrade irrigation of the left colon via PEC would be beneficial in these cases. 
Furthermore, PEC offers a less invasive, reversible alternative to colectomy and 
ileorectal anastomosis or ACE procedure. 
Herriot et al reported on the case of a 52-year-old woman with a chronic history of 
obstructed defecation in whom standard treatment had failed 209 . The patient refused 
a colostomy. PEC was inserted in the descending colon using conscious sedation and 
irrigated with one to two litres of water twice a day. She was able to evacuate within 
10 minutes and had no further abdominal pain. The original 14 French gastrostomy 
tube (Freka, Frenius, UK) was replaced with a flat Mic-key tube (Vygon, UK). The 
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patient remained asymptornatic at six months. Baraza et al treated 10 patients with 
slow transit constipation but had variable success with the procedure with three 
patients choosing to have their tubes removed and return to conservative 
treatment 223 . 
11.10 PEC and the management of incontinence and constipation in 
adults with neurological disease 
Severe bowel dysfunction with intractable constipation and or faecal incontinence is 
common in neurological diseases such as multiple sclerosis, spinal cord injury or 
cerebrovascular disease 249,250. As in idiopathic constipation, conservative treatments 
are not always successful. 
Options for intractable disease unresponsive to conservative therapy include ACE 
251252 253 254 
procedure ,, sacral nerve stimulation or colostomy formation . The inherent 
risks of surgery and general anaesthesia exist with no absolute guarantee of success. 
Daniels reported on one patient with MS who was treated by PEC for her refractory 
constipation 21 1. Following discharge the patient's carers irrigated the sigmoid colon 
on alternate days to remove faeces. The irrigation took approximately 20 minutes to 
perform and improved the patient's quality of life by removing the incontinence and 
easing the distressing symptoms of constipation. 
Davis et al, reported on a series of nine patients, age 38-72 years with severe 
neurological disease 212 . Six of the patients were suffering from multiple sclerosis. 
Symptoms included severe constipation and faecal incontinence. After insertion the 
subjects were followed up for a period ranging from two to forty months. All 
reported significant improvement in their Wexner incontinence score, reduction in 
use of bowel regulating medications, reduction in toilet time and improved quality of 
life. The combined experience of several centres in the use of PEC for the 
management of faecal incontinence caused by central neurological disease has been 
reported as an abstract 255 . 
Twenty six patients aged between 7 and 86 years were 
studied. Nine patients suffered from MS, seven with spina bifida, four with 
tetraparesis, three with parkinsonism, one with Alzheimer's disease, one motor 
neurone disease and one patient suffered from dystonia. Eighty five percent of 
-231 - 
patients had good outcome with PEC. There was improvement of incontinence score 
using irrigation on alternate days. Two patients did not benefit from PEC and 
underwent surgery. 
11.11 Percutaneous Endoscopic Colostomy in children 
Rawat et al, reported on a series of 15 children who underwent PEC procedure for 
the management of refractory constipation and concurrent faecal incontinence 226 . 
PEC was inserted into the left colon using the "pull through" technique. In contrast 
to the adult population, the procedure was performed under general anaesthesia. 
Following insertion, washout of the distal colon was performed with water (and 
enema if necessary). 
The outcome measure to assess response was a "clean score". This recorded the state 
of daily soiling between spontaneous or washout induced evacuations. At two-month 
follow up all 13) patients reported significant improvement in their continence. The 
PEC was tolerated well by the children and parents. Rivera et al, similarly treated 
children with chronic constipation and faecal soiling caused by neurological 
handicaps. Average follow-up was 13 months. All patients and families were pleased 
with the PEC. The authors concluded that PEC was a safe and effective method for 
treatment of intractable constipation. They recommended the procedure for selected 
patients with spina bifida, spinal cord injury, anorectal abnormalities and severe 
neurological handicaps 224 . 
11.12 Percutaneous endoscopic caecostomy 
Following the early case reports concerning percutaneous endoscopic ceacostomy 
207,218,219 
, two case series have been published. Ramage presented 5 patients (3 with 
neurological constipation and 2 with acute colonic pseudo-obstruction) in whom 
there were improvement in symptoms. The mean follow up was 6.6 months. Uno 
presented 20 patients in whom percutaneous endoscopic caecostomy was performed. 
This series included 15 patients with neurological constipation in whom an 
"introducer technique" was used. Here, the caecum was identified by 
transillumination. Under endoscopic visualisation, the caecum was pierced by a 
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double needle suturing device. The caecurn was secured to the abdominal wall by 
three retention sutures arranged in a triangular formation. In the centre of this the 
caecurn was pierced by an introducer that allowed the stoma to be formed. This was 
kept patent by a plasticised catheter. In 9 of these, conversion to a low profile Chait 
Trapdoor Caecostomy Catheter (CTCC) 217 was performed. These patients were 
reported as having improvement of their constipation with a mean follow up of 8.8 
months. Uno reported lower rates of infection in patients with CTCC inserted by the 
"introducer technique" compared to the 5 in whom caecostomy was fashioned using 
222 the "pull through" technique 
Both Rivera and Depeppo have used the "pull through" technique for insertion of 
percutaneous endoscopic caecostomy in children with defecatory difficulties with 
224 225 
good results 
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11.13 Complications of Percutaneous Endoscopic Colostomy 
Overall, the literature suggests that PEC is a low risk procedure with few serious 
complications reported. However, small patient numbers and variable periods of 
follow up mean that the accurate assessment of complications is limited. Several 
complications have been reported in the adult and paediatric literature and are 
summarised in Table 61 and Table 62. 
Complications ofPEC insertion in the adultpopulation 
In the management of RSV, recurrence was observed in those subjects who had PEC 
removed 213,214 . In the series reported 
by Daniels, the PEC tube was removed at six 
weeks in three cases and this led to recurrence. At laparotomy in these patients, no 
residual fixation of the colon to the abdominal wall was seen. It would appear that in 
some patients, a period of time (more than six weeks) is required before the colon 
adequately adheres to the abdominal wall. This process is likely to be incomplete if 
removal is too early. However in 10 of their patients (including five who had PEC 
removed at six weeks) no complications or recurrence were reported. Baraza et al 
found PEC to be effective at controlling RSV but encountered an episode of fatal 
PEC related peritonitis caused by tube migration and faecal contamination 223 . 
Brown et al, reported no complications in two patients treated with PEC for acute 
Cp0208. One patient however had a relatively short follow-up period of three months 
and PEC was only in situ for one-month. It would appear that the tube was removed 
because of resolution of symptoms rather than the onset of complications. The other 
patient was followed up for 12 months. 
With regard to PEC insertion in chronic CPO, Thompson encountered no 
complications in three patients with a follow up ranging from five weeks to 54 
months210. In contrast, Baraza et al encountered peritonitis in a patient with CPO that 
necessitated tube removal and laparotomy, bowel resection and end sigmoid 
Colostomy 
223. 
Daniels found no complications in a patient with MS, although follow up was limited 
(one month)21 1. In a larger series of 7 neurological patients, the only problem 
encountered was a patient who developed pressure sores whilst sitting on the 
commode when irrigating the PEC. Although the PEC improved symptoms the 
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patient elected to convert to ileostomy. Infections at the site of insertion were not 
212 
reported in any of the cases 
Faecal leakage from the insertion site was reported at six weeks in a patient with 
obstructive defecation 209 . This was managed successfidly 
by conversion to a low 
profile button tube (flat Mic-Key tube, Vygon, UK). 
Complications ofPEC insertion in the paediatric series 
Outcomes and complications associated with the PEC insertion in the paediatric 
group are summarised in Table 62. Rawat encountered several minor 
complications 226 . These 
included granuloma formation at the insertion site, 
abdominal pain associated with enema and local tract infection. The infections were 
treated successfully with five days of antibiotics. The number of patients affected 
was not reported. A major complication occurred in one patient whom sepsis 
occurred post procedure. This necessitated removal of the tube and colostomy was 
subsequently performed. In one case, PEC was not possible because of failure to 
identify an insertion point. 
In the series by Rivera et al, several complications were reported. One patient who 
had previously undergone surgical intervention for Hirschsprung's disease developed 
enterocolitis nine days after insertion. Pressure necrosis from the external bolster 
occurred in another. This was due to abdominal distension but was treated 
successfully by venting the colon via the PEC. Urinary tract infection occurred in 
one case, seizures in one and fever (with negative blood cultures), abdominal 
distension and pain in another. Five children in the series developed granulation 
tissue around the stoma. This was managed with silver nitrate and topical steroid 
cream. None of these complications led to PEC removal. One patient suffered an 
unrelated death at nine months because of deterioration of their original illness 224 . 
-235- 
CL 
=3 
.2 0 LL 
:3 41 U) 
a) 
c 
0 
tr, 
to 
CL 
E 
0 
E 
:i Z 
r_ 
1 
0 
E 
04 
vl- 
-a 
C 
0 
E 
2 
II 
=I 
z 
C%4 
6 
CL. 
0c 
0,0 
0.92 
<0 
. '0 co -(5 9 
it iF= 
co 
C) 
M 04 
(0) 
I 
z 
m 
0- 
m 
CL 
Ee 
0 C: ) 
(D 
c 0 E 
(0 
ca 
0 v 
F31 
to 
m 
(D 
0) 
(a 
0 -ýe (1) 4) 
(a (1) 
LL 
T- 
r_ 
0 
LP 
m 
CA 
. 92 0 
C%j 
0 
C) 
04 
< U) 
(D 
0 
=0 
U) 0 
. C-- m 
00 
EE 
coco 0 
(I) 
4J 
r_ 
0 
E 
(1) 
CO Q 0 Cý 3: 
CO co C14 
C 
0 
0 
E 
0 . 2) z U) 
w ýa 
75 
> 
0 E 
Z-) G) 
> 
a) la C: 
> 
o 
(D 
CD 
, ZZ Q_ < 
U) U) 
W (D 
W 
U) U) mm w m (. ) Q (L) 0 
V) tr) Cl) Ir- 
> 
C') 
0 
CD 0 
C'4 
c4 LZ 
it .2 Ul U) 
0 C) 
4-a 
C 
0 
E 
0 
E 
I 
z 
a) U) 
V- 
(a ý 
0 
CL 
C: 0 
0 
L- 
(D 
7j) 
CY) m 0) 0 V.. 
c 
-0 
0 0 
E C: CL 
C) 0 IE 
0 C) 0 04 Nr z 
U) 
0c =1 
E 
C, 4 00 
T- EE 
(b Lo 04 
0 m 0 
r- (0 to 
E 'c CL 
0 
E CD 0 E 0 0 
C: ) CD 0 Z (6 
E 
to 
E 
c4 
c 0 
E 
«0 0 
0 r, 
CM 
«a 
c: m 0 
0 
0 
Cl. 
2 
8 93 2m --2 CL Wm . < in 
* CL E (1) , :3 0-a 
0 
OC 
E u) 
_C 00 -zc C U) 0M 1- 0 
E 
0 C. c- 0E '5 
(1) 
cm 
m 
r- 
CD , q; r 
3 u) cm u) r- 
= - " 35 0 = 0 ý Z :ý a- Z 
U) 
0 U) 01 U) ul 8 f1-) 8 8 8 8 
fl, r- v- «2 
0 
C U) (U cn 
(U (L) *0 " CL c UM %z3 0r 
6) C) 0 (>--OCD 
*E (0 ": 3 11 
0 () (D C 
LL 
cf) > C) 
CD Ir- 
C-4 -1 
L0 
r_ 
0 
CL 
1P 
0 
C) 
L) 
2 
:3 
Z< 
cqr) 
0 
c) < 
C14 C/) 
d) 
CY) U 
(a C) 
E 5, 
ýr 
0 
Z0 OM LO 
c: ýz c) in 
Jo- eo cm E 
(D CY 
0 
OD 0 E 
0 U) 
> 0 E 
0 
Ir- 
w 
0 
0 
0 .- r- 
12 *0E AM üZ CL 
ja) 
m 
(P 0 (D'&- 
cu 
LL izm, 
(0) 0 
Q (L) (L) (1) 
u) U) u) 0) 
8888 
cy) T- (D V- 
C) 
TI- 
d 
0 
(o 
CL 
=0 
0 
2 
C14 
75 
(D'o 
m U) =) 
to 
r_ 
0 
CL. 9) 
to 
ýo 
m 
c1111 
9 
-Z G 
'0 
0 0 
0 0 0 
ý0 
to c 
0 ci C) CL 00 CL 0 CL 0 CL 0 CL 0 
U- Z EZ Z Z ZE 
C) 
0 
0 0 
0. 
0 
Ci. 
00 
CL 
0 
CL 
00 
c2. E 1Z2 Z 2 (U u3 0 0 0 0 0 cý 
c3. E Z Z Z ZZ 
U) U) 
C) 
m a) m 
> 
mr 
0 (1) U) o 0 0 _ 0 c C: 9 
CL 
0 
(0 0 2 -: r- 
00 C) 
(n 0 E. 0 
- . 3Q - 
ýu 92- 
8 a 0 0 a u) (0 a) E 
0 
U) -0 (L) r Ci. (U Z0 00 m Z 
0 
00 
CL e 0 0 0 0 - (0 5 
CL 
0 i6 (1) 0 41= 
0 
(0 0) crj C c: (n .. E 00 
lö U) 
cn 
(L) 0- 
-0? -% 
iý r- -0 
0 0.0 IL) (0 
_c 2 
:3 - < 
8 c 
0 t5 0 
0 L) 
0 (L) 
:ý .-. 0 EEt 
U) 00 ýQ) C. ) 0cm 
E 
m :3 0 (4) E 00ý * 1 ) 0 r- (L) 
> 
(1) 0 
a) 0 tE w c- - IL) (0 r- 
0 Z) CI) U« 0 0- a. "- a) 
(1) (D 
(1) U) 0 0 U) U) U) U) cn 
0 
.0 c4 U) 
c: 9) 0 
CL 2 0 cu 0 0 
0 c) r- -0 (L) -r -0 C) T) 0cý0 « - C) c: C) (U 0 Fo 0 m. 
C) C: ) 
CD 
rý4 0 
C: ) d 
cý 0 
5 a), e -0< 3. '0 : 0 
N 
m 
Complications related to conscious sedation and colonoscopy 
Patients undergoing PEC insertion are at risk of the cardiovascular and respiratory 
complications associated with conscious sedation. Colonoscopy is integral to 
insertion and the risk of perforation therefore exists. In cases of acute CPO, the risk 
of perforation may be higher than that expected in purely diagnostic procedures. 
Complications occurring at the site of insertion 
The procedure requires the participation of experienced endoscopists because it is 
essential to confidently identify a safe insertion point. It is critical that the risk of 
transfixing overlying bowel during insertion is minimised. This can be achieved by 
using endo luminal landmarks, digital indentation and transillumination through the 
abdominal wall. Fluroscopic screening with an image intensifier can also be used. 
A degree of leakage of bowel contents is to be expected at the time when the colon 
wall is pierced. Such leakage is likely to cause a localised peritonitis for the first 24- 
48 hours following insertion. It could be argued that the "introducer" method used 
for endoscopic caecostomy (as described in section 11.12) reduces this leakage since 
the loop of bowel already secured by sutures to the inner wall before it is pierced to 
allow insertion of the tube. 
Infection at the site of insertion is a recognised complication. This may be associated 
with leakage of bowel contents that are not sterile. Infection may occur soon after 
insertion (days to weeks) or may arise later (months). Data are lacking regarding the 
long-term incidence of infection whilst PEC is in situ or the effect that these episodes 
have on prognosis after removal. The culprit organisms are not reported although it 
can be assumed that gut organisms and skin commensals are likely to be involved. In 
the paediatric series by Rawat, one case of tract infection was identified. This was 
classified as a minor complication and antibiotic treatment was successful. In 
addition, there was another case of significant sepsis that necessitated tube removal. 
This patient proceeded to colostomy. It is unclear whether this was as a result of the 
septic episode or whether the decision to proceed was made electively. Baraza et al 
encountered site infection in 6 patients (although it was not reported whether this was 
recurrent episodes of infection or merely one episode). In all but one of these patients 
infection settled with antibiotics. In the remaining subject, tubes were removed as a 
223 consequence of infection 
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Granuloma formation was reported frequently in the paediatric population. The 
factors that predispose to granulation are unknown but adequate toilet of the insertion 
site may help prevent this problem. Faccal leakage occurring even after PEC has 
been established for some time has been reported 209 . Management was achieved by 
replacing the original tube with a low profile device. The practice of replacing the 
original tube is reported by several authors but the timing of replacement varies 
between institutions. 
11.14 Current guidelines for the insertion of PEC 
The National Institute for Health and Clinical Excellence issued guidance for the use 
of PEC procedure in March 2006. This includes an overview of the indications, 
efficacy and safety profile of the technique. The primary indications recognised were 
treatment of RSV and Cp0256. The document includes recommendations for patient 
preparation, the procedure for insertion ("pull through" technique) and immediate 
after care. The guidance is based on expert opinion and a review of the existing 
literature. 
The available published data is limited to small case series with variable follow up. 
The patients are heterogeneous and unmatched for age, sex or co-morbidity with a 
control population. Unpublished data from a multi-centre audit was also used to 
produce the guidance. It was noted that some of the patients included in the existing 
literature were also included in the unpublished data. 
11.15 Summary 
PEC insertion represents an alternative to established invasivc surgery that has been 
used to manage patients with conditions that remain refractory to conservative 
treatments. The technique is becoming increasingly rccognised. However, long term 
data regarding efficacy, outcome, complications and the effect insertion has on 
prognosis are lacking. 
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12 USE OF PERCUTANEOUS ENDOSCOPIC 
COLOSTOMY (PEC) IN THE LEFT COLON FOR THE 
TREATMENT OF LOWER GASTROINTESTINAL 
DISORDERS: A CASE SERIES OF 27 PATIENTS 
FROM A SINGLE UNIT. 
12.1 Abstract 
Background: Percutaneous Endoscopic Colostomy (PEC) in the left colon is a 
minimally invasive endoscopic technique increasingly used to treat lower 
gastrointestinal conditions. 
Aim: To evaluate efficacy and safety of PEC insertion at a single unit. 
Methods: Retrospective data collection. 
Results: Between 2001 and 2005,31 patients attended for PEC. Insertion was 
possible in 27. Indications included functional constipation n--8, recurrent sigmoid 
volvulus, n--8, colonic pseudo-obstruction n--5, neurological constipation n--6. In 22 
patients (81%), symptoms were significantly improved after insertion. Sigmoid 
volvulus did not recur with PEC in situ. Mean duration with tubes in place was 9.5 
(sd 8.4) months. Tubes were removed in 13 patients due to complications. Only 2 
patients still have PEC in situ. Infective episodes occurred in 77% of the group 
necessitating removal in 44% of patients. Other complications included buried 
internal bolster, faecal leakage and pain. Mortality was high (26%) with 7 deaths; 5 
deaths from unrelated causes and 2 deaths from faecal peritonitis. 
Conclusion: Symptoms were effectively controlled by PEC and RSV was prevented. 
Recurrent complications caused significant morbidity. Infection necessitated removal 
in the majority of patients. Fatal faecal peritonitis occurred in two patients. 
Indiscriminate use of PEC is not recommended. PEC should only be considered in 
carefully selected cases. 
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12.2 Aims 
The objectives of this retrospective study were to evaluate the results and 
complications of PEC insertion in patients with a variety of lower gastrointestinal 
conditions. A subsidiary aim was identifying case histories that highlight specific 
issues related to the technique. The results of histological examination of PEC tracts 
are also discussed. The results of this assessment were to be used to inform the 
design of a prospective study of the efficacy of PEC in refractory idiopathic 
constipation. 
12.3 Patients and Methods 
Thirty-one patients attended for PEC insertion between 2001 and 2005. The group 
included patients with recurrent sigmoid volvulus (RSV), patients who had colonic 
pseudo-obstruction (CPO) and patients with neurological constipation (NC). In these 
latter patients, constipation was attributable to a neurological condition. In the RSV 
group the diagnosis was made on the basis of characteristic radiological and 
endoscopic appearances 216 . The patients with idiopathic constipation met Rome Il 
criterialo for functional constipation (FC). 
12.4 Patient selection for insertion of PEC 
PEC was considered in the FC group because symptoms were refractory to 
conservative treatments (laxatives, enemas, biofeedback training and rectal 
irrigation) and because quality of life was significantly impaired. These patients were 
on the waiting list for surgical intervention and were offered PEC as an alternative. 
Likewise, the patients with NC had not responded to conservative treatments. PEC 
was considered instead of surgery in RSV patients because of high surgical risk 
related to co-morbidity and frailty. The patients with chronic CPO had not responded 
to symptomatic treatments, prokinetic agents, neostigmine infusion or colonoscopic 
decompression and were offered PEC as an alternative to surgery. PEC was 
performed for acute CPO in patients deemed high risk for surgery where supportive 
therapy, neostigmine infusion and colonoscopic decompression had failed. All 
patients had provided written consent for the procedure and were made aware of the 
perceived risks, benefits and alternatives to PEC insertion. 
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12.5 Procedure for PEC tube insertion 
Preparation included full bowel clearance 24 hours before insertion. Intravenous 
cefuroxime, 750mg (Glaxo Smith Kline, Uxbridge UK) and metronidazole, 500mg 
(Winthrop Pharmaceuticals, Guildford UK), were given before the procedure as 
prophylaxis against infection. Intravenous midazolarn (Roche, Welwyn UK) and 
pethidine (Martindale, Brentwood, UK) were titrated to achieve conscious sedation 
with analgesia. Colonoscopy was performed to identify a site for insertion in the left 
colon. This site was the point of maximal transillumination and indentation of the 
abdominal wall suitable for placement of the tube. The area was infiltrated with local 
anaesthetic. An 18-gauge Seldinger needle was passed through the abdominal wall 
and its entry into the colonic lumen observed endoscopically. A guide wire was 
passed through the Seldinger needle and grasped by a polypectomy snare. The guide- 
wire was pulled through the anus by withdrawing the colonoscope. The PEC tube 
was attached to the guide-wire and pulled through the abdominal wall via the anus 
("pull through" technique). Typically, 20 Fr gastrostomy tubes (Merck 
Pharmaceuticals, UK) or specifically designed 12 Fr PEC tubes (Merk 
Pharmaceuticals, UK) were used. The colonoscope was reinserted to check the 
position of the internal bolster. Finally, the tube was attached to the abdominal wall 
to avoid dislodgement using an external bolster (Merk Pharmaceuticals, UK). After 
the procedure patients were admitted for observation. Intravenous antibiotic therapy 
was continued for a further 5 days. The patients were followed up regularly after 
insertion. 
12.6 Data collection 
Efficacy was assessed by reviewing the medical records and classifying patients 
according to an assessment of their symptoms after insertion. The categories 
included markedly improved, minimally improved, unchanged and symptoms 
worsened. A subgroup of constipated patients was selected to undergo pre and post 
insertion colonic transit studies using radio-opaque markers 53 - All complications 
were recorded irrespective of severity. 
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12.7 Statistical methods 
Incidence density (ID) was used to determine the rate at which complication episodes 
occurred with PEC in situ. Incidence density is the measure of each complication 
episode per 100 patient months with PEC in situ and takes into account that the 
duration with PEC in place is different for each individual. The following equation 
was used for the calculation: 
ID = 
No of complication events with PEC in situ 
x 100 
Total patient-months with PEC in situ 
Normality of data was assessed by the Kolmogorov-Smirnov test. Normally 
distributed data were analysed with Student's t test for unpaired samples. Non- 
normally distributed data were analysed with the Mann-Whitney U test and the 
Kruskal-Wallis test. Categorical data were analysed using Fisher's Exact test. Ap 
value of < 0.05 was considered statistically significant and ap value of < 0.01 
considered highly significant. 
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12.8 Results 
The characteristics of the 31 patients are sunimarised in Table 63. There were II 
patients with FC, 8 with RSV, 8 with CPO and 7 patients with NC. In the NC group, 
one patient had cerebral palsy, two patients spinal cord injury and four had multiple 
sclerosis (MS). The CPO group contained 2 cases of acute CPO (Ogilvie's 
syndrome 230) and 3 cases of chronic CPO. All of the FC patients had slow colonic 
transit. 
The RSV and CPO patients represented an elderly cohort in whom coexisting 
medical conditions were common. Two thirds of the RSV group had a WHO 
performance status of 3 or higher (limited self care, resting >50% of daylight 
hours)257 . Four CPO patients 
had a WHO performance status of 4 (minimal or no self 
care, bed bound). In the cases of chronic CPO the mean duration of the condition was 
3.3 years (sd 1.15). Prior to insertion the mean history of RSV was 6.4 months (sd 
3.96). All 8 of the RSV patients described symptoms of bloating and distension 
during this time. Seven also suffered constipation. 
None of the 31 patients were taking steroids or immunosuppressant treatments at the 
time of insertion. Two of the RSV patients had type Il diabetes mellitus. The 
characteristics of each specific patient selected for PEC insertion are summarised in 
Appendix C, Table I through to Appendix C, Table 4. 
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12.8.1 Insertion 
From the 31 patients, there were 4 (13%) in whom a suitable site for insertion could 
not be identified and the procedure was abandoned. In the remaining 27 patients, a 
total of 28 PEC tubes were inserted in the left colon. This included one patient who 
had two tubes, inserted on separate occasions at different sites in the left colon. This 
patient had a history of chronic CPO and co-existing medical conditions. 'Me first 
tube, inserted in the mid-descending colon stayed in situ for 6 months. At the 
patient's request and because of an improvement in her overall condition, the tube 
was removed. After 8 months, her quality of life was again severely impaired by 
colonic symptoms. PEC was reinserted in the mid-sigmoid, leading to symptom 
resolution. 
In the whole group, the mean duration of the procedure was 30 minutes (sd 10.8). 
The commonest point of insertion was the mid sigmoid (40% of insertions). The 
remaining insertion positions were; distal descending (33% of insertions), mid- 
descending (15%) and proximal sigmoid (15%). Twenty patients had 20Fr tubes 
inserted and 8 patients had 12 Fr tubes inserted. 
In 9 patients the original PEC was removed and a replacement tube inserted down 
the existing tract. The majority of these changes were performed because of recurrent 
complications including episodes of infection and faecal leakage. 
12.8.2 Hospital stay 
Mean hospital stay for all patients was 15.4 days (sd 10-8). The CPO and RSV group 
had prolonged stays because their coexisting conditions required on going 
management. 
The FC patients only required in-patient management for the effects of insertion and 
their length of stay gives a clearer idea of the hospital stay attributable to PEC itself. 
The mean hospital stay for these patients was 6.9 days (sd 4.5). 
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12.8.3 Duration with PEC in situ 
The mcan duration that the PEC tubcs rcmained in situ was 9.5 (sd 8.3) months 
(range 4 days to 26 months). In 22 of the 27 patients symptoms were deemed to be 
markedly improved after insertion. In those with RSV, no further episodes of 
volvulus occurred with PEC in situ. Tubes stayed in place for a mean of 8.8 (sd 6.5) 
months in the RSV patients. 
12.8.4 Assessment of efficacy 
In 22 of the 27 patients symptoms were deemed to be markedly improved after 
insertion. In those with RSV, no further episodes of volvulus occurred with PEC in 
situ. Figure 39 shows the results of the assessment of efficacy. 
Six patients with constipation had transit studies performed pre and post insertion. 
Delayed transit was demonstrated (mean colonic transit time 69.3 hours (sd 3.3), 
before insertion. Following the procedure, the tubes were irrigated regularly and 
transit studies repeated after 3 months. There was a mean reduction in transit time of 
35.7 hours (sd 16.6), (p=0.003). 
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Figure 39. Symptoms after PEC insertion. 
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12.8.5 PEC tube outcome 
PEC tube outcomes for the total group are shown in Table 64 and Figure 40. Of the 
28 tubes inserted, only 2 remain in situ. Two were removed because of resolution of 
symptoms. 17 were removed due to complications such as recurrent infection, buried 
bumper, abdominal pain or faecal leakage. Two tubes were inadvertently dislodged. 
Category Details Number of tubes 
Elective Resolution of symptoms 2 
removal Immunosuppressive medication started 1 
Recurrent infection 7 
Planned Recurrent pain 2 
removal Recurrent infection, pain and leakage 1 
Removed Buried bumper 1 
due to An episode of infection and pain 3 complications 
Infection Wth subcutaneous abscess 
Emergency An episode of infection and pain removal 
Faecal peritonitis four days following insertion 
Dislodged Inadvertently pulled out by patient 2 
In situ at the Patients who died from unrelated causes with point of PEC in situ 
4 
death 
In situ May Two patients who continue in follow up with 2 06 the PEC tube in situ 
Table 64: Outcomes for PEC tubes. 
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Figure 40: PEC tube outcomes. 
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12.8.6 Patient outcome 
Figure 41 summarises patient outcome. Seven patients from the group of 27 have 
died. Of these, 5 died from unrelated causes with the tube still in situ (4 cases of 
pneumonia and I patient with lung cancer) at a mean of 8.2 months (sd 6.5) after 
PEC was inserted. These unrelated deaths all occurred in the RSV patient group. The 
remaining 2 deaths were caused by faecal peritonitis (patients RSV I and CPO 1). The 
details of these patients are described as case histories (section 12.9). 
In the remaining 20 patients, two still have PEC in place and 18 no longer have tubes 
in situ. The 2 patients with PEC in place (NC5 and CP02) have been followed up for 
10 and 7 months respectively. Their symptoms are successfully controlled. 
The remaining 18 patients have been followed up after their tubes were removed for 
a mean of 20.4 months (sd 3.5). This group includes: 5 who had tubes removed and 
recommenced conservative treatment; 2 who remain symptom free requiring no 
specific treatment after tubes were removed or dislodged and II patients who 
required a dcfinitive surgical procedure following removal. The surgical procedures 
were performed because of ongoing symptoms relating to the underlying 
gastrointestinal disorders. All 8 of the FC patients had tubes removed and 6 of these 
proceeded to surgery; including colectomy and ileorectal anastomosis in 5 (patients 
FC3, FC4, FC5, FC6, FC7) and Malone Antegrade Colonic Enema procedure 259 
performed in I case (FC2). 
The outcomes for each individual patient are displayed in Appendix C, Table 5 
through to Appendix C, Table 8. 
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12.8.7 Complications 
A variety of complications were recorded. Localised peritonism at the PEC site 
occurred frequently in the period immediately after insertion, being present in 18 of 
the 27 patients. The mean duration of peritonism in affected patients was 1.5 days (sd 
1.4). When 20 Fr tubes were used, peritonism. occurred on II occasions after 
insertion. When 12 Fr tubes were used, there were 4 episodes when peritonism, 
occurred immediately after insertion. There was no difference in the incidence of the 
episodes of peritonism between groups defined by PEC tube diameter (Table 65). 
The mean duration of peritonism after insertion in patients with a 20 Fr tube and 
those with a 12 Fr tube was not significantly different; mean duration 1.5 days (sd 
1.4) and mean 1.7 days (sd 1.6) respectively, (p = 0.78). Furthermore, the duration of 
peritonism immediately after insertion did not differ significantly between the 
conditions (p =0.12), (Table 66). 
In the absence of haemodynamic compromise, localised peritonism universally 
responded to conservative treatment and analgesia. However, the presence of 
haemodynamic compromise was a poor prognostic marker, being present in those 
patients who went on to develop serious complications in the period immediately 
after insertion. 
The incidence density of other complications encountered is expressed in Figure 42 
and Table 67. These complications included granulation tissue formation, buried 
internal bolster, leakage, painful episodes and infective episodes. 
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Tube Number Number of episodes where Number of episodes where 
diameter oftubes NO peritonism occurred peritonism occurred after inserted after insertion insertion 
20 Fr 20 
12 Fr 8 
9 
4 
11 * 
*p=1.0 (Fishees Exact test) 
Table 65: Episodes of peritonism immediately after insertion 
Condition Number of Duration of peritonism immediately p value PEC insertions after insertion, days 
mean (scl) 
FC 8 2.4(1.4) 
RSV 8 0.8(1.0) 0.12 
NC 6 1.2(1.6) 
CPO 6 1.7(1.6) 
* Kruskal-Wallis test 
Table 66: Duration of peritonism Immediately after Insertion 
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Figure 42: Incidence density of complications 
Incidence density per 100 months with PEC in situ 
Buried Granulation Faecal Painful Infective 
bumper tissue leakage episodes episodes 
Functional 0 0 11 26.5 53 
constipation 
Recurrent 
sigmoid 1.4 1.4 1.4 0 7.1 
volvulus 
Neurological 2.2 2.2 0 6 6 17 6 
constipation . . 
Colonic 
pseudo- 0 0 0 1.6 13.1 
obstruction 
Total group 0.7 1.1 0.7 15.1 19.8 
Table 67: Incidence density of complications 
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Bu fied Granulabon Faecal Painful Infective 
bumper leakage episodes episodes 
Twenty of the patients suffered one or more episodes of infection whilst PEC was in 
situ. The incidence density of infective episodes for the total group was 19.8 per 100 
patient months with PEC in situ. The incidence density of infection was greatest in 
FC (Figure 42 and Table 68). Table 69 shows a comparison of the rate of infection 
between patients with FC and patients without FC. The rate of infection was 
significantly higher in FC compared to the other conditions (p = 0.0004). The results 
of the Kruskal-Wallis test for differences in rates of infection between groups are 
shown in Appendix C, Table 9. 
A total of 53 infective episodes occurred in the whole group. In 50 of these, a culprit 
organism was identified. In the remaining episodes the diagnosis of infection was 
made on clinical grounds and antibiotics were prescribed empirically. In episodes 
where organisms were identified, Staphylococcus aureus accounted for 26%, mixed 
skin organisms 26% and mixed faecal organisms 26%. 
Patients NC6 and FC8 complained of significant recurrent pain that prompted tube 
removal. In both cases pain at the insertion site persisted even after removal and 
closure of the stoma. The symptom was refractory to simple analgesia but responded 
to Gabapentin (non-proprietary) suggesting a neuropathic or functional element to 
the pain. 
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Mean Mean Incidence 
Number Number duration density 
of of sd with PEC sd 
Per 100 
patients infective in situ patient 
episodes months months with PEC in situ 
Functional 8 3 1.51 5.65 6 29 53 constipation . 
Recurrent 
sigmoid 8 0.63 0.92 8.75 6.49 7.1 
volvulus 
Neurological 6 2.67 1.2 15.16 9.64 17 6 Constipation . 
Colonic 
pseudo- 5 1.33 1.50 10.18 10.08 13.1 
obstruction 
Table 68: Incidence density of infection 
Patients with FC 
Patients without FC Mann Whitney 
p value (RSV, NC, CPO) U statistic 
n= 8 n= 20 
Mean rate of sd 
Mean rate of sd infection infection * 
1.23 1.27 0.16 0.24 10.0 0.0004 
* Infective episodes / month 
Table 69: Rate of Infection In FC and non FC patients 
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12.8.8 Patients in whom insertion was unsuccessful 
In 4 patients from the original 3 1, it was not possible to insert a PEC (patients NC7, 
FC9, FC10, and FC11). These patients have been followed up for a mean of 24.6 
months (sd 7.27) following these unsuccessful attempts. Two patients underwent 
surgery and at two years, reported symptom improvement, no complications and no 
episodes of infection. The other two patients declined surgery, preferring to continue 
with conservative therapy even though symptoms of constipation persisted. 
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12.9 Case histories 
12.9.1 Fatal faecal peritonitis occurring one year after PEC insertion 
Patient RSVI, an 85-year-old lady with advanced dementia and a WHO functional 
status of 4 had PEC inserted for RSV because surgery was deemed high risk due to 
her frailty. Over the next 12 months she enjoyed a good quality of life in a nursing 
home with no further admissions with volvulus. Both she and the staff coped well 
with the tube. The tube was vented regularly and if constipation developed the PEC 
was irrigated. After one year the patient inadvertently pulled the tube out. She was 
admitted with peritonitis and declined rapidly and unfortunately died. Post mortem 
examination demonstrated a perforation of the sigmoid colon adjacent to the site of 
the PEC tract. Figure 43 shows the sigmoid to be grossly distended (25cm diameter) 
with the site of perforation marked with a probe. Proximal to this point the colonic 
diameter was normal having been decompressed by the PEC tube. Distal to this point 
the colon and rectum were obstructed with impacted faeces. 
Figure 43: Post mortern appearances in patient RSVI. 
Following inadvertent traumatic removal of PEC tube; the sigmoid colon (A) Is 
distended. The surgical probe marks the site of sigmoid perforation (B). 
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Under normal circumstances this would have presented as abdominal distension with 
dilation of the proximal colon. Venting the PEC tube prevented the proximal dilation 
and masked the problem. It is likely that the combination of obstruction, stercoral 
ulceration and traumatic removal of the tube caused perforation and fatal faecal 
peritonitis. The case illustrates the dangers of inadvertent traumatic removal of PEC. 
This danger can exist even in cases where enough time has elapsed for a mature tract 
to develop. The risk of inadvertent removal may be increased in demented patients. 
It is important that faecal impaction in the colon distal to the insertion point is 
prevented. Should this occur, the usual signs of obstruction (proximal dilation) will 
not be present. 
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12.9.2 Fatal faecal peritonitis occurring 48 hours after PEC insertion 
The case concerns an 85-year-old man (CPO]) with a five-year history of chronic 
CPO complicated by constipation and overflow incontinence. Ills quality of life was 
significantly reduced. PEC was inserted without incident into the sigmoid colon. 48 
hours after insertion he complained of abdominal swelling with pain in association 
with haemodynamic compromise. Plain abdominal radiography demonstrated 
pneumoperitoneum (Figure 44). Although free gas is not unexpected following PEC 
insertion, the degree of pneumoperitoneum was excessive. Fluoroscopic imaging 
demonstrated that the loop of colon was no longer closely opposed to the interior 
surface of the abdominal wall. A contrast study via the tube failed to show leakage of' 
contrast into the peritoneal cavity. 
4, 
Figure 44. Radiological appearances in patient CPOI 
a) Plain abdominal radiograph with pneumoperitoneum. b) Fluoroscopic image 
showing significant pneumoperitoneum. The PEC tube and internal bolster are 
indicated by arrows. The loop of sigmoid colon is no longer opposed to the inner 
surface of the abdomen. 
However, due to the clinical suspicion of peritonitis ernergencv laparotoniv was 
undertaken. Faecal leakage was apparent from the point where the tube entered the 
colonic lumen. The edges of the puncture site were inflained and the margins did not 
completely grip around the tube. Colectorny was performed and 11costonly created. 
Despite full support in the post-operative period. he deteriorated and died four davs 
after insertion. 
In this case, faeculcrit material leaked from the puncture site and caused gcncralIscd 
peritonitis. A significant pricurnoperitoncurn was caused hý leakage ol' colonic gas 
and passage ofair through the tract in the abdominal wall. I [ad the 1001) OfSIgInOld 
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remained tightly opposed to the inner surface of the abdomen then the degree of 
leakage and pneumoperitoneum may have been less. Until adherence has occurred 
between these two surfaces, then traction created by the fixing components of the 
tube is all that prevents the colon falling away from the inner surface. 
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12.10 Discussion 
In this chapter we report on a four-year experience of the use of PEC. The current 
evidence base regarding the use of PEC is limited. Data are only available trom small 
retrospective case series with varied indications for insertion. The long-term 
effectiveness, tolerability or incidence of complications remains unknown. 
In this current series, PEC effectively controlled symptoms in patients with 
refractory FC and constipation caused by neurological disorders. Whilst in sitLi, PEC 
prevented RSV in all patients. In subjects with acute CPO (Ogilvie's syndroMe230 
PEC helped to decompress the colon. 
If the patients in whom symptoms were deemed to be markedly improved are 
considered, PEC can be said to be effective in 81% (22 out of 27 patients). From the 
original group of 27, two patients died from faecal peritonitis and one patient had 
PEC removed because immunosuppressive medications were started. It' these 
subjects are excluded, it might be hoped that 24 patients would still be receiving the 
benefits of PEC. However, only 7 patients (26%) had PFC in situ at the point that 
observation for this report ceased (including 5 patients who died ofunrelated causes 
and 2 patients still under follow up with PEC still in place). This high degree of' 
attrition is due to the significant complication rate that led to removal ol'the tubes in 
approximately three quarters of patients. 
In RSV patients, whilst PEC was in place there was good control ol'symptorris and 
more importantly volvulus was prevented. When PFC was renlovcd either 
inadvertently or electively RSV reoccurrcd. This observation has also been reported 
by other authors 214. In our series recurrence happened in tile short term (3 (lays) or in s 
the medium term (7 months) after removal. It is believed that Pl,. C prevents RSV hv 
anchoring the sigmoid colon to the abdominal wall. Immediately following insertion 
the loop ofbowel is anchored by the traction created by tile lastcning components of 
the tube. After a period of time adhesion occurs between the colon and tile inner 
surface of the abdominal wall (an appearance reported at laparotomy). Daniels et al 
reported on patients who had PEC removed at six %vecks and then suffered further 
Vo I VUIUS214 . 
At laparotomy in these patients there was no residual adlicrencc o[ tile 
colon to the abdominal wall. Laparotornies performed in our unit Suggest that CVC11 
after 3 months adhesion may not be complete. 
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The mean duration of PEC tubes in situ for RSV was approximately 8.8 months. 
Little is known about the longer term effects of PEC in RSV. The longest reported 
214 follow Lip in the literature is a mean of 12.6 months . In our cohort there were five 
deaths from unrelated causes at 8.2 months after insertion. It is interesting to 
speculate whether the PEC tubes would have kept these patients volvulus free in tile 
longer term, had they not died ofunrelated causes. 
Regarding patients with CPO; insertion in the two patients with acute CPO produced 
clinical and radiological evidence of decompression. Ponce et a 1235 have 
demonstrated the effectiveness of intravenous neostigmine in acute CPO. However. 
there are a small proportion of patients who do not respond to infusions or 
colonoscopic decornpression. It is recognised that persistent colonic dilation can lead 
to perforation. Traditionally, urgent surgical intervention would be required"'. In 
these circumstances, PEC offers a less invasive and reversible method of 
208 decompression 
There were 3 patients suffering chronic CPO in our series. In two ofthese the degree 
of decompression was minimal after insertion. This is in contrast to the spectacular 
decompression encountered in the acute CPO cases. This is possibly because 
different underlying pathological processes exist in these two conditions 212,259. 
Although abdominal distension was not improved, troublesome symptoms of' 
constipation, soiling and overflow diarrhoea were improved. 
In this series 77% of patients suffered one or more episodes of infection, a figure 
higher then previously reported. This result is also significantly higher then that 
quoted in recent PEC guidance, in which unpublished audit data Suggested ýJjj 
infection rate of 12 %256. 
The explanation for this is difference is unclear. Immuno-comprornisc in the collort 
does not seem to be a factor since only two patients had diabetes mell1tUS and no 
subjects were taking steroids. It is not known whether previous studies have 
underestimated infection because the criteria t1or reporting Iril , cction or the intensity 
of follow tip have been different. Patient selection may also contribute. Infection 
appears to be more common in FC patients and in this study these patients accounted 
for almost a third of the total group. Previously published series liavc included 
smaller proportions of FC patients. If we accept the theory that int'ection risk is lowcr 
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in non-FC, this may explain why overall infection rates were less in previous reports. 
However, this argument is negated somewhat because infection rates in our non-FC 
patients were still higher than previously quoted. 
It is not known why infection is more common in FC. The frequency of tube 
irrigation and the volumes used tended to be higher in this group. These patients 
were also generally more mobile and active. It is possible that greater mobility and 
frequent, large volume irrigations traurnatise and contaminate the tract to greater 
extent than in other patient groups, resulting in more infective episodes. 
Other factors that might predispose to infection when enteral conduits are formed 
include the use of the "pull througlP method (as opposed to the "introducer 
method")260, the effect of pressure damage caused by tension between the internal 
and external bolster of the PEC tube 261 and the patients' innate wound healing 
abilities. Further study is necessary to assess these factors. 
Infection was the most frequent and important complication necessitating removal. 
imaging with isotope labelled leucocyte scans and Magnetic Resonance Imaging 
suggests that infection occurs not only along the tract but also within the planes of 
the abdominal wall (Figure 45 and Figure 46). 
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Figure 45. Labelled leucocyte scan image of PEC tube tract infection 
An abnormal collection of white cells is present running along the tract (A). 
Figure 46. MRI images of patient with PEC tube tract infection 
(A) internal bolster of tube. (B) inflammatory changes along the tract. (C) inflammatory 
changes spreading within the abdominal wall. 
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Patient NC2 illustrates this concept. After 21 months she was admitted with a tender 
mass adjacent to the PEC site. Ultrasonography identified a subcutaneous abscess. At 
laparotomy a fistula was discovered that connected the abscess to the PEC tract. The 
fistula and abscess were situated between the layers of fascia in the abdominal wall 
(Figure 47 and Figure 48). Treatment involved removing the PEC, laying open the 
abscess and performing sigmoid colectomy. 
Figure 47. Laparotomy images. 
The PEC tube (A) passes through the tract in the abdominal wall into the lumen of the 
colon. The subcutaneous abscess cavity (B) arises from the tract and has been laid 
open. The midline Laparotomy incision (C) is shown. 
Figure 48. Laparotomy images 
The abscess cavity (D) sits in the subcutaneous tissues of the abdominal wall and Is 
contiguous with the PEC tube tract (E). 
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The high rate of infection in PEC patients is in contrast to that in patients who have 
had a "Malone" procedure to administer antegrade colonic enemas (ACE). In the 
archetypal procedure 258 , an appendicocaecostomy was 
fashioned through which 
catheterisation and irrigation could be performed. An immediate epithelial lining to 
the tract is created at the time of surgery and infection rates as low as 2.9% have 
94 been reported . In contrast, histological examination of PEC tracts shows limited 
epithelisation. Tract I in Figure 49 was excised at 12 months because of an episode 
of infection. Tract 2 was excised at 16 months for elective non-infective reasons. In 
both cases there is predominately granulation tissue and inflammatory material rather 
then a complete epithelial lining. 
Tract I 
IN" 
A 
B 
. _1 
Figure 49. Histological images of PEC tracts 
(A) Granulation tissue. (B) Regenerating bowel epithelium. (C) Isolated island of 
squamous epithelium. (D) Granulation tissue and inflammatory reaction. 
:: 1 
'.: -- 
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A theoretical model of the tracts (based on histology and laparotomy findings) can be 
proposed (Figure 50). Immediately after insertion, there is a raw surface lined by 
acute granulation tissue associated with inflammatory infiltrate. As months pass the 
tract organises. Squamous epithelium from the skin surface migrates downwards and 
isolated islands of metaplastic squamous epithelium are seen replacing the 
granulation tissue. In the lower portions of the tract, the lining is loose granulation 
tissue characterised by inflammatory infiltrate, micro-abscesses and reaction to 
foreign body material (faeces). Infection can develop from the micro-abscesses and 
spread between the fascial planes. At the deepest part of the tract, the colon is 
connected to the inner surface of the abdominal wall by a cuff of fibrous tissue. A 
degree of epithelialisation with metaplastic glandular epithelium can be seen in this 
region. Although the cuff prevents leakage into the peritoneal cavity, faeculent 
material and colonic organisms contaminate the intra abdominal portion of the tract. 
The persistent irritation and inflammation prevents adequate epithelialisation even 
after 23 months of "maturation". Similar histological appearances are found in 
pilonidal sinus disease 262 . 
In cases of Percutaneous Endoscopic Gastrostomy (PEG), there is also no immediate 
or complete epithelial lining of the tract. However, in comparison to PEC, infection 
in PEG patients is rare 263,264 . Since the content of the stomach is generally sterile the 
tract is exposed to less bacteria and infection is less likely. Furthermore, the presence 
of acidic gastric juices may cause fibrosis, enhancing the formation of a mature tract 
that is an effective barrier to infection. Histological comparison of PEC and PEG 
tracts is required to confirm these theories. 
Limitations of this series exist. Collectively the number of patients included is 
comparable to that of other series, however, the numbers for each specific condition 
are small. A prospective assessment of PEC would be preferable. However the 
complications encountered mean that PEC is being inserted less frequently at our 
unit and the possibility of a prospective study is unlikely. 
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(2) Normal squamous epithelium (skin surface) 
(3) Metaplastic squamous epithelium 
(4) Islands of metapalstic squamous epithelium 
(5) Granulation tissue 
(6) Fibrous cuff. 
(7) Loop of colon 
(8) Micro abscess and inflammatory reaction to faeces 
(9) Subcutaneous infection and abscess formation 
Figure 50. Histological model of PEC tracts 
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12.11 Future Directions 
The main limitation for the widespread use and study of PEC is the high rate of 
infective complications. Three factors influence infection; firstly the lack of an 
immediate and complete epithelial tract lining; secondly the inadequate 
epithelialisation of the tract and thirdly persistent tract contamination with colonic 
and skin organisms. 
Salm et al performed Endoscopic Percutaneous Caecostomy (EPC) in patients with 
acute Cp0219. In the technique the caecum was sutured to the inner surface of the 
abdominal wall before the tract into the colon was made. The tract was 
6'epitheliased" at the time of the procedure by pulling up a cuff of colonic mucosa 
that was sutured to form a stoma. The advantage of this is that an immediate and 
complete epithelial lining was created. The disadvantage is that general anaesthesia 
is required and the technique is more invasive then the "pull through" method. 
During a short follow up no infections occurred. A variation on this technique is the 
"introducer" method to perform caeCoStomy 222. Uno reported infection in 2 of 5 
patients who had caecal PEC inserted by "pull through" but no infection in 15 
patients who underwent insertion by the "introducer" technique. Comparisons of 
tract cpithelialisation between the "introducer" and "pull through" techniques have 
not been performed. It is possible that suturing the loop of colon to the abdominal 
wall gives more opposition and facilitates epithelisation such that infections are less. 
Further study is required to examine this hypothesis. 
Canine animal studies have been performed to assess tract formation in Percutaneous 
Endoscopic Gastrostomy (PEG)261 . Animal studies of PEC could be considered to 
determine whether factors that promote epithelialisation improve tract formation and 
reduce infection. Possible candidates for study include exogenous epidermal growth 
factor (EGF) and recombinant human granulocyte macrophage colony stimulating 
factor (molgramostim). These have been used experimentally to improve dermal and 
265-267 
anastornotic wound healing experimentally 
The properties of the tube material may influence tract epithelialisation. Latex has 
been used to promote the formation of a fibrotic tract after placement of a T-tube in 
biliary surgery268,269. It is not clear whether promoting PEC tract fibrosis would be 
beneficial for reducing infection. Furthermore, there are suggestions that latex maybe 
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270,271 detrimental to wound and anastomosis healing Again, animal studies may help 
investigate these issues. The use of drug eluting stents in the biliary system has been 
reported. Zhang et al showed in vitro inhibition of bacterial growth on the surface of 
stents 267 . Undoubtedly, PEC tubes could be designed so that the intra abdominal 
portion elutes factors that have antibacterial properties or promote epithelialisation. 
However, the topical application of metronidazole cream (Medlock, Bristol, UK) to 
infected tracts in some of the patients in the series was ineffective. 
Contamination of the tracts by colonic bacteria leads to infection. Bacterial 
concentrations in the intestine increase aborally. It is interesting to speculate what 
effect the position of PEC has on infection and whether caecal tracts are exposed to 
lower concentrations of bacteria compared to tracts in the distal colon. Poorly 
absorbable antibiotics (such as rifaximin 272) have been used to selectively 
decontaminate the gut but their effect in PEC patients has not been studied. 
272 
12.12 Conclusions 
The overall aim of was to evaluate the efficacy and safety of PEC in the left colon, to 
treat patients with idiopathic refractory constipation. However, the findings from the 
retrospective data collection of patients who had undergone PEC at our centre 
suggested that a prospective study would not be possible. 
Although the primary aim was not achieved the experience of inserting PEC in a 
variety of lower gastrointestinal conditions highlighted several key factors relating to 
the technique; 
Insertion of PEC is straightforward and can be performed in less then 30 minutes. In 
some patients selecting a site for insertion can be difficult using transillumination 
alone. Fluoroscopy with an image intensifier improves the chances of success. 
immediately after insertion localised peritonism is common and a degree of 
pneurnoperitoneurn is to be expected. In the absence of haernodynamic compromise 
these features tend to resolve with conservative measures. The presence of 
haemodynamic instability is a poor prognostic sign. 
PEC is efficacious for treating functional constipation and constipation caused by 
neurological disorders. Faecal incontinence associated with neurological disorders 
can also be improved. Whilst PEC is in situ, recurrent sigmoid volvulus is prevented. 
PEC effectively decompresses the colon in acute colonic pseudo-obstruction. 
Insertion does not decompress the colon in chronic colonic pseudo-obstruction. 
Constipation and overflow diarrhoea associated with chronic colonic obstruction can 
be treated by PEC. 
Infective complications are common and can occur at a rate higher than quoted in 
current guidance. Infection often necessitates removal and this reduces the long-term 
usefulness of PEC. Major surgery is sometimes required to deal with severe 
infection. 
Two cases of fatal faecal peritonitis have occurred as a consequence of PEC. 
The results bring into question the validity of widespread application of PEC. Our 
findings contrast with those from previous studies that suggested that PEC is well 
tolerated with low complication rates. Incomplete tract epithelisation represents a 
major shortcoming of the "pull througW' technique. It is possible that strategies to 
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deal with this problem could be developed in animal studies. However, it is unlikely 
that robust, prospective human studies will be performed to assess their 
effectiveness. Insufficient long-term data have been published to determine whether 
the "introducer" technique represents a viable option for insertion. 
Our findings suggest that PEC is not a meaningful alternative to surgery in refractory 
FC or NC and that insertion should only be considered for treating selected cases of 
RSV and acute CPO in patients unfit for surgery. 
The results provide new and dramatic evidence regarding the safety of PEC in the 
left colon. NICE issued guidance on PEC in 2006, before these data were available. 
It is interesting to speculate whether less supportive guidance would have been 
issued in the light of our findings. 
The NICE document recognises that the recommendations it makes are based on 
limited data derived from heterogenous retrospective case reports and unpublished 
data (that possibly included duplication of existing results) 
256 
. This raises the 
question of whether a more rigorous assessment of efficacy and safety should have 
been performed before PEC was endorsed for use in the UK. 
The Medicines and Healthcare products Regulatory Agency (MRHA) currently 
recommends that before any new medical device is issued with CE marking it must 
comply with relevant essential requirements on safety and efficacy 
273. To 
demonstrate this compliance it is necessary to provide clinical data regarding the 
device. This can be clinical data complied from relevant literature regarding similar 
or existing techniques or data and conclusions obtained from specifically designed 
clinical investigation. For any existing device or technique that is modified or applied 
to a different use than originally intended, clinical investigation may not be needed 
providing adequate information can be presented from the existing literature to 
support the new role for the device. Interpretation of these issues is open to 
subjective judgement but the MRHA does suggests that where an existing device is 
modified or applied to a different use, if the modification "might significantly affect 
the clinical performance andlor safety of the device". a clinical investigation is 
273 required to assess efficacy and safety 
PEC was originally evaluated in 2003 by SERNIP (Safety and Efficacy Register of 
New Interventional Procedures). It was further evaluated in 2005 under the auspices 
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of NICE where advice was sought from the Association of Coloproctology of Great 
Britain and Ireland and the Association of Endoscopic Surgeons of Great Britain and 
Ireland. The outcomes of the evaluations in 2003 and 2005 were to endorse the use 
of the technique (whilst recognising that emerging evidence could change that 
recommendation) 256. In both instances an assumption was made that the safety data 
for Percutaneous Endoscopic Gastrostomy (PEG), e. g. an existing similar 
technology, could be applied in the evaluation of the new technique. In retrospect it 
could be argued that instead of making this assumption in the initial stages of 
evaluation, it would have been prudent to undertake a rigorous UK based prospective 
efficacy and safety assessment rather than assume that the experience of PEG was 
transferable to PEC. 
Such a move may have meant that the guidance subsequently released in 2006 would 
not have been reliant on data from retrospective series, case reports (which by their 
very nature maybe biased and report on patients of particular interest rather than 
those typically selected to undergo PEC) or indeed unpublished data. These issues 
highlight the fact that in an era where new endoscopic and minimally invasive 
techniques develop rapidly, it is necessary to perform robust evaluation of efficacy 
and safety using adequate and appropriate data perhaps in keeping with the rigorous 
273 evaluation processes used for new pharmaceuticals 
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The overall aims of this thesis were to examine three main themes in reference to 
constipation. 
The first aim was to identify factors that can predict disease-specific quality of life in 
refractory idiopathic constipation. The second aim was to examine the observation 
that patients with constipation can be separated into distinct groups based on their 
urge to defecate. The objective here was to determine whether this was due to 
distinct pathophysiological processes in the two groups. The third aim was to 
evaluate prospectively the efficacy of a novel therapy that was potentially an 
alternative to invasive surgery. 
The first aim was achieved and predictors for disease-specific quality of life were 
identified. The results could be used as the basis for future hypothesis driven 
research regarding QOL in constipation. A limitation of the study is the fact that a 
convenience sample of patients was examined. Subjects were recruited from the 
constipation clinic and referral bias means that the results are only applicable to a 
specific group of constipated subjects. The study does not involve constipated 
patients from the general population and the findings relate to female patients only. 
Future directions include studying the relationship between additional demographics 
(education, marital and employment status etc) and QOL. Other potential predictor 
variables could have been studied. For example, a patient's perception of their illness 
274 has been shown to be a predictor of QOL in several chronic conditions . This trait 
could be measured in constipation using the Illness Perception Questionnaire 
(, pQ)275 (although modification of the measure maybe required). Previous authors 
have used the Inventory of Interpersonal Problems (11p) 276, the Bem Sex Role 
Inventory (BSRI) 277 and the General Health Questionnaire (GHQ) 278 to demonstrate 
psychological morbidity in constipated females 40. The variables evaluated by these 
measures could conceivably be additional predictors of disease specific QOL. 
However, it was not practical to include them or other variables in this current study. 
Our subjects were already completing 3 different measures (PAC-SYM, PAC-QOL 
and SF-36) and the burden of completing more questionnaires would have been too 
great. 
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Our study also demonstrated psychological morbidity in a cohort of patients in whom 
only a minority had a history of psychiatric illness or depression. The implication of 
this is that clinicians need to be aware of the problems of psychological wellbeing in 
constipated patients. Screening strategies need to be considered to identify those who 
may benefit from psychological or psychiatric input. The results do not support the 
use of transit study or proctography for the assessment of severity. These 
investigations did not predict QOL and their use should be reserved for selected 
patients. 
In the process of achieving the first aim, the psychometric properties of PAC-SYM, 
PAC-QOL and SF-36 were studied. The results provided preliminary psychometric 
validation of the measures for severe refractory idiopathic constipation. Previous 
validation studies have not evaluated this particular patient group and have 
concentrated on subjects with less severe constipation or opiate induced constipation. 
Confirmation of the psychometric properties provides us with greater confidence to 
use these measures for future prospective studies in our patients. However, it must be 
noted that these findings provide preliminary validation and that more extensive 
psychometric analyses could not be performed because the measures were 
administered only once. Future research could be performed to confirm test-retest 
reliability and to fin-ther evaluate construct validity, for example through factor 
analysis. Evaluation of test-retest reliability will require administration on more than 
one occasion. The predictive validity of the measures, responsiveness and sensitivity 
to change (eg following treatment) would also require repeated administrations of the 
measures. 
The second aim of this thesis was to test a specific hypothesis; that in idiopathic 
constipation the frequency of sampling events is less in patients with a reduced rectal 
urge to defecate compared to patients with a normal rectal urge to defecate. The 
hypothesis was not proven and no difference in the frequency of sampling reflects 
was found between the patient groups. To determine whether there are indeed 
pathophysiological differences between these two groups different techniques will be 
required for ftirther investigation. The process of testing the hypothesis has provided 
valuable experience in the use of semi-ambulatory manometry that can form the 
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basis for future studies with fully ambulatory recordings of the colon for more than 
24 hours. 
The third aim of the thesis was to study prospectively the efficacy of Percutaneous 
Endoscopic Colostomy (PEC). Ultimately, this aim was not achieved. In preparation 
for implementing a prospective study, a detailed retrospective analysis was made of 
PEC insertion at our institution. The results highlighted significant problems with 
unacceptably high infection rates, morbidity and mortality. Our findings have had a 
direct impact on clinical practice. We recommend that PEC is only used in selected 
patients who are unfit for surgery. Our results do not support the use of PEC as an 
alternative to surgery in idiopathic constipation. The findings provide valuable 
additions to the existing literature on PEC which has previously reported good 
efficacy and minimal complications. 
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14.1 Appendix A 
PAC-QOL Q 
PATIENT ASSESSMENT OF CONSTIPATION 
The following questions are designed to measure the impact constipation has had on your daily life during 
the past 2 weeks. For each question, please tick one box. 
The following questions ask you about 
the intensity of your symptoms. To what 
extent, during the past 2 weeks... Not at all A little bit Moderately Quite a Extremely 
0 1 2 bit 4 
3 
1. have you felt bloated to the point of El El 0 El El 
bursting? 
2. have you felt heavy because of your 11 El 13 13 1: 1 
constipation? 
The next few questions ask you about 
the effects of constipation on your daily 
life. How much of the time, during the 
past 2 weeks... 
None of 
the time 
0 
A little of 
the time 
1 
Some of 
the time 
2 
Most of 
the time 
3 
All of 
the time 
4 
3. have you felt any physical El El 11 13 
discomfort? 
4. have you felt the need to open your D El 11 D El 
bowel but not been able to? 
5. have you been embarrassed to be El 13 0 E3 0 
with other people? 
6. have you been eating less and less E3 0 El El 
because of not being able to have 
bowel movements? 
Appendix A, Table 1. PAC-QOL questionnaire. 
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The next few questions ask you about 
the Weds of constipation on your ALily 
life. To %-h2t extent, during the past 2 
weeks. - 
Not at all 
0 
A little bit 
1 
Moderatel 
y 
2 
Quite a 
bit 
3 
Extremely 
4 
7. have you had to be careM about 1: 1 El 1: 1 
what you cat? 
8. have you had a decreased appetite? El 1: 1 El 1: 1 1-: 1 
9. have you been worried about not 
being able to choose what you eat 
(for example, at friend's)? 
10. have you been embarrassed about 1: 1 El 
staying in the toilet for so long 
when you were away from home? 
11. have you been embarrassed about 1-: 1 0 El El 1: 1 
having to go to the toilet so often 
when you were away from home? 
12. have you been worried about having El 1: 1 El 1: 1 
to change your daily routine (for 
example, travelling, being away 
from home)? 
The next few questions ask you about 
your feelings. How much of the time, 
during the past 2 weeks- 
Noneof 
the time 
0 
A little of 
the time 
1 
Some of 
the time 
2 
Most 
of 
the 
time 
3 
All of the 
time 
4 
13. have you felt irritable because of 
your condition? 
14. have you been upset by your 
condition? 
15. have you felt obsessed by your 
condition? 
16. have you felt stressed by your 
condition? 
17. have you been less self-confident El 
because of your condition? 
Is. have you felt in control of your 
situation? 
Appendix A, Table 1. PAC-QOL questionnaire (continued) 
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The next questions ask you about your 
feelings. To what extent, during the 
past 2 weeks... 
Not at all 
0 
A little 
bit 
Moderately 
2 
Quite a 
hit 
3 
Extremely 
4 
19. have you been worried about not 
knowing when you are going to be 
able to open your bowels? 
20. have you been worried about not 
being able to open your bowels 
when you needed to? 
21. have you been more and more El El El bothered by not being able to open 
your bowels? 
The next questions ask about your life None of A little Some of Most All of the 
with constipation. How much of tCc the time of the time of time 
time, during the past 2 weeks... 0 the 2 the 4 
time time 
3 
22. have you been afraid that your El 11 
condition will get worse? 
23. have you felt that your body was not El 13 
working properly? 
24. have you had fewer bowel El 0 0 El 
movements than you would like? 
I 
I 
I 
The next questions ask you about how, 
satisfied you are. To what extent, 
during the past 2 weeks. - 
Not at all 
0 
A little 
bit 
Moderately 
2 
Quite a 
bit 
3 
Extremely 
4 
25. have you been satisfied with how 0 0 
often you open your bowels? 
26. have you been satisfied with the El 13 0 
regularity with which you open your 
bowels? 
27. have you been satisfied with your 
bowel function? 
28. have you been satisfied with your El El 13 13 
treatment? 
Appendix A, Table 1. PAC-QOL questionnaire (continued) 
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The PAC-QOL contains 28 items within four subscales: 
Physical discomfort (4 items) 
1. felt bloated to the point of bursting 
2. felt heavy because of constipation 
3. felt any physical discomfort 
4. felt the need to open your bowel but not been able to 
Psychosocial discomfort (8 items) 
1. been cmbarrassed to be with other people 
2. been eating less and less because of not being able to have bowel movements 
3. had to be careful about what you cat 
4. had a decreased appetite 
5. been worried about not being able to choose what you eat 
6. been embarrassed about staying in the toilet for so long when you were away from home 
7. been embarrassed about having to go to the toilet so often when you were away from home 
8. been worried about having to change your daily routine 
Worries and concerns (I I items) 
1. felt irritable because of your condition 
2. been upset by your condition 
3. felt obsessed by your condition 
4. felt stressed by your condition 
5. felt less self-confident because of your condition 
6. felt in control of your situation 
7. been worried about not knowing when you are going to be able to open your bowels 
8. been worried about not being able to open your bowels when you needed to 
9. been more and more bothered by not being able to open your bowels 
10. been afraid that your condition will get worse 
11. felt that your body was not working properly 
Satisfaction (5 items) 
1. fewer bowel movements than you would like 
2. satisfied with how often you open your bowels 
3. satisfied with the regularity with which you open your bowels 
4. satisfied with your bowel function 
, 
5. satisfied with your treatment 
Appendix A, Table 2. PAC-QOL domains. 
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Items are rated on a 5-point scale: 
O=not at all/none of the time 
I =a little bit/a little of the time 
2=moderately/some of the time 
3=quite a bit/most of the time 
4=extremely/all of the time 
The value will be the numeric score for each item, except for items 18,25,269 
27, and 28. The scoring for these items should be reversed: 0-+4,1-0,2->2, 
3-+1, and 4-+0 
Also, define the following parameters: 
PAC-QOL overall score: value = (sum of scores of all non-missing 
items) / (number of non-missing items) if at least 14 items are non- 
missing; value is missing if more than 14 items are missing. 
Subscale values are defined as (sum of scores of non-missing included 
items) divided by (number of non-missing included items) if the missing 
data handling rule is not met. The value is missing if the missing data 
handling rule is met. The table below defines the included items and 
missing data handling rules for each subscale. 
Missing data handling rule 
Subscale parameter Included Missing data handling rule description items 
PAC-QOL Dissatisfaction 24-28 
If >2 items are missing, set scale to 
missing. 
PAC-QOL Physical 14 
if >2 items are missing, set scale to 
discomfort missing. 
PAC-QOL Psychosocial 5-12 
If >4 items are missing, set scale to 
discomfort missing. 
PAC-QOL Worries and 13-23 
If >5 items are missing, set scale to 
concerns missing. 
Appendix A, Table 3. Scoring algorithm and missing data rule for PAC-OOL. 
-285- 
PAC-SYM 
PATIENT ASSESSMENT OF CONSTIPATION 
This questionnaire asks you about your constipation symptoms in the past 2 weeks. 
Answer each question according to your symptoms, as accurately as possible. There are 
no right or wrong answers. 
For each symptom below, please indicate how severe your symptoms have been during 
the past 2 weeks. If you have not had the symptom during the past 2 weeks, tick 0. If 
the symptom seemed mild, tick 1. If the symptom seemed moderate, tick 2. If the 
symptom seemed severe, tick 3. If the symptom seemed very severe, tick 4. Please be 
sure to answer every question. 
How severe have each of these 
symptoms been in the past 2 weeks? 
Absent 
0 
Mild 
1 
Modera 
te 
2 
Severe 
3 
Very 
severe 
4 
1. discomfort in your stomach 0 0 
2. pain in your stomach 13 11 13 
3. bloating in your stomach 11 D 13 13 
4. stomach cramps 13 13 El 13 0 
5. painful bowel movements 0 13 El 1: 1 
6. rectal burning during or after a bowel 0 1: 1 El 13 
movement 
7. rectal bleeding or tearing during or El 1: 1 13 
after a bowel movement 
8. incomplete bowel movement, as 13 1: 1 
though you didn't "finish" 
9. stools that were too hard 11 13 
10. stools that were too small 11 0 0 El 
11. straining or squeezing to try to pass El 11 13 0 
stools 
12. feeling like you had to pass a stool El 13 13 
but you couldn't (false alarm) 
Appendix A, Table 4. PAC-SYM questionnaire. 
286 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
The PAC-SYM is a 12-item subject self-administered instrument that measures the 
severity of constipation-related symptoms. Items are rated on a 5-point Likert 
scale, where 
O=absent 
I=mild 
2=moderate 
3=severe 
4=very severe 
The PAC-SYM contains the foll owing three subscales: 
Subscale parameter Included Missing data handling rule 
description items 
PAC-SYM stool symptoms 8-12 If >2 items are missing, set scale to 
missing. 
PAC-SYM abdominal 1-4 If >2 items are missing, set scale to 
symptoms missing. 
PAC-SYM rectal symptoms 5-7 If >1 items are missing, set scale to 
I I missing. 
Stool symptoms (5 items) 
-bowel movements that require straining or squeezing 
-bowel movements that are too hard 
-bowel movements that are too small 
-bowel movements that result in a sensation of incomplete evacuation 
-the feeling of having to pass a bowel movement but couldn't (false alarm) 
Abdominal symptoms (4 items) 
-abdominal discomfort 
-abdominal pain 
-abdominal cramping 
-abdominal bloating 
Rectal symptoms (3 items) 
-Painful bowel movements 
-rectal burning 
-bleeding or tearing during or after a bowel movements 
PAC-SYM overall score: value = (sum of scores of all non-missing items) 
(number of non-missing items) if at least 6 items are non-missing; value is missing 
if more than 6 items are missing. 
Subscale values are defined as (sum of scores of non-missing included items) 
divided by (number of non-missing included items) if the missing data handling 
rule is not met. The value is missing if the missing data handling rule is met. The 
table below defines the included items and missing data handling rules for each 
subscale. 
Appendix A, Table S. PAC-SYM domains and data handling rules 
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Symptom I characteristics Coding 
0 1 day 
1 2 days 
Days between defecations with laxative 
2 3-4 days 
3 5-6 days 
4 7-14 days 
5 > 14 days 
0 Never 
1 Occasionally 
Laxative use 2 Most days 
3 Every day 
0 Never 
1 Rarely 
Unsuccessful defecatory attempts 2 Some of the time 
3 Usually 
4 Always 
0 Never 
1 Rarely 
Time spent attempting to defecate 2 Some of the time 
3 Usually 
4 Always 
0 <5 min 
1 > 5-10min 
Straining during defecation 2 >1 0 -20 min 
3 > 20-30 min 
4 >30 min 
0 Never 
1 Rarely 
Painful defecation 2 Some of the time 
3 Usually 
4 Always 
0 Never 
1 Rarely 
Sensation of incomplete evacuation 2 Some of the time 
3 Usually 
4 Always 
0 Never 
1 Rarely 
Digitation to assist defecation 2 Some of the time 
3 Usually 
4 Always 
0 Never 
I Rarely 
Vaginal pressure to assist defecation 2 Some of the time 
3 Usually 
4 Always 
Appendix A, Table 6. Coding details for symptoms I characteristics assessed in 
cumulative constipation score. 
288 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
svmptom Coding 
0 Never 
1 Rarely 
Abdominal bloating 2 Some of the time 
3 Usually 
4 Always 
0 Never 
I Rarely 
Abdominal pain 2 Some of the time 
3 Usually 
4 Always 
Appendix A, Table 6. Coding details for symptoms I characteristics assessed In 
cumulative constipation score (continued) 
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14.2 Appendix B 
Subject 
Colonic transit (hours) 
Right Left Rectosigmoid Total Subject 
Colonic transit (hours) 
Right Left Rectosigrnoid Total 
1 12 25 2 39 60 17 11 40 68 
2 26 36 4 66 61 67 4 0 71 
3 7 20 1 28 62 32 25 11 68 
4 14 11 39 64 63 30 40 1 71 
5 48 14 9 71 64 9 15 21 45 
6 13 18 26 57 65 29 30 13 72 
7 2 23 43 68 66 20 7 29 56 
8 36 14 22 72 67 18 49 0 67 
9 35 18 3 56 68 5 62 2 69 
10 70 0 0 70 69 4 54 0 58 
11 17 33 18 68 70 4 34 0 38 
12 40 23 6 69 71 25 37 6 68 
13 38 33 0 71 72 9 16 25 50 
14 39 24 0 63 73 24 30 15 69 
15 27 7 24 58 74 37 21 14 72 
16 9 41 8 58 76 15 16 20 51 
17 6 18 10 34 76 2 0 0 2 
18 0 9 22 31 77 18 23 30 71 
19 27 33 10 70 78 15 24 19 58 
20 4 12 28 44 79 24 13 18 55 
21 12 31 0 43 80 23 45 0 68 
22 2 10 11 23 81 13 20 22 55 
23 27 26 1 54 82 8 37 21 66 
24 14 23 33 70 83 7 62 2 71 
25 42 24 3 69 84 29 28 7 64 
26 7 15 50 72 85 9 13 19 41 
27 16 42 12 70 86 35 34 0 69 
28 15 25 11 51 87 1 23 68 
29 a 3 0 9 88 14 40 18 72 
30 20 48 3 71 89 8 44 16 68 
31 18 41 12 71 90 25 31 10 66 
32 23 21 19 63 91 25 30 12 67 
33 17 20 8 45 92 38 26 0 64 
34 1 20 18 39 93 13 25 9 47 
36 5 12 43 60 94 20 15 5 40 
36 22 33 13 68 95 3 11 40 54 
37 12 18 2 32 96 2 22 25 49 
38 27 10 2 39 97 7 1 0 a 
39 0 4 0 4 98 28 6 1 3ý 
40 27 15 30 72 99 14 40 18 72 
41 20 17 5 42 100 32 27 13 72 
42 37 35 0 72 101 51 21 0 72 
43 3 11 8 22 102 47 13 12 72 
13 49 10 72 103 7 42 21 70 
45 29 20 23 72 104 35 32 5 72 
46 25 24 4 53 105 10 37 18 65 
47 35 10 3 48 106 66 4 ý0 
48 14 12 7 33 107 3 0 5 a 
49 12 26 34 72 108 22 38 H 6H 
so 19 34 18 71 109 67 3 D 10 
51 9 46 9 64 110 16 28 9 53 
52 51 20 0 71 ill 42 19 11 72 
53 18 41 8 67 112 6 32 8 46 
54 12 30 28 70 113 4 48 18 70 
55 10 37 5 52 114 31 33 0 64 
56 10 1 9 20 115 33 15 22 70 
57 24 20 20 64 116 48 17 3 68 
58 5 24 21 50 117 25 39 6 70 
59 2 22 19 43 118 4 5 23 32 
Appendix B, Table 1. Colonic transit data for 118 subjects. 
Aberrant colonic transit results from subjects 29,39,76,97 and 107 (highlighted). 
290 
Quality of Life, physiological evaluation and novel treatment in refractory constipatiom 
A study of patients from a specialist clinic in the North East of England. 
Slow transit Normal transit 
p value constipation constipation 
n=87 n=26 
mean sd Mean sd 
Overall PAC-QOL score 2.48 0.68 2.39 0.88 0.57 
Appendix B, Table 2. PAC-001- in slow and normal transit constipation. 
Cut off ;! 50 hours 
4 
15 
.. j 
2ý5 
2 
15 
0.5 
0 
Appendix B, Figure 1. PAC-QOL according to transit categories. 
Transit category Number of patients 
Overall PAC-QOL score 
Mean sd 
13-24 hours 3 2.55 0.03 
25-36 hours 7 2.31 1.08 
37-48 hours 15 2.32 0.81 
49-60 hours 20 2.51 0.63 
61-72 hours 68 2.48 0.70 
Kruskal-Wallis Statistic KW = 0.8225 (corrected for ties) p=0.93 
Appendix B, Table 3. PAC-QOL scores according to transit category. 
No significant differences in PAC-QOL scores between groups of patients defined by 
category of colonic transit time (p = 0.93) 
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13-24 hrs 25-36 hrs 37-48 hrs 49-60 hm 61-72 hra 
_Variable 
Coding Details I score 
1 Infancy (birth to age three) 
2 Early childhood (ages 4 to 8 years) 
3 Later childhood (ages 9 to 12 years) 
4 Adolescence ages 13 to 19 years) 
5 20 -29 years 
6 30 -39 years Age of onset 7 40 - 49 years 
8 50 -59 years 
9 60 -69 years 
10 70 -79 years 
11 80 -89 years 
12 90 -99 years 
1 <l year 
Duration of symptoms 
2 1-2 years 
3 3-5 years 
46 -10 years 
5 11 -15 years 
6 > 15 years 
1 Exposed 
Exposure to child birth 2 Not exposed 
Exposure to abdominal / pelvic surgery 
1 Exposed 
2 Notexposed 
1 Yes 
Coexisting medical problems 2 No 
1 ypýq 
Psychiatric History 
2 No 
Radiologically significant rectocoele 
(RSR) 
1 
2 
Non FRSR or No rectocoele 
RSR 
Slow Transit Colonic Constipation 
1 
2 
Slow colonic transit 
Normal colonic transit 
Cumulative Constipation score 0-44 
Evacuation time Seconds 
% Evacuation % 
Rectocoele size cm 
Total colonic transit time Hours 
Physical Component Summary 0-100 
Mental Component Summary 0-100 
PAC-SYM Stool symptom score 0-4 
PAC-SYM Abdominal symptom score 0-4 
PAC-SYM Rectal symptom score 0-4 
Overall PAC-QOL score 0-4 
Appendix B, Table 4. Coding details for predictor variables. 
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Descriptive Statistics Score code 
Mean sd Number 
overall PAC-QOL score 2.49 0.77 97 
Age (years) 42.97 14.01 97 
Cumulative constipation score 22.69 4.91 97 
Age of onset 3.65 2.12 97 
Duration of symptoms 4.67 1.77 97 
Exposure to child birth 1.31 0.46 97 
Exposure to abdominal / pelvic surgery 1.65 0.48 97 
Coexisting medical problems 1.60 0.49 97 
Psychiatric History 2.87 0.34 97 
%Evacuation 70.29 16.79 97 
Evacuation time (seconds) 68.29 78.93 97 
Rectocoele size (cm) 2.44 1.34 97 
Radiologically Significant Rectocoele (RSR) 1.13 0.34 97 
Slow Transit Colonic Constipation 0.91 0.29 97 
Physical Component Summary 42.75 9.04 97 
Mental Component Summary 35.84 14.80 97 
PAC-SYM stool symptom score 2.37 0.91 97 
PAC-SYM Abdominal symptom score 2.39 0.90 97 
PAC-SYM Rectal symptom score 1.41 0.99 97 
Total colon transit time (hours) 58.84 14.00 97 
Appendix B, Table 6. Descriptive statistics for variables entered Into forward, stepwise 
and backwards regression strategies. 
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ANOVA 
Model 
Sum of 
Squares 
Degrees of 
freedom Mean Square F statistic 
p 
value 
I Regression 22.42 1 22.42 62.69 <0.01 
Residual 33.98 95 0.36 
Total 56.40 96 
2 Regression 28-34 2 14.17 47.48 <0.01 
Residual 28.06 94 0.30 
Total 56.40 96 
3 Regression 31.57 3 10.52 39.42 <0.01 
Residual 24.83 93 0.27 
Total 56.40 96 
Predictor variables included in each model 
model 
1 PAC-SYM Abdominal symptom score 
2 PAC-SYM Abdominal symptom score, Mental Component Summary 
3 PAC-SYM Abdominal symptom score, 
Mental Component Summary, PAC- 
SYM stool symptom score 
Appendix B, Table 6. Summary of Analysis of Variance (ANOVA) for forward 
regression strategy 
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Residuals Statistics(a) 
Minimum Maximum Mean 
Standard 
Deviation Number 
Predicted Value 1.13 3.84 2.50 0.56 108 
Residual -1.62 1.46 -0.03 0.51 108 
Std. Predicted 
-2.37 2.36 0.17 0.98 108 Value 
Std. Residual -3.14 2.83 -0.05 0.99 108 
a Dependen t Variable: Overall PAC -QOL score 
Appendix B, Table 7. Summary of residual statistics for forward regression. 
Dependent Variable: Overall PAC-QOL score 
C 
LL. 
lean = -0.09 td. Dev. = 0.989 
= 113 
Appendix B, Figure 2. Histogram of the stanclardised residual for forward regression. 
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Appendix B, Figure 3. Cumulative plot of stanclardised residuals for forward 
regression. 
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Appendix B, Figure 4. Scatter plot of the predicted scores against residuals for 
forward regression. 
296 
Dependent Variable: Overall PAC-001- score 
Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
ANOVA 
Model 
Sum of 
Squares 
Degrees of 
freedom Mean Square F statistic 
p 
value 
1 Regression 22.42 1 22.42 62.69 <0.01 
Residual 33.98 95 0.36 
Total 56.40 96 
2 Regression 28.34 2 14.17 47.48 <0.01 
Residual 28.06 94 0.30 
Total 56.40 96 
3 Regression 31.57 3 10.52 39.42 <0.01 
Residual 24.83 93 0.27 
Total 56.40 96 
Predictor variables included in each model 
model 
1 PAC-SYM Abdominal symptom score 
2 PAC-SYM Abdominal symptom score, Mental Component Summary 
3 PAC-SYM Abdominal symptom score, 
Mental Component Summary, PAC- 
SYM stool symptom score 
Appendix B, Table 8. Summary of Analysis of Variance (ANOVA) for stepwise 
regression strategy 
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Std. Predicted 
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a Dependen t Variable: Overall PAC-QOL score 
Appendix B, Table 10. Summary of residual statistics for stepwise regression. 
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Quality of Life, physiological evaluation and novel treatment in refractory constipation: 
A study of patients from a specialist clinic in the North East of England. 
Minimum Maximum Mean Standard Deviation Number 
Predicted Value 1.13 3.84 2.50 0.56 108 
Residual -1.62 1.46 -0.03 0.51 108 
Std. Predicted 
-2.37 2.36 0.17 0.98 108 Value 
Std. Residual -3.14 2.83 -0.05 0.99 108 
a Dependent Variable: Overall PAC-QOL score 
Appendix B, Table 12. Summary of residual statistics for backwards regression. 
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Group definition Number Sum of ranks 
Mean of 
Ranks 
Rate of infection in FC 8 186 23.25 
Rate of infection in NC 6 68.5 15.33 
Rate of infection in RSV 8 92 8.50 
Rate of infection in 6 59.0 10 00 CPO . 
Kruskal - Wallis statistic 15.26 
p=0.0014 
Dunn's Multiple Comparisons Test 
Comparison Mean rank difference p value 
Rate of infection FC v Rate of infection RSV 14.688 <0.01 
Rate of infection FC v Rate of infection NC 7.917 >0.05 
Rate of infection FC v Rate of infection CPO 13.333 <0.05 
Rate of infection RSV v Rate of infection NC -6.771 >0.05 
Rate of infection RSV v Rate of infection CPO -1.354 >0.05 
Rate of infection NC v Rate of infection CPO 5.417 >0.05 
Appendix C, Table 9. Rate of Infection In different conditions 
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